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E. coli O157:H7 is the most important serotype of enterohaemorrhagic E. coli 
(EHEC) which is of concern to public health worldwide. As a common cause 
of haemorrhagic colitis, EHEC infection can progress to life threatening 
sequelae including haemolytic uraemic syndrome (HUS) in humans. Human 
infection rates are higher in Scotland than found in the rest of the UK. Cattle 
are asymptomatic carriers of EHEC and are an important reservoir from 
which disease outbreaks can spread. The terminal rectum has been indicated 
as a site of E. coli O157:H7 colonisation in the bovine intestinal tract. This is 
the location of numerous lymphoid follicles which contain dendritic cells 
(DCs) which are professional antigen presenting cells and important 
directors of immune responses. DCs are likely to come into contact with 
EHEC and therefore could be key in this location for enabling EHEC to 
colonise the bovine host. The first aim of this project was to characterise 
dendritic cells within the bovine intestinal tract at various anatomical 
locations, including the terminal rectum, using immunohistochemistry 
techniques. Following this, work to extract and further phenotype dendritic 
cells from terminal rectal tissues was undertaken. Finally, a widely-used 
bovine dendritic cell model was employed to generate dendritic cells from 
circulating blood monocytes. This model was utilised to investigate the 
interactions of dendritic cells with EHEC strains compared with responses to 
bovine enterotoxigenic (ETEC) and bovine commensal E. coli strains.  
Early work identified that there are potentially numerous DCs within the 
bovine intestinal tissues and these cells were found in greater numbers at the 
terminal rectum. Protocols to extract and further characterise these cells were 
developed but proved inconsistent, with large variation between animals. 
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Using the monocyte derived dendritic cells (moDCs), differences were 
observed between immunological responses to challenge with E. coli 
O157:H7 strains and bovine pathogenic or commensal E. coli strains. 
Cytokine production, cell surface molecule expression, cell phenotype and 
viability as well as intracellular bacterial counts were compared. The data 
presented here shows that the bovine moDCs respond differently to EHEC 
strains when compared with commensal or pathogenic E. coli in several key 
areas. This has important implications for the responses of the bovine host to 
various E. coli strains. This work also indicates that dendritic cells could be 
central to these responses and if studied further still, may hold the key to 
reducing the colonization and persistence of E. coli O157:H7 in cattle, and 
subsequent human disease outbreaks. 
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TTC   2,3,5 Triphenyl Tetrazolium chloride 
TTP   Thrombotic thrombocytopaenic purpura 
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TTSS   Type three sectretion system 
U   Units 
UPEC   Uropathogenic E.coli 
UV   Ultraviolet 
VLA   Veterinary Laboratories Agency 
v/v   Volume per volume 
vol   Volume 
V   Volt 
VT   Verotoxin 
VTEC   Verotoxigenic E. coli 
VTRI   Veterinary Training and Research Initiative 
WT   Wild type (bacterial strain) 
w/v   Weight per volume 
ZSF   Zinc salts fixative 
Δ (delta) in front of a gene name to denote that the gene has been 
deleted 
μg   Microgram 
μl   Microlitre 
μm   Micrometer 

























1.1 Escherichia coli 
Escherichia coli are Gram negative facultative anaerobic bacilli of which 
numerous strains have been identified not only in diverse animal species but 
also at varied anatomical locations. As a predominant component of 
mammalian intestinal microflora, many strains of E. coli can be of benefit to 
the host. However, pathogenic strains can severely affect human and animal 
health. It is because of this potent health risk that E. coli has been the focus of 
much research over the years. 
 
As a member of the Enterobacteriaceae family, E. coli are related to several 
other bacterial genera which are causative of a wide range of diseases.  These 
strains include Salmonella, Shigella, Yersinia, Citrobacter and Klebsiella. The E. 
coli species is, however, of particular interest because strains can have very 
divergent roles. These may range from harmful pathogenic strains, causing 
serious, sometimes fatal, infections to commensal strains which provide 
important benefits to the host. Enteric disease, urinary tract infections and 
septicaemia meningitis can all be caused by pathogenic E. coli strains.  Non-
pathogenic strains, too, can cause pathology and disease if disruptions in the 
host defences allow access to the body. This can be the case in 
immunosuppression, or if the host is compromised by some other disease 
process or in some other way, and this is the case for many predominantly 
harmless organisms which can be termed opportunistic pathogens. E. coli 
strains that are pathogenic often carry specific arrays of virulence factors; the 
commensal types tend not to possess these. Pathogenicity factors can be 
essential in eliciting disease by disrupting host physiological mechanisms. 
Different strains employ different pathogenicity factors and can show host 
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and tissue specificity in the species and anatomical environments in which 
they have their main effects.  
 
Pathogenic E. coli strains which predominantly cause gastrointestinal disease 
are shown in table 1.1. Of these strains, enterohaemorrhagic E. coli (EHEC), 
which is the focus of this study, are most closely related to enteropathogenic 
E. coli (EPEC) strains. Enterotoxigenic E. coli (ETEC) are also important 
intestinal pathogens of animals and man which have been utilised for 
comparative experiments within this work. The ETEC pathotype is 
introduced further in section 1.1.2.1. 
 
1.1.1 Commensal E. coli 
Commensal bacteria are found in the gastrointestinal tract, without causing 
harm, even though there are around 1011 bacteria per gram of intestinal 
contents. Indeed, commensal micro-organisms play vital roles in host 
metabolism, host immune system development and prevention of infiltration 
of pathogenic bacteria (Niedergang & Kweon, 2005). Intestinal commensal E. 
coli strains have been shown to provide nutrients for the host as well as 
playing a role in protection against colonisation and infection by pathogenic 
species of bacteria (Dam, 1935; Hudault et al., 2001; Mann & Westblom, 1999; 
Price, 1988). Non-pathogenic E. coli strains have been investigated in human 
patients as potential pro-biotic organisms. For example the Mutaflor E. coli 
isolate (Nissle 1917), has shown effects on the intestine by reducing the 
colonisation by pathogenic strains and having some efficacy in the 
therapeutic regimens of inflammatory bowel disorders IBD and Crohn’s 
Disease (Kamada et al., 2008; Lodinova-Zadnikova et al., 2003; Lodinova-
Zadnikova & Sonnenborn, 1997; Trebichavsky et al., 2010). 
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Watery diarrhoea +/- blood, 
progressing to HC and systemic 
disease 






Watery diarrhoea in naïve adults 
and weaning diarrhoea in 
young children 
6, 8, 11, 15, 20, 25, 27, 
78, 128, 148, 149, 159, 173 
Heat labile (LT) 
and/or 




Watery diarrhoea in young 
children and animal species 
 
26, 55, 86, 111, 114, 119, 
125, 126, 127, 128, 142, 158 
Possible proteins 





Persistent mucoid diarrhoea 
predominantly in developing countries 








28ac, 29, 112ac, 124, 136, 






Watery diarrhoea, often in children O126:H27 None Described 
 
Table 1.1 Diarrhoeagenic E. coli of animals and man. Data compiled from Nataro & Kaper 1998, and Scmidt, 2010. HC: Haemorrhagic Colitis, 
VT: Verotoxin, EAST1: Enteroagregative heat-stable toxin, PET: plasmid-encoded heat-labile toxin ( 1994; Nataro & Kaper, 1998; Schmidt, 2010).
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1.1.2 Pathogenic E. coli  
As already mentioned there are numerous pathogenic strains of E. coli, which 
cause disease in a variety of species and diverse body systems. This study 
focuses on E. coli O157:H7, and also utilises ETEC for comparative purposes, 
therefore, it is these two which will be introduced here. Pathogenic E. coli are 
reviewed by Kaper et al. 2004 in more depth than can be included in this 
study (Kaper et al., 2004).  
 
1.1.2.1 Enterotoxigenic E. coli (ETEC) 
Enterotoxigenic E. coli are responsible for intestinal disease. They are a 
common cause of human diarrhoea world-wide, and are often the cause of 
what is commonly known as ‘traveller’s diarrhoea’. As many as 20 - 60 % of 
travellers new to areas such as those of the developing world may succumb 
to ETEC infection. Also a problem in these areas is the numerous cases of 
infant diarrhoea that occur at the time of weaning. Around 10 – 30% of cases 
of infant diarrhoea are thought to be caused by ETEC (Elliott et al., 1999; 
Nataro & Kaper, 1998). Antibiotic resistance is increasing, but as the infective 
dose required for infection is high and exposed individuals develop mucosal 
immunity, hygiene has to be the cornerstone of prevention strategies (Nataro 
& Kaper, 1998). As important as ETEC is as a human pathogen, it was first 
discovered in piglets and remains a significant cause of death of neonates of 
this species (Wilson & Francis, 1986). ETEC also cause diarrhoea in cattle and 
are, in fact, the most common cause of diarrhoeal signs in calves in the first 
seven days of life (Moxley & Smith, 2010). ETEC are non-invasive but can 
colonise the GI tract and cause diarrhoea by binding to the host intestinal 
cells and causing secretion of fluids and electrolytes. ETEC adhere to 
intestinal epithelia by means of fimbriae, and the fimbrial type directs host 
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pathogenicity with K99 causing disease in calves, lambs and pigs (Cassels & 
Wolf, 1995). ETEC also produce toxins: a heat labile enterotoxin (LT) and a 
heat stable toxin (ST), which affects host cells by activating cellular enzymes 
(adenylate and guanylate cyclases respectively) and this initiates a sequence 
of events which induces large volumes of fluid to accumulate within the 
lumen of the gut (Gill & Richardson, 1980). This leads to profuse watery 
diarrhoea and ensuing dehydration which in young humans and animals can 
prove fatal if steps are not taken to maintain fluid intake. 
1.1.2.2 Enterohaemorrhagic E. coli (EHEC) 
Enterohaemorrhagic E. coli (EHEC) was first discovered as a cause of human 
intestinal disease in the 1980s when cases of haemorrhagic colitis (HC) were 
observed (Riley et al., 1983). The serotype O157:H7 has since been indicated 
to be involved in outbreaks of disease worldwide and E. coli O157:H7 is the 
most widely documented member of the enterhaemorrhagic group and 
indeed the term EHEC is often used solely to describe this organism. The 
first human infection was traced back to fast food restaurants serving 
hamburgers in USA (Riley et al., 1983), and was thought to have spread 
during the abattoir or meat preparation process from infected animals at 
slaughter. Not all cases have been caused by this route and in fact confirmed 
cases have been food- and water-borne as well as following direct contact 
with infected animals. However, animals as a reservoir of infection play an 
integral role in many outbreaks whether directly or indirectly. 
 
The early signs of human EHEC infection include abdominal pain and 
watery diarrhoea. In some case this can progress to haemorrhagic colitis 
(HC) with significant blood loss through the intestinal wall (Riley et al., 1983). 
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Some patients, in particular young children and the elderly may be affected 
by more serious sequelae such as Haemolytic Uraemic Syndrome (HUS) 
(Griffin & Tauxe, 1991). HUS can be characterised by microangiopathic 
haemolytic anaemia, thrombocytopaenia and acute renal dysfunction or 
failure. The effect of VT acting on the blood vessel endothelial cells in 
particular within the kidney is the cause of these life-threatening sequelae 
(Karmali et al., 1983). Neurological symptoms and disorders can also result 
from EHEC infection with or without a preceding diarrhoeal episode. 
Thrombotic thrombocytopenic purpura (TTP), which presents as a 
neurological process is usually observed in adult patients (Pickering et al., 
1994).  
 
Symptomatic treatment is at present the only route open to the medical 
profession, as there is no specialised treatment for human EHEC infection. 
Fluid therapy and generic treatments for intestinal disorders and damage are 
commonly used and dialysis when the severity of kidney damage warrants 
this. No adequate studies have been carried out into the use of antibiotics 
preventing the progression of disease in EHEC infection, although some 
reports suggest an effect when used early in treatment. (reviewed in (Nataro 
& Kaper, 1998)). Successful treatment and control methods for this severe 
and sometimes fatal condition would undoubtedly be of great benefit for 
human health. As vaccines can in some cases be used in the face of a disease 
outbreak as treatment (for example influenza), a full understanding of the 
immune responses involved and work towards a vaccine strategy in the 




1.2 E. coli O157:H7 Epidemiology 
Although E. coli O157:H7 is the serotype most commonly found worldwide  
(Gyles, 2007), other EHEC serotypes have also been found in limited 
geographical areas. For example, E. coli O157:H- (sorbitol-fermenting) 
isolates were discovered following outbreaks of human disease only in 
continental Europe until the same organism was recently found to be the 
cause of outbreaks in Scotland (Karch & Bielaszewska, 2001).  
 
Host factors are likely to play an important role in disease progression 
following EHEC infection, as a wide range of outcomes have been observed. 
The more serious sequelae occur with increased regularity in children and 
elderly patients. Healthy adults may only suffer with watery diarrhoea, and 
it has even been known for these patients to be asymptomatic (Rios et al., 
1999; Silvestro et al., 2004; Wilson et al., 1996). Most human outbreaks of 
disease have been linked to bovine hosts and consumption by humans of 
faecally- contaminated goods such as undercooked meat, unpasteurised 
milk, vegetables, fruit juices or drinking water (Besser et al., 1993; Borczyk et 
al., 1987; Licence et al., 2001; Morgan et al., 1988; Riley et al., 1983; Swinbanks, 
1996; Yarze & Chase, 2000). In the UK, human contact with infected farm 
animals or environments is by far the most common route of EHEC 
infections, and this occurs with a greater frequency than food-borne infection 
(Locking et al., 2001; O'Brien et al., 2001). Wild animals may be important in 
the spread of EHEC between farms via contact with livestock (discussed 
further in section 1.4). Although numerous hosts have been found for E coli 
O157:H7; cattle are the reservoir of infection of most concern for human 
health (Kassenborg et al., 2004; Locking et al., 2001; O'Brien et al., 2001). This 
is of particular importance in the UK where prevalence of EHEC in cattle is 
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estimated to be around 4.7% in England and Wales and as high as 8.6% in 
Scotland (Paiba et al., 2002; Synge & Paiba, 2000) (Fig.1.1.), compared to just 
2% found in the herds in Japan, Australia and the USA (Cobbold & 
Desmarchelier, 2000; Faith et al., 1996; Miyao et al., 1998). The data for 
incidence of human infection follows the trend of levels of cattle prevalence 
as Scotland has consistently higher numbers of cases than the rest of the UK 
(Locking et al., 2006; Lynn et al., 2005). Clearly, the carriage of EHEC by cattle 
has a significant impact on public health. The number of outbreaks is 
increasing each year and so there is a real need to research all aspects of E. 















Fig. 1.1 Prevalence of E. coli O157:H7 in areas of the UK. (Adapted from Locking et al, 
2006: data collated from Health Protection Scotland and Health Protection agencies). 
Historically cases of E. coli O157:H7 have been consistently higher in Scotland than in the 
rest of the UK. 
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1.3 Control of human EHEC infections 
There is no specific treatment for established EHEC infection in humans, as 
mentioned earlier, and so prevention of infection is likely to be of greatest 
benefit to public health. During an outbreak, E. coli O157:H7 can spread 
easily and quickly between patients if stringent hand and food preparation 
hygiene are not observed. The number of organisms required to cause 
disease is thought to be small. A couple of studies have addressed this area, 
one concluded that the infective number of organisms is in the region of 20 -
700 (Tuttle et al., 1999), and another proposes that the number of bacteria 
required to cause infection is less than 100 (Willshaw et al., 1994). Thus a 
reduction of EHEC in environmental and animal reservoirs should be the 
cornerstone of any prevention strategy. Targeting the bovine host to reduce 
its impact as an important reservoir of infection could in turn reduce the 
number of human outbreaks. Basic hygiene methods, in particular 
concentrating on drinking water, feed and pens could go some way to 
reducing human disease (Dodd et al., 2003; Garber et al., 1999; LeJeune et al., 
2001; Smith et al., 2001). Asymptomatic carriage of E. coli O157 by humans is 
difficult to estimate; it has been observed infrequently during outbreaks 
however it could be a more widespread event because stool samples are 
rarely collected from people who do not show clinical symptoms of disease. 
E. coli O157:H7 has been found in several species of wild animals including 
animals that graze similar pasture to cattle herds (section 1.4). It is possible 
that wildlife could be contributing to the spread of this organism between 
herds or enabling its persistence within a herd. Reducing probable contact 
between cattle and wildlife is therefore an area to consider for control of this 
disease. Because EHEC has caused disease in humans following ingestion of 
contaminated meat, aiming to reduce carriage of the organism prior to 
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slaughter has been suggested. Research into dietary controls before 
slaughter, namely choosing a hay diet over grain, to adjust intestinal acidity 
has undergone some early testing but has not been proven in a large scale 
study (Diez-Gonzalez et al., 1998; Hovde et al., 1999).  
 
Antimicrobial agents have been investigated with a view to control of EHEC 
(Elder et al., 2008), however there are disadvantages with this method that 
could prove detrimental to both human and animal health. Antimicrobial 
treatment not only alters normal intestinal flora, having downstream effects 
on host digestion, but also selects for antibiotic-resistant bacterial strains. 
 
Production of a vaccination for E. coli O157:H7 is also an interesting area of 
research and although several ideas have been put forward an effective 
vaccine is yet to arrive on the market (Ahmed et al., 2006; Dean-Nystrom et 
al., 2002; Konadu et al., 1999; McNeilly et al., 2008; Potter et al., 2004). 
Development of an effective vaccine will only be possible with a solid 
understanding of host immune responses. In particular, the early interactions 
with host immune cells are an important area of investigation for the 
assessment of whether it is possible to harness or alter these interactions to 
reduce carriage and spread of O157:H7 or the pathogenic sequelae of 
colonisation. It is important to understand how E. coli O157:H7 can colonise 
and persist in the bovine host without causing overt clinical disease. 
 
Mouse models have been used to assess the efficacy of bacteriophages to 
prohibit E. coli O157:H7 and while this has been successful, these methods 
have yet to be proven in the bovine host (Sheng et al., 2006). Probiotic 
bacteria, most commonly Lactobacillus acidophilus, are suggested to reduce 
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numbers of pathogenic strains of bacteria within the bovine intestine. This 
Lactobacillus strain is widely obtainable in the United States as a feed additive 
(Elam et al., 2003). Probiotic E. coli strains have also been assessed for their 
potential to reduce EHEC carriage in ruminants with some success 
(Hakkinen & Schneitz, 1996; Schamberger et al., 2004; Schamberger & Diez-
Gonzalez, 2004; Tkalcic et al., 2003; Zhao et al., 1998).  
1.4 Animal hosts 
Several animal hosts may also be sub-clinical carriers of E. coli O157:H7 and 
it has been discovered in several species to date. Ruminants are the most 
common carrier of EHEC, while cattle are the predominant source of human 
disease, goats (Bielaszewska et al., 1997) and sheep (Ogden et al., 2002) have 
also been implicated in outbreaks.  EHEC has, in addition, been detected in 
other domestic species including pigs, dogs, cats and chickens (Beutin et al., 
1993; Doyle & Schoeni, 1987; Griffin & Tauxe, 1991; Nakazawa & Akiba, 
1999) Wildlife species which often share the same grazing grounds as cattle 
too have been discovered as reservoirs of infection, and has been 
demonstrated for both deer and rabbits (Garcia & Fox, 2003; Garcia-Sanchez 
et al., 2007; Pritchard et al., 2001; Renter et al., 2001). However cattle are 
deemed to be the principal reservoir hosts, and have on many occasions been 
confirmed as the source of organisms responsible for disease outbreaks 
(Besser et al., 1993; Chapman, 2000; Riley et al., 1983).  
1.5 EHEC in cattle  
The carriage of E. coli O157:H7 by cattle is of obvious importance to human 
outbreaks of disease; however cattle are largely asymptomatic carriers. Only 
very young calves have been shown to develop clinical symptoms of 
diarrhoea associated with the presence of E. coli O157:H7 (Kang et al., 2004). 
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Other human EHEC serotypes however, such as O5, O26 and O118, have 
caused diarrhoeal symptoms in weaned cattle associated with the presence of 
massive attaching and effacing (A/E) lesions along the large intestine 
(Moxley & Smith, 2010; Stordeur et al., 2000). The haemorrhagic symptoms 
seen in man are not replicated in the bovine situation except for in very 
young calves and similar to the human case, because there are no specific 
treatments, it is only possible to provide symptomatic care (Pearson et al., 
1999; Sandhu & Gyles, 2002; Stevens et al., 2002; Wieler et al., 1996). The 
above strains that cause bovine diarrhoea have their effect along the length of 
the bovine large intestine. E. coli O157:H7 however has been found to 
primarily locate to the recto-anal junction (RAJ) (Lim et al., 2007; Low et al., 
2005; Naylor et al., 2003). It was thought that O157:H7 could colonise 
multiple intestinal sites in the bovine host and early research suggested a 
general predilection for large intestinal areas (Brown et al., 1997; Cray, Jr. & 
Moon, 1995; Dean-Nystrom et al., 1998; Laven et al., 2003). Later it was noted 
that large intestinal colonisation was found up to 16 days post infection, yet 
faecal shedding of the organism was still occurring at 34 days (Grauke et al., 
2002). More recently it has been shown that this extended shedding could be 
due to colonisation of the terminal rectum where the O157:H7 organisms 
were found to localise to the terminal intestine up to 5 cm proximal to the 
RAJ following experimental infection (Naylor et al., 2003). Naturally 
colonised cattle have since been shown to demonstrate this colonisation 
pattern also (Lim et al., 2007; Low et al., 2005).  
 
Bovine ‘super-shedders’ have been identified and it is suggested that they 
are largely responsible for the dissemination of E. coli O157:H7 in cattle herds 
and therefore are an important risk factor for human health (Chase-Topping 
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et al., 2007; Matthews et al., 2006a; Matthews et al., 2006b). Persistent rectal 
colonisation has been proposed to be an element of such ‘super-shedders’ 
(Cobbold et al., 2007) The organism enters the environment coating the faecal 
matter as it passes through the RAJ and as such it allows infections to persist 
within herds.  
 
The terminal rectal localisation of E. coli O157:H7 may indicate an important 
area for research into a targeted approach to reducing the carriage of this 
organism by cattle.  
 
 The last 5cm of bovine intestines are densely populated with lymphoid 
follicles (LF) which contain large numbers of immune cells (Parsons et al., 
1989). This population of immune cells is likely to come into contact with the 
E. coli O157:H7 bacteria (via several methods discussed further in section 
1.10.1 and Fig. 1.5), and as such could be an important area of study with the 
aim to target control of this organism within the cattle herds. Although the 
terminal rectum is fairly accessible in terms of treatment, for example by 
topical application of an antimicrobial, this may however not be a practical 
solution. This method has been investigated under experimental conditions 
and has shown some ability to reduce shedding of the organism; however 
this is yet to be implemented or investigated in naturally-infected cattle 
(Naylor et al., 2007).  
 
The carriage and shedding into the environment of E. coli O157:H7 by cattle 
is an obvious risk factor for human infection. Cases of infection occur 
following contact with infected animals or their environments (Chapman, 
2000) or following ingestion of contaminated food or water (Besser et al., 
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1993; Riley et al., 1983; Yarze & Chase, 2000). Reducing the contamination of 
environments and the food chain by cattle is likely to have its effect by 
reducing the outbreaks of human illness and so is an important area of 
investigation. 
 
1.6 Colonisation and virulence factors of E. coli O157:H7 
The mechanisms of pathogenicity employed by EHEC are numerous and 
multifaceted. The ways in which EHEC has developed to evade host 
defences and cause disease are multitudinous. Key virulence factors of E. coli 
O157:H7 are Verotoxin (VT), a type three secretion system (TTSS), and 
flagella, although other factors also contribute. 
 
1.6.1 Attaching and Effacing lesions (A/E lesions) 
Attaching and effacing lesions (A/E lesions) are a histopathological finding in 
EHEC infections. Intestinal epithelium has its brush border microvilli 
destroyed and the bacteria are then found intimately attached to the 
epithelial cells. A pedestal-like structure can be seen and is formed by 
reorganisation of the host cell cytoskeleton (Frankel et al., 1998). The genes 
which encode the A/E phenomenon are found within the Locus of Enterocyte 
Effacement (LEE). The LEE is likely to have arisen in E. coli through 
horizontal transfer from another bacterial species. This has been postulated 
due to its lower content of C and G than the rest of the E. coli chromosome. 
The A/E phenotype is determined by this LEE, which is a 35.5kbp 
pathogenicity island (McDaniel et al., 1995). This A/E phenotype of EHEC is 
determined by LEE genes which are arranged as five operons (LEE1 to 5) 






Fig.1.2. Organisation of the genes of the E. coli O157:H7 LEE  
Adapted from Castillo et al. 2005 and Garmendia et al. 2005 (Castillo et al., 




separate part of the genome to form the A/E lesions (Elliott et al., 1999; 
McDaniel & Kaper, 1997). Several cytoskeletal proteins are directed to the 
EHEC attachment site including structural and effector proteins (Cantarelli et 
al., 2002; Goosney et al., 2001; Ismaili et al., 1995). A translocated intimin 
receptor (Tir) encoded by EHEC requires E. coli secreted protein Fu (EspFu) a 
proline rich actin assembly effector protein (Campellone et al., 2004). EspFu or 
Tir-cytoskeleton coupling protein (TccP) is a novel, non-LEE encoded EHEC 
effector protein that has been shown to be similar to the host adaptor protein 
Nck (non-catalytic region of tyrosine kinase). EHEC-encoded Tir requires 
this TccP to mediate the EHEC neuronal Wiskott-Aldrich Syndrome protein 
(N-WASP) signalling (Campellone et al., 2004; Garmendia et al., 2004). TccP 
has an effect on the recruitment of α-actinin, actin-related protein 3 (Arp3), 
N-WASP and actin to the bacterial adhesion site.  This condensation of F 
actin produces the effacement and intimate attachment and results in the 
characteristic pedestal formation. 
 
1.6.2 TTSS 
An essential part of the A/E lesion is the formation of a functional Type Three 
Secretion System (TTSS) (Jarvis et al., 1995; Jerse et al., 1990) (Fig.1.3). The 
TTSS is encoded by the E. coli secretory genes (esc genes) found at LEE1, 2 
and 3 (Elliott et al., 1998; Kaper, 1998; Perna et al., 1998). Following contact of 
the bacterium with the host cell the TTSS can allow proteins to be directly 
inserted into the cytoplasm of the host cells. These proteins travel through 
the TTSS across both the bacterial and host cell membranes (Hueck, 1998). 
The complex through which secreted effector proteins reach the host cell 
cytoplasm is formed by bacterial secreted proteins EspA, B and D (E. coli 




















Fig. 1.3 Diagrammatic representation of the structure of the Type Three Secretion 
System (TTSS) of E. coli O157:H7. The tube-like arrangement of the TTSS facilitates its 
function to secrete effector molecules directly into the host cell cytoplasm. The long EspA 
structure protrudes from the bacterial outer membrane connected to the EspF needle 
complex. The effector molecules travel through this assembly eventually emerging through 
an EspB and EspD pore in the host cell plasma membrane. This apparatus is anchored to the 
bacteria via the basal body of EscR, S, T, U, & V proteins within the inner membrane, the 
transmembrane EscJ, and the outer membrane EscC ring. EscN provides energy for the TTSS 




 structural protein and forms the needle of the TTSS. The proteins which 
form the pore are EspB and EspD (Delahay et al., 1999; Garmendia et al., 2005; 
Ogino et al., 2006). Operon LEE5 encodes eae and tir genes. Eae encodes for 
intimin, an outer membrane protein whose receptor Tir (translocated intimin 
receptor) is inserted into the host cell and becomes part of the host cell 
membrane.  
 
The role of the TTSS may well be more wide reaching than initially thought. 
Bioinformatic analysis of the E. coli O157:H7 genome has yielded several 
additional potential effector proteins and further studies confirmed that at 
least 39 of these are injected into the host cell (Tobe et al., 2006) although 
functions are yet to be ascribed to them all. 
 
To conclude, the TTSS has effects that are wide ranging and still to be fully 
defined. It plays a role in affecting the host cells to the likely benefit of the 
bacterium and knowledge of the methods by which it does this are likely to 
evolve as further work is carried out into the nature of the effector proteins. 
 
The LEE also contains other smaller operons and ORFs (open reading 
frames) which encode for other proteins, many of which have roles in 
changing the host cell cytoskeletal structure. EspF (Crane et al., 2001) and 
Map (mitochondrial associated protein) (Kenny & Jepson, 2000) are likely to 
interfere with transepithelial resistance and mitochondrial membrane 
potentials (McNamara & Donnenberg, 1998; McNamara & Basbaum, 2001). 
Map, EspH (Tu et al., 2003) and EspB modulate the host cell skeleton and 
initiates filopodia. EspF also plays a significant role in the initiation of cell 
death (Crane et al., 2001; Viswanathan et al., 2004). EspG has been shown to 
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disrupt the microtubule network (Tomson et al., 2005). A chaperone protein 
for Tir, CesT is also encoded (Abe et al., 1999). There are several LEE-encoded 
effector proteins that have not as yet been assigned a function for example 
EspZ. There are other TTSS effector proteins that are non-LEE encoded, 
NleA, NleB, NleC, NleD, NleE, NleF and NleH (Deng et al., 2004; Gruenheid 
et al., 2004; Kanack et al., 2005). Of these, NleA may inhibit host cell protein 
export (Kim et al., 2007) and it is proposed that NleD is somehow involved in 
the colonisation of calves in the experimental environment. The exact role 
which it plays has not been established (Dziva et al., 2004).  
 
LEE1 encodes Ler, which regulates the expression of LEE-encoded operons. 
This regulator allows the TTSS to be expressed at the most useful time 
during the interaction between the bacterium and the host cells. Ler 
upregulates virulence factors (both LEE-encoded and non-LEE-encoded) 
(Friedberg et al., 1999; Mellies et al., 1999; Sanchez-Sanmartin et al., 2001; 
Sperandio et al., 2000). Quorum sensing may be a factor in the initiation of 
the transcription of the LEE-encoded genes (Sperandio et al., 1999).  
 
1.6.3 Tir & Intimin 
Intimin is an adhesin which is central in the process of forming A/E lesions 
(Deibel et al., 2001; Kenny et al., 1997; Kenny & Finlay, 1997). A second 
method in which intimin is proposed to have a role in adherence is 
interaction with nucleolin, a host protein. This method is Tir independent 
(Sinclair & O'Brien, 2002). Intimin is a 94 - 97 kDa outer membrane protein 
which the bacterial cells use to become intimately attached to the host cells. 
The TTSS injects the Tir, intimin’s primary receptor, into the host cell which 
enables this attachment to take place. Binding of intimin to Tir causes 
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Phosphorylation of Tir’s C-terminal 170 amino acids which precedes actin 
polymerisation. Following intimin/Tir binding, the actin polymerisation 
which occurs forms the pedestal part of the A/E lesion (Cantarelli et al., 2002; 
Goosney et al., 2001). This intimate adherence allows bacterial microcolonies 
to form on host cells. Underneath the microcolonies on the cell surface 
aggregation of filamentous actin (F-actin) occurs which gives rise to 
effacement of the microvilli and formation of the pedestal like structures. Tir, 
as well as acting as a receptor for intimin also initiates this pedestal 
formation. 
 
At present there has been found to be 14 different intimin types, which have 
been named using Greek letters α (alpha) to ξ (xi) (Adu-Bobie et al., 1998; 
Agin et al., 1998; Agin & Wolf, 1997; Jores et al., 2003; Oswald et al., 2000; Tarr 
& Whittam, 2002; Zhang et al., 2002). In vitro organ culture (IVOC) 
experiments have shown that substitution of the intimin type will change the 
tropism of E. coli (Fitzhenry et al., 2002; Hartland et al., 1999; Phillips et al., 
2000). This may indicate a receptor independent of Tir such as the intimin γ 
attraction for nucleolin in E. coli O157:H7 (Sinclair & O'Brien, 2002). This 
suggests the possibility that these subtypes of intimin play a role in tissue 
and host specificity. A role for intimin-Tir binding has been found in the 
colonisation of ruminants. A/E lesions have been observed on both bovine 
and ovine intestinal tissues infected with EHEC, even though these hosts 
generally remain sub-clinical (Cornick et al., 2002; Dean-Nystrom et al., 1998; 
Naylor et al., 2005a; Naylor et al., 2005b; Woodward et al., 2003).
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1.6.4 Verotoxin (VT) 
A key virulence feature of many bacteria is the ability to produce toxins. EHEC 
produces a toxin called verotoxin (VT), named for its potent ability to rapidly 
kill Vero cells. This toxin is also termed Shiga-toxin (Stx) as it is closely related to 
the toxin produced by Shigella dysenteriae. For these reasons EHEC are also 
known as Shiga-toxigenic E. coli (STEC) or Vero-toxigenic E. coli (VTEC). EHEC 
has acquired the VT genes via integrative bacteriophages (Konowalchuk et al., 
1977; Scotland et al., 1983). Translocation of VT across the intestinal interface is 
responsible for serious human illness from intestinal, renal and CNS 
complications and can ultimately be fatal (Frankel et al., 1998). VT mediates 
disease processes in several ways. Locally, diarrhoea follows from the 
disruption of epithelial integrity, and this can progress to haemorrhagic 
diarrhoea due to damaged mucosal blood vessels. Systemically, if the toxin 
becomes disseminated several body systems may be affected with the most 
serious affects observed on the kidneys, the circulatory vasculature and the 
neurological tissues. These effects can progress the clinical condition to include 
HUS, TTP or neurological deficits (O'Brien & Holmes, 1987).  
 
There are two sub-groups of VT, named VT1 and VT2; these can be expressed 
individually or together by E. coli O157:H7 strains (Scotland et al., 1983; 
Strockbine et al., 1986). VT1 is highly conserved, but VT2 has multiple variants, 
these two groups vary in toxicity and affinity for tissues (Jacewicz et al., 1999). 
The structure of VT is relevant to its function. There are two subunits termed A 
and B forming a structure comprising a single central A subunit surrounded by 
5 B subunits. These B subunits bind to a receptor found on eukaryotic cells, 
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called globotriaosylceramide (Gb3 or CD77) (Lingwood, 1996) and the toxin is 
then internalised into the cell cytosol (Sandvig & van, 2002). During this process 
the A subunit is cleaved to facilitate its action. Furin, a protease, cleaves the A 
subunit to release A1 peptide which is inhibitory to cellular protein synthesis by 
affecting the 28S subunit of 60S rRNA. Affected cells undergo apoptosis due to 
this inhibitory effect on vital protein synthesis as well as other proposed 
mechanisms such as VT inhibition of cellular anti-apoptotic factors and 
triggering of caspase and mitochondrial apoptosis pathways (Erwert et al., 2003; 
Tetaud et al., 2003).  
 
VT action on host cells is clearly a key determinant of pathogenicity and the 
progression of disease in human EHEC infection. Epithelia are the first cells to 
come into contact with EHEC following ingestion and although human epithelia 
lack the VT receptor CD77; these interactions are an important factor in the local 
effects of EHEC and VT (Holgersson et al., 1991; Kasai et al., 1985). VT in the sub-
epithelial tissues targets endothelial cells of the vasculature, causing 
haemorrhagic conditions. The epithelia are induced to produce several pro-
inflammatory cytokines by VT; these include IL-1, TNFα, IL-6 and IL-8. These 
can cause inflammatory damage to the intestinal tissues as well as providing 
signals to stimulate infiltration of phagocytic cells (Harel et al., 1993; Tesh et al., 
1994; Thorpe et al., 1999; Yamasaki et al., 1999). Of these cells CD77+ phagocytes 
may take up VT and facilitate spread of the toxin around the body, and this 
factor is important for the development of systemic complications (Hurley et al., 




Although VT has been detected in the faecal matter of cattle colonised with 
EHEC, these animals remain clinically normal (Ball et al., 1994; Hyatt et al., 2001). 
However, anti-VT antibodies have been detected in the serum and colostrum of 
colonised cattle, suggesting that the bovine immune system does indeed 
recognise VT (Johnson et al., 1996; Pirro et al., 1995).  
 
These disparate consequences to VT in human and bovine hosts could be due to 
a number of factors. VT may be important in cattle for modulating the mucosal 
immune response and reducing local tissue damage as VT has been shown in 
vitro to affect immune cells by reducing proliferation of PBMCs and limiting 
cytokine production by intestinal lymphocytes (Menge et al., 2004; Menge et al., 
1999). This could be an important factor for the species differences because if the 
pro-inflammatory effects of the immune cell populations, including dendritic 
cells (DCs), are reduced in vivo, then a consequent reduction in tissue damage 
and limiting of systemic features is likely to ensue, as well as potentially 
permitting persistent colonisation with EHEC (Westerholt et al., 2003). There 
could however be other elements to these disparate responses relating to CD77 
expression. In cattle CD77 is not expressed by vascular endothelial cells 
(Pruimboom-Brees et al., 2000), and the CD77 expressing crypt cells of the 
intestinal tissue have been shown to internalise VT into lysosomes which results 
in functional abrogation (Hoey et al., 2003).  
 
1.6.5 Flagella 
Flagella are an important virulence factor as they confer motility on bacteria 
enabling them to effectively select preferred microenvironments (Monday et al., 
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2003). E. coli flagella have been implicated in several modes of virulence 
including roles in adhesion, microcolony formation, and persistence (Giron et 
al., 2002; La Ragione et al., 2000; Mahajan et al., 2009). H7 flagellin has been 
implicated in mucus binding in the intestine, which could point to a role in early 
localisation of bacteria to the intestinal surface (Erdem et al., 2007). H7 has also 
been demonstrated to produce specific serum IgA responses in E. coli O157:H7 
challenged cattle (McNeilly et al., 2008). The structure and functions of the 
EHEC flagella share some aspects with the TTSS. The assembly of the flagella 
filaments is similar to the mechanisms involved in TTSS injection of effector 
proteins into host cells, with exported flagellin molecules travelling down the 
centre of the structure to be assembled at its distal end (Galan et al., 1992; 
Macnab, 2003). Polymerised flagellin monomers form chains to make up the 
long filamentous structure of the flagella. These filaments are anchored to the 
bacterium via a membrane embedded rotary motor and hook (Macnab, 2003). 
 
Flagella are recognised by the host innate immune system via toll-like receptor 
(TLR) -5 (Hayashi et al., 2001). This is one of ten related pattern recognition 
receptors (PRR) which are discussed further in section 1.9.1. Binding of the 
highly conserved D1 region of the flagellin monomer to the TLR5 receptor on 
the host cell surface initiates signalling which prompts various defences for 
example mucin, antimicrobial peptides, nitric oxide and IL-8 (Eaves-Pyles et al., 




1.7 Pathogenic Bacteria and the Intestinal Environment 
There are numerous ways in which hosts have developed to prevent 
colonisation and disease with pathogens. Both structural and functional 
adaptations aim to circumvent the pathogenicity factors of common disease-
causing microorganisms.  
 
1.7.1 Intestinal microflora 
As mentioned previously, there can be approximately 1011 commensal bacteria 
per gram of intestinal contents within the colon, which can consist of up to 500 
various bacterial species (Eckburg et al., 2005; Evaldson et al., 1982). The bacteria 
and their hosts have a symbiotic relationship whereby hosts provide favourable 
environments in terms of nutrients and temperature and the microorganisms in 
turn provide some protection from cellular insult, regulation of lipid storage, 
stimulation of development of the mucosal tissues and inhibition of colonisation 
by pathogenic bacteria (Backhed et al., 2004; Rakoff-Nahoum et al., 2004; 
Stappenbeck et al., 2002). The normal intestinal flora is important for 
development of the gut associated lymphoid tissue (GALT) as well as epithelial 
function (Steege et al., 1997), and this feature is highlighted in the intestines of 
animals which are reared in germ-free environments. These animals have a 
much thinner gut wall with smaller areas of GALT, compared to conventionally 
reared animals. 
 
Although under normal circumstances commensal bacteria are harmless, the 
study of some human intestinal diseases suggests that the way in which the host 
perceives bacteria, either as pathogen or commensal, can depend upon host 
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‚sensing‛ and responding to microbial stimuli as much as factors associated 
with the bacterial strain. For instance, inappropriate inflammatory responses in 
Crohn’s disease and Inflammatory Bowel Disease can cause significant damage 
to the normal structure and function of the gastrointestinal system; and these 
have been proposed to be instigated in part by commensal bacterial flagellin 
(Lodes et al., 2004; Sansonetti, 2004). Moreover, for protection of the gut and 
optimal intestinal function it is important that inflammatory responses are 
generated against pathogenic bacteria without responses directed at the 
commensal types which may share many of the same features. 
 
1.7.2 Intestinal physiology and anatomy  
A common feature of many of the diarrhoeagenic E. coli including O157:H7 
strains is that they are able to colonise the intestinal tract despite numerous 
physiological and structural host factors designed to make the intestine a sub-
optimal environment for such accomplishments. These factors include 
peristalsis, intestinal mucus and the presence of commensal microflora among 
others (Nataro & Kaper, 1998).  
   
1.7.3 The Epithelial Layer 
Epithelial cells are found covering the full length of the intestine and are 
therefore the first line of contact with the host for all ingesta including 
pathogenic and commensal organisms. The epithelium is a barrier, the 
thickness of a single cell, between the external and internal environments and is 
faced with a massive antigenic milieu on a day-to-day basis. The mechanisms 
that have evolved to cope with this load of antigen are highly complex. To 
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differentiate between commensal and pathogenic organisms, as well as food and 
self-antigens, requires the immune system to be highly sophisticated and well-
regulated. Some disease states indicate the complex role of the mucosal system 
as proposed in the situation in Crohn’s disease patients. One theory suggests 
that the pathogenesis of this disease is triggered by inappropriate mucosal 
responses to intestinal commensal bacteria (Blaser et al., 1984; Walmsley et al., 
1996). There are several cell types within the epithelial layer, and regular 
replacement of these cells is driven by the rapid turnover of the crypt cells from 
which all intestinal epithelia are derived. The cells which originate in the crypts 
gradually migrate upwards to an apical position, mature to form enterocytes 
and goblet cells within 3-5 days. The rapid turnover of these cells provides 
defence in itself as the intestinal lining is constantly being shed into the lumen, 
inhibiting adherence and colonisation by pathogens. Tight junctions between 
the epithelial cells maintain integrity of the layer and function to maintain 
epithelial cell polarity and regulate any paracellular movement of molecules. 
This paracellular permeability is affected by host as well as extrinsic factors 
(McKay & Baird, 1999).  
 
1.7.4 The Mucus Layer 
The intestine is covered with a layer of mucus which in itself makes it difficult 
for pathogens to contact the epithelial layer, but it also contains anti-microbial 
peptides and secretory IgA which are further protective of this continually 
challenged environment. The mucus layer is produced mainly by goblet cells 
and is highly viscous and elastic (Rhodes, 1990). The intestinal mucus is a 
glycoprotein secretion of these goblet cells of high molecular weight (Lamont, 
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1992) Mucus is resistant to enzyme digestion and in this feature is thought to 
inhibit its breakdown by host enzymes but also to protect the host epithelia 
from enzymes produced by microbes. Mucus further protects epithelial cells 
from pathogenic bacteria by trapping organisms in its matrix as well as masking 
cellular binding sites with mucin and secretory IgA (LaMont, 1992); 
 
1.7.5 Secretory IgA 
Secretory IgA is the main mucosal antibody (Lamm, 1997). Plasma cells produce 
dimeric IgA within the lamina propria (LP) and this is then secreted into the 
lumen of the intestine via the basolateral epithelial Ig receptors. Secretory IgA is 
transported across the epithelial layer captured within vesicles attached to a 
polymeric immunoglobulin receptor (pIgR) and released at the luminal surface 
following proteolysis of pIgR (Macpherson et al., 2001). The main role for 
secretory IgA involves inhibition of microbial attachment to host cells as well as 
neutralisation of bacterial products (Brandtzaeg et al., 1999; Brandtzaeg, 2003; 
Silvey et al., 2001).   
 
1.8. The Structure of the Intestinal Immune System  
The intestinal immune system is complex in structure and function. Numerous 
immune cells are found within the tissues of the intestine. The function of these 
cells is primarily to perform and respond to continual sampling of the antigenic 
load of the luminal contents. A diagrammatic representation of the mucosal 
immune system is shown in Fig. 1.4. The intestinal immune system can be 
broadly divided into inductive sites including mesenteric lymph nodes (MLN) 
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and the lymphoid follicles as well as effector sites such as the epithelium and 















































Fig. 1.4 The structure of the Intestinal Immune System (modified from Eberl G, Nature 
Reviews Immunology Vol 5: 413 – 420, 2005) Individual DCs are present throughout the lamina 
propria and many within discrete lymphoid tissues of the intestine as indicated here by the 
Peyer’s patch. Numerous other cell types are involved in the immune system of the intestine 




1.8.1 Gut Associated Lymphoid Tissue (GALT) 
As well as individual immune cells scattered throughout the intestine tissues, 
individual intraepithelial lymphocytes have been observed within the epithelial 
layer close to the lumen contents. The function of such cells is unclear, however 
it is possible that they respond to features of the microenvironment and secrete 
cellular signals or are cytotoxic to pathogens (Cerf-Bensussan & Guy-Grand, 
1991). The intestinal tissues also have associated with them numerous 
aggregations of immune cells. These immune cell clusters are called lymphoid 
follicles and these small collections of immune cells may be found as individual 
lymphoid follicles (ILF) in the intestinal tissues or grouped together in some 
numbers to form patches of GALT. These patches are observable by eye as 
thickenings of the gut wall. The precise locations of GALT tend to be species 
specific, albeit with some individual animal variation however there are some 
areas which are consistently present for example the tonsillar tissues and the PP 
of the small intestine; reviewed in (Liebler-Tenorio & Pabst, 2006). 
 
Close to the Recto Anal Junction (RAJ) in several species, including cattle, there 
are dense patches of lymphoid follicles (LF). These follicles contain numerous 
immune cells. The structure of the follicles consist of follicular B cell areas and 
parafollicular T cells zones, overlaid by a sub-epithelial dome highly populated 
by DCs, as can been seen in Fig.1.4. The epithelium immediately covering the 
lymphoid follicles contains a greater number of specialised epithelial cells called 
M cells (see section 1.8.2) and is termed follicle associated epithelium (FAE) 
(Mahajan et al., 2005; Owen et al., 1986). The main function of the GALT is 
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antigen sampling of the intestinal contents and to facilitate generation of the 
appropriate local immune responses at the gut surface.  
 
1.8.2 M cells  
Specialised epithelial cells called M cells (microvillous or microfold cells) are 
found in the FAE of LF, PP, isolated lymphoid follicles (ILF) and appendix. They 
were discovered in 1965 in the rabbit appendix but were not named until 1974 
when electron microscopy (EM) was used to view the microfolds on the surface 
of these cells (Owen, 1975). M cells function in transportation from the intestinal 
lumen to the subepithelial dome region. Microorganisms as well as various 
macromolecules and soluble molecules are all transported. The subjacent cells 
within the subepithelial dome then have access to these luminal antigens and 
can initiate immune responses (Gebert et al., 1999).  
 
M cells have shorter, more irregular microvilli when compared to enterocytes. 
The M cells have only a thin glycocaylx layer, which has been suggested to 
permit them greater access to the intestinal luminal antigens. Enterocyte brush 
borders have alkaline phosphatase and sucrose-isomaltase, but these are not 
found on M cells and therefore have been used as negative markers (Gebert et 
al., 1996). One of the most striking features of the M cell is an invagination of its 
membrane at the basolateral surface (Neutra et al., 1996). It is in this pocket that 
immune cells are often found including DCs and B and T lymphocytes, which 
are the cell types required to generate immune responses. This close association 





1.8.3 Lamina propria (LP) 
The LP is a highly vascular layer of loose connective tissue which underlies the 
epithelium providing support. There are numerous cell types within the LP to 
facilitate its effector functions. These cell types have varied roles in structure, 
such as smooth muscle cells and fibroblasts, as well as function; for example, the 
cells of the immune system. Numerous plasma cells in the LP function to 
produce secretory IgA (section 1.7.5). Immune responses are generated in the LP 
by interaction of DCs with T and B lymphocytes, including production of 
cytokines and other signals directed towards eliminating pathogens and 
maintaining tolerance to self. The populations of these cells between species is 
heterogeneous (Haverson & Riffault, 2006). 
 
1.9. The Intestinal Immune Response 
The immune response generated within the mucosal tissues of the intestine may 
be broadly categorised into the innate and adaptive (or acquired) immune 
responses. Both innate and adaptive arms of the immune response involve 
activity of various leukocytes to protect the host. 
 
1.9.1 The Innate Immune Response 
The innate immune response is the first line of defence against foreign material. 
It is a more immediate response and has evolved to recognise conserved 
features of pathogens, termed pathogen associated molecular patterns (PAMP). 
Recognition of a PAMP induces cellular responses and secretion of soluble 
factors, such as complement components and cytokines, all directed towards 
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elimination of the organism. Cell types which are involved in the recognition 
and elimination of foreign material include macrophages, natural killer cells, 
basophils, eosinophils, neutrophils and DCs. An important discrimination 
between self and non-self molecules must be made to prevent inappropriate 
damaging inflammatory responses towards harmless molecules. The innate 
immune system has evolved to effectively meet this challenge (Janeway, Jr. & 
Medzhitov, 2002). Central to this discriminatory role are the TLR (Beutler, 2003) 
which recognise PAMPs. TLR are transmembrane proteins with a high degree of 
evolutionary conservation. To date, at least ten TLR have been discovered in 
mammals including cattle (Werling et al., 2006). Of these several are of 
importance to the recognition of bacterial factors which will be involved in 
responses to E. coli O157:H7 in vivo. TLR2 recognises bacterial membrane 
components including lipoproteins (Cario, 2005; Medzhitov & Janeway, Jr., 
1997b). TLR4 recognises the lipid A portion of bacterial lipopolysaccharide (LPS) 
in conjunction with LPS binding protein and CD14 (Cario, 2005; Chow et al., 
1999). Flagella and flagellated bacteria have been shown to be a specific ligand 
for TLR5 (Hayashi et al., 2001), and TLR9 is involved in recognition of bacterial 
CpG motifs (Hemmi et al., 2000). Binding of the specific ligands to the TLR 
initiates signalling cascades via activation of MyD88 which promotes the action 
of NF-κB and MAP kinases on transcription of pro-inflammatory genes (Takeda 
& Akira, 2004). The cell types which express these TLRs are often the cell types 
which will first encounter foreign material and are in anatomical positions to 
provide effective clearance; these include epithelial cells, DCs, macrophages and 




1.9.2 The Adaptive Immune Response  
The adaptive immune response takes longer to become activated but is highly 
specific to the pathogen involved. (Abbas, 2000) The innate immune system acts 
in the first instance to prevent spread of infection, however while this is 
occurring, antigenic information about the causative organism is transported 
from the local site to secondary lymphoid organs often via antigen-presenting 
cell types such as DCs. It is in this location that the host lymphocytes are 
stimulated to generate effector T cells which are able to specifically recognise the 
pathogen. This response is characterised by clonal selection and differentiation 
and includes stimulation of B cells to produce specific antibodies (Medzhitov & 
Janeway, Jr., 1997a). These specific cells and antibodies are often able to clear the 
pathogen and during this process memory T and B cells are also generated for 
host protection against future challenge. The two types of immune response 
while seemingly distinct from each other, nonetheless are integrated to provide 
a comprehensive host defence system against innumerable pathogens (Hoebe et 
al., 2004).  It is important to the host that all responses generated are appropriate 
to the level of threat and therefore immune recognition is a delicate balance. As 
an example of aberrant immune responses, autoimmune disorders exist 
whereby inappropriate response to self tissues is poorly regulated such as 
arthritis or asthma (Hoebe et al., 2006; Hoebe et al., 2004; Janeway, 1989). DCs are 





1.10 Dendritic cells  
Dendritic cells are one of the most important cell types involved in initiating 
intestinal immune responses or generating tolerance to encountered molecules. 
DCs are potent stimulators of both primary and secondary immune responses to 
infections (Bell et al., 1999). These professional antigen presenting cells (APCs) 
ingest and process antigens, to present to T cells which promote the immune 
responses. Proliferation of the T cell follows, along with cytokine release and 
alteration of expression of surface co-stimulatory molecules to direct immune 
responses.  
 
Characterisation of DCs is complex; phenotypically they elaborate long 
dendritic processes, and functionally they are highly active cells, but they are 
multifarious and take up many positions both anatomically and functionally 
(Haverson & Riffault, 2006). Traditionally, identification of DCs has been based 
upon investigation of cellular morphology (Steinman & Cohn, 1973). The 
irregular cellular structure coupled with constitutive expression of MHC II is 
now often used to identify DCs. Expression of other cell surface molecules tends 
to vary between tissues and species and state of maturity. Identification of DCs 
and cell surface molecule expression is discussed further in Chapter Two. 
Surprisingly, the early DC development from haematopoietic precursors is one 
of the least understood areas of DC biology. Predominantly, research has been 
carried out with mice and human cells (Wu & Dakic, 2004). Traditionally DCs 
were categorised as developing from myeloid precursors, then further work 
suggested that DCs can develop from lymphoid precursors (Manz et al., 2001a; 
Manz et al., 2001b). These lineages were thought to remain separate during 
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development. More recent views are that the lineages are not so distinct and that 
DCs may demonstrate differentiation and plasticity within and between DC 
subsets (Grohmann et al., 2003) (A. MacDonald, BSI Summer School Lecture, 
2006). Similarly, bovine DCs are widely accepted to be heterogeneous with a 
poorly characterised lineage (Mirkovitch et al., 2006).   
 
DCs are found in various tissues throughout the body; however this study is 
concerned with intestinal dendritic cells and methods by which they may 
interact with E. coli O157:H7. Intestinal DCs are found in discrete lymphoid 
tissue of the intestine such as Peyer’s patches and lymphoid follicles (as 
described in section 1.8.1) and also individually throughout the lamina propria 
(Stagg et al., 2004). Subsets of intestinal dendritic cells have been identified in 
porcine and ovine intestinal tissues but no such study has been carried out for 
the bovine intestinal DC populations. 
 
1.10.1 DC Antigen Capture in the Intestine 
The role of DCs in antigen uptake and presentation is more widely understood. 
Immature DCs migrate from the bone marrow to seed peripheral tissues 
including the intestine. These peripheral DCs encounter antigen which 
stimulates them to mature and migrate. In the intestine, the DCs may sample 
antigen by a number of methods, both directly and indirectly. DCs can extend 
dendrites into the intestinal lumen between the cells of the epithelial layer to 
directly capture antigen. By expressing epithelial tight junction molecules the 
DCs do not interrupt the epithelial integrity (Rescigno et al., 2001b). Physical 
damage to the epithelial cell layer also allows DCs to access and uptake luminal 
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antigen. Indirectly, DCs may receive antigen via epithelial cells; either by uptake 
and transport by the epithelial cell, or following DC phagocytosis of apoptotic 
cells. M cells also provide DCs directly with antigenic material (Milling et al., 
2005; Mohamadzadeh et al., 1993; Stagg et al., 2003). DCs phagocytise antigenic 
molecules obtained via these multiple routes and process the antigens for 
presentation to T cells. This processing occurs during maturation and migration 
of the DCs. The DCs employ three main methods of internalising antigens. 1) 
Phagocytosis of particles following binding of Fc or complement receptors 
mediates actin polymerisation and then internalisation (Carroll, 1998). 2) 
Macropinocytosis is a method by which DCs can sample large amounts of fluid 
from the surrounding microenvironment. Any antigens present are quickly 
concentrated and processed for presentation on the DC surface. The initial 
events also require actin polymerisation, but direct antigen contact is not 
required, and in fact this process appears to occur constitutively in human DCs 
(Sallusto et al., 1995). 3) The third method of uptake is initiated by binding of 
PAMPs to PRR such as TLR (section 1.9.1.) and is termed receptor-mediated 
endocytosis. Other PRR exist such as CD205, DC-SIGN, and the mannose 
receptor (MR) (Engering et al., 2002; Sallusto et al., 1995; Swiggard et al., 1995). 
Following binding to the receptor, uptake occurs into invaginations of the host 
cell membrane called clathrin-coated pits, which then contain the antigen and 
receptor. These pits then separate from the cell membrane and the resulting 
intracellular vesicles may bind with lysosomes to facilitate inactivation of the 
antigen (Steinman & Swanson, 1995).  
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Fig. 1.5 Intestinal DCs: antigen 
sampling methods. Imange adapted from 
Uhlig, 2003, Journal of Clinical 
Investigation. Four methods which DCs 
use to capture antigen are demonstrated 
here (Uhlig & Powrie, 2003). 
I: Via M cells 
II: DC extending dendrites between 
epithelial cells to directly contact antigens 
in the luminal contents 
III: Uptake of translocated bacteria which 
arrive in the LP via transcellular routes or 
via transport by epithelial cells 
IV: Uptake of bacteria which reach the 
lamina propria following disruption of the 
epithelial layer. 
Following uptake of antigen the DCs 
migrate to draining lymph nodes (MLN -
mesenteric lymph node) to initiate immune 
responses via lymphocyte interactions. 
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1.10.2. Migration & maturation of DCs 
Maturation of DCs, characterised by upregulation of MHC II expression, 
cytokine secretion and expression of high levels of cell surface co-stimulatory 
molecules, occurs soon after encountering antigen. The levels of cellular 
expression of MHC II, CD40, CD80 and CD86 are all upregulated in response to 
antigen uptake (Cella et al., 1996). The DCs will then migrate to lymphoid tissue 
in order to drive the appropriate T cell response (Niedergang & Kweon, 2005; 
Stagg et al., 2004). The changes in cell surface expression and the production of 
cytokines during DC migration and maturation facilitate T cell interactions 
(Cella et al., 1996).  
 
1.10.3. Antigen presentation 
The ability of APCs to stimulate naïve T cells is unique to DCs. Memory T cells 
are targeted by other APC types. This means the DCs are in a unique position to 
direct inflammatory and immune responses against, or tolerance to, 
encountered molecules. The interaction of DCs and T cells involves two main 
signals. Firstly, interaction of the MHC II/antigen complex with the T cell 
receptor and secondly, ligation of DC CD80 or CD86 with T cell CD28, or 
interaction of CD40 with CD154. Whether an immune response is generated or 
not, and indeed what type of immune response, (for example Th1 or Th2), is 
driven through a number of mechanisms by DCs. For instance, cytokine 
production by DCs determines qualitatively any immune response by 
stimulation of different arms of immune responses. Production of IL-12, IL-18 
and IL-23 by DCs is more likely to drive a Th1 response, whereas a Th2 response 
is more likely to result from IL-4 or IL-10 secretion (Stagg et al., 2003). 
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Furthermore CD80 ligation with CD28 has been shown to bias towards a Th1 
response, with the Th2 bias resulting from CD86-CD28 interaction (Sansom et 
al., 2003).  
 
1.11 DCs in situ 
DCs have been found in many tissues of the body subsequent to in situ studies. 
These studies have successfully identified tissue- and species-specific subsets of 
DCs. In ruminant species the ovine pulmonary and intestinal DCs have been 
investigated using immunohistochemistry (IHC) techniques (Akesson et al., 
2008; McNeilly et al., 2006). In cattle, the tissue resident DC populations have not 
been extensively examined in this way. The in situ IHC techniques are useful to 
indicate tissue distribution of cells and cellular expression of molecules of 
interest. However, they cannot fully characterise the complex cellular expression 
of the DC subsets or permit functional studies of these cells, thus, further 
techniques are required. 
 
1.12 Ex vivo DCs 
Several limitations to working with ex vivo DCs are evident. Firstly, there are 
relatively few DCs within the peripheral blood.  DCs from tissues are also 
relatively difficult to collect. A pure DC population from tissues may contain 
contaminating cell types and involve surgical or necropsy techniques. 
Furthermore, the resulting cells may have to undergo separation, digest and 
culture techniques which have potential to affect the phenotype of the cell 
population present. In addition to this a lack of DC specific molecules in most 
species and a relative scarcity of ruminant reagents in particular have 
43 
 
necessitated development of other methods of studying ex vivo DCs. Because 
these cells are migratory in nature and demonstrate plasticity in their 
phenotype, the same cell is likely to display different properties depending at 
which point in its development it is collected. However, the majority of the 
knowledge of bovine DC phenotype and function comes from work on afferent 
lymph dendritic cells (ALDCs). These are DCs which have captured antigen in 
the peripheral tissues and are travelling back to the local lymph node to present 
antigen. Cannulation of lymph ducts in both cattle and sheep has been 
described (Epardaud et al., 2004; Hope et al., 2006). These techniques have 
provided a means of collecting circulating DCs over extended periods. 
Information on DCs returning from various tissues including, for example, the 
skin of cattle (Hope et al., 2006), mucosa of the ovine head (Epardaud et al., 2004) 
and rat intestinal tissues (Milling et al., 2006) have been provided. These 
techniques however are not suited to all species and tissues due to the 
complexities of the anatomical features and surgery involved. 
 
1.13 In-vitro culture of DC 
To facilitate investigation of the properties of DCs it is necessary to carry out in 
vitro experiments. One widely used method of generating numerous DCs for in 
vitro studies is to stimulate differentiation of blood monocytes using cytokines 
and culture techniques. This method was first demonstrated for human cells by 
Sallusto et al in 1994 (Sallusto & Lanzavecchia, 1994). These techniques have 
been utilised for DC studies with numerous species. In cattle, the in vitro culture 
of CD14+ blood monocytes with granulocyte macrophage colony-stimulating 
factor (GM-CSF) and interleukin 4 (IL-4) produces cells of an immature DC 
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phenotype after 3 days (Hope et al., 2000a; Werling et al., 2002) (see also Chapter 
4) and has been employed in the investigation of various bovine diseases. 
Similar culture methods with bone marrow precursors have also been described 
in cattle (Hope et al., 2000b). The surface phenotype of GM-CSF- and IL-4-
stimulated cells is comparable but not identical to in vivo cells, and cultures 
must also contain cells at various stages of differentiation. Despite these 
limitations, culture techniques are still a useful model for studying DC 
interactions with various infectious agents. 
 
1.14 Bovine DCs 
To date relatively little work has been carried out on bovine intestinal DCs in 
comparison with rodent and human DC research; hence it is a rapidly-growing, 
exciting and relevant area of investigation. As mentioned earlier, studies of the 
distribution and presence of subsets of DCs within intestinal tissues have been 
published for pigs (Bimczok et al., 2005) and sheep (Akesson et al., 2008), but no 
comparable study is available for bovine cells. It is important to recognise 
species differences in phenotype and function of cells. While investigating the 
relationship between DCs and EHEC in cattle, we must be aware that the 
human EHEC interactions are likely to be different to that which occurs in the 
ruminant host. Not all of the investigative techniques may be appropriate for all 
species and there may be ways in which bovine DCs differ from that which has 
been discovered so far. Most work has discovered DC subsets that differ in cell 
surface molecule expression; however these subsets are not the same in all the 




1.15 Bovine DCs and interaction with E. coli O157:H7 
During infection EHEC is likely to encounter intestinal DCs. The terminal 
rectum of cattle, which is this organism’s predilection site for colonisation, is 
also an area which contains numerous lymphoid follicles. Lymphoid follicles, 
like other GALT, contain numerous immune cells, and although the presence of 
DCs within bovine terminal rectal tissue has not been confirmed prior to this 
study, it is postulated that these are a predominant cell type underlying the 
epithelium. Furthermore, bovine primary epithelial cells express CCL-20, a DC 
chemo-attractant chemokine, in response to challenge with E. coli O157 in vitro 
(Dr. Mahajan, personal communication), and secondly, DCs can directly sample 
the intestinal lumen and collect antigens from food, organisms and apoptotic 
epithelial cells (Rescigno et al., 2001b; Rescigno et al., 2001a). DCs (as well as 
other cells) express TLR and these PRR recognise PAMPs. EHEC possesses 
several PAMPs that may be recognised by TLRs. Among these, flagella (the H7 
antigen) which is recognised by TLR5, has a significant role in host recognition 
(Hayashi et al., 2001; Tsujimoto et al., 2005). Other PAMPs such as LPS 
(recognised via TLR4), lipoproteins (TLR2), or CpG (TLR9) may also be of 
importance.  
E. coli O157:H7 could in some ways be classified as a ‘commensal’ bacteria in 
cattle because it does not appear to induce significant clinical changes in this 
species. However, A/E lesions have been shown to be formed on cattle epithelial 
cells, on intestinal explants and during calf challenges (Sandhu & Gyles, 2002). 
These lesions are a characteristic more commonly associated with disease 
(Dean-Nystrom et al., 1998; Phillips et al., 2000). Coinciding with A/E lesion 
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formation is the secretion of IL-8, a chemokine that is key in the promotion of 
inflammation (Moxley, 2004). IL-8 acts as a neutrophil chemoattractant, however 
there is no conclusive evidence that neutrophil infiltration is observed as a 
feature of E. coli O157:H7 colonisation in cattle.  It is therefore possible that this 
bacterium alters and controls mucosal defences to promote its colonisation, 
potentially to include signals affecting DC function. Although phagocytic cells 
and antigen-presenting cells play central roles in directing host defences, the 
interplay between these cells and E. coli O157:H7 in cattle has received relatively 
little attention.  Dendritic cells are of major significance in directing defences at 
mucosal surfaces but have as yet not been studied in this context.  
In Summary, E. coli O157:H7 is a significant cause of human disease. Cattle have 
been shown to be an important reservoir for this pathogen and are often the 
cause of outbreaks of disease within the human population. Cattle carry E. coli 
O157:H7 asymptomatically within the intestine, in particular at the terminal 
rectum. Due to the tissue distribution of lymphoid follicles there are likely to be 
numerous DCs within the terminal rectum. DCs are key directors of immune 
responses and will interact with intestinal bacteria in the bovine host. The 
hypothesis of this study is that these terminal rectal DCs are important for the 





1. To characterise the dendritic cell population in the bovine intestine at 
various sites to include the terminal rectum. 
2. Evaluate extraction of ex vivo DCs using several methods to generate a 
protocol for extraction, and if successful, to characterise the cells and 
compare phenotype and function with the monocyte-derived dendritic 
cell (moDC) system. 
3. To characterise the response of moDCs to various E. coli strains and 
components, looking at cytokine responses, cell surface molecule 
expression and cell viability after challenge. Intracellular bacterial 










Chapter 2 Investigation of cell surface molecule 


















2.1 Introduction  
The intestine constantly comes into contact with a wide variety of foreign 
material. Pathogens must be differentiated from commensal organisms and 
harmless food antigens by the host, and an appropriate response has to be 
initiated. It is important to prevent an excessive inflammatory response to 
harmless food or self-antigens and it is equally vital not to neglect to respond 
to potentially harmful stimuli. 
 There are several sites in the intestine at which immune responses can be 
generated and distinct anatomical locations in which numerous immune cells 
can be found. Individual lymphoid follicles can be found within the 
intestinal wall at numerous sites; however there are patches where abundant 
follicles are found in the same location in thick aggregations. These 
aggregations are observable by eye and are generally referred to as mucosa-
associated lymphoid tissue (MALT) or gut associated lymphoid tissue 
(GALT). MALT is found in all species and the locations are species specific, 
although there are parallels between species. In cattle, MALT occurs most 
notably as the Peyer’s patches of the ileum, within the proximal colon and at 
the terminal rectum. Reviewed in (Liebler-Tenorio & Pabst, 2006) 
 These aggregates of lymphoid follicles (LF) which make up the MALT at the 
bovine terminal rectum occur for only a short distance up to 3cm proximal to 
the recto-anal junction (RAJ). Individual LFs can be observed becoming more 
sparse proximal to this (Mahajan et al., 2005). The lymphoid follicles are so-
named because they consist of organised groups of lymphocytes: a large 
number of B cells are found in the germinal centres within a network of DCs 
and T cells are found in the inter-follicular areas. It is within these follicles 
that immune responses are generated. The follicles are covered by a single 
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layer of specialised epithelium which is termed the follicle associated 
epithelium (FAE). The FAE is a thinner layer with less prominent microvilli 
than that found in the villous regions and contains a higher number of 
specialised M cells. M cells, along with DCs, are responsible for antigen 
sampling from the intestinal lumen. M cells transfer captured antigen to DCs 
which can be found inside a specialised invagination of the M cell basal 
membrane. The area directly below the FAE is sometimes termed the sub-
epithelial dome (SED) and can contain large numbers of DCs, as well as other 
immune cells, at a prime location for collecting antigens from the intestinal 
contents.  
It is known that FAE secretes chemokines, including the DC chemoattractant 
CCL20 (Cook et al., 2000; Iwasaki & Kelsall, 2000). DCs are recruited to the 
SED in response to this chemokine in mice and humans in vitro (Iwasaki & 
Kelsall, 2000; Thorley et al., 2005). It is known that bovine primary rectal 
epithelial cells also express CCL20 (Dr. Mahajan, personal communication) 
and so it seems likely that there could be numerous DCs within the follicles 
of the bovine terminal rectum although this has not been investigated prior 
to this study. DCs at this site then will come into contact with E. coli O157:H7 
due to their antigen uptake abilities. 
Intestinal DCs obtain antigens by several methods and subsequently 
generate immune responses. They are able to obtain antigens via specialist M 
cells which have been shown to occur in higher numbers in the FAE. M cells 
have been identified within the FAE of the bovine ileum and the terminal 
rectum (Momotani et al., 1988) (Dr. Mahajan, thesis, 2005) DCs have been 
shown to directly sample the gut lumen by expressing tight junction proteins 
to extend dendrites directly into contact with the gut contents (Chieppa et al., 
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2006; Collan, 1972; Rescigno et al., 2001b; Rescigno et al., 2001a). Apoptotic 
epithelial cells can be efficiently phagocytosed by DCs and in this way even 
self-antigen can be taken up and processed. It has been shown in rats that a 
population of SIRPα- DCs draining the intestine constitutively phagocytoses 
and transports apoptotic epithelial cells to T cell rich lymph node areas and it 
is proposed that these cells are involved in the maintenance of peripheral 
self-tolerance (Huang et al., 2000). Epithelial cells in mice have been shown to 
have a rapid turn-over, dependent on intestinal location, of one to four days 
(CREAMER et al., 1961) and so are continually being replaced. This rapid 
epithelial shedding is known to be a feature in all species. Although many of 
these cells are shed into the intestinal lumen, DCs can obtain food and micro-
organism antigens from these apoptotic epithelial cells. DCs which have 
captured antigen travel in the lymph to the local draining lymph node. It is 
here that DCs can present antigen to naive T cells and in this way generate a 
response, whether it be tolerance, Th1 or Th2 type. 
DCs in peripheral tissues are central to directing immune responses. They 
are the only cell type so far discovered capable of presenting antigen to naive 
T cells and thus directing immune responses.  The presence of these highly 
inductive follicles at the site of preferential colonisation of EHEC implies a 
central role for DCs in the asymptomatic persistence of EHEC in cattle. 
The study of DCs in various species and tissues has been an area of much 
interest in recent years, however the DC populations in the bovine intestine 
have yet to be characterised. 
Ovine dendritic cells have been studied by immunohistochemistry at 
different anatomical locations within the lung and differential expression of 
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cell surface markers CD205, CD1b and SIRPα have been found (McNeilly et 
al., 2006). Ovine intestinal dendritic cells have been characterised 
phenotypically using immunohistochemistry and immunofluorescence 
techniques. A wider range of markers were assessed including MHC II, 
CD11c, CD205, CD1b and CD209 and populations of immune cells were 
identified. The majority of DCs in peripheral tissues were found to co-
express CD11c, CD205 and MHC II and very often were located in the lamina 
propria and SED, at a prime location for sampling intestinal antigens 
(Akesson et al., 2008). 
Porcine DC populations in the small intestine have been studied in a similar 
way. Subsets of DCs were discovered in the jejunum and ileum by using 
SIRPα and CD11b co-staining with MHC II (Bimczok et al., 2005). 
Immunofluorescence in mice has also yielded information about DC subsets 
in intestinal tissues and in particular the Peyer’s patches. CD11b, CD11c, 
CD8α and CD205 have been used to localise subsets to anatomical locations 
within the Peyer’s patches. Some functional properties, involving the role of 
chemokines in the migration of DCs, have been attributed to these subsets 
(Iwasaki & Kelsall, 2000). 
Molecules specific to DCs in humans, in particular Dendritic cell lysosome-
associated membrane protein (DC-LAMP or CD208) (de Saint-Vis et al., 1998) 
and Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-
integrin (DC-SIGN; also known as CD209) (Geijtenbeek et al., 2000), have 
helped in the identification of these cells in this host. In earlier murine DC 
research, CD11c had been used as a specific DC cell surface molecule. 
However, it is clear now that this is not the case. In fact, in veterinary species 
studied to date, there has been no individual cell surface molecule identified 
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that is specific for dendritic cells. The isolation and identification of DCs 
therefore relies on a series of identifying features that must be assessed in 
conjunction with one another including morphology as well as expression of 
various molecules. DCs are generally defined as large irregular cells which 
express MHC II with heterogeneous expression of additional molecules 
including CD205, CD1b, SIRPα and CD11c among others. These molecules 
associated with DCs tend to have different expression patterns and functions 
which can be used to partition DC populations into phenotypic and 
functional subsets. Characterisation of these subsets in different anatomical 
compartments and species is an active and dynamic area of research.  
MHC II molecules are involved in presenting antigen to T cells in 
conjunction with co-stimulatory molecules. Any captured antigen is 
phagocytosed into MHC II lined endosomes and this promotes up-regulation 
of MHC II and movement of the MHC II-antigen complex to the cell surface 
where it can be presented (Shin et al., 2006).  
CD205 is a member of the C-type multilectins and is thought to act as an 
endocytic receptor for antigen uptake (Gliddon et al., 2004b). In sheep CD205 
has been shown to be expressed by the majority of afferent lymph dendritic 
cells (ALDCs) draining tissue such as the skin, intestine and mucosal surfaces 
of the cranium, and has also been shown to be expressed by ovine dendritic 
cells within lung and intestinal tissues in situ (Akesson et al., 2008; McNeilly 
et al., 2006; Ryan et al., 2000; Watkins et al., 2005). Bovine ALDC draining the 
skin also express CD205 (Gliddon et al., 2004b). CD205 is of further interest in 
dendritic cell research:  a recent study has indicated that CD205+ dendritic 
cells can be targeted and manipulated in cancer models in vitro to increase 
antigen presenting capacity (Birkholz et al., 2010). 
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SIRPα, a member of the signal regulatory protein family, is involved in the 
interactions of DCs with CD4+ T cells. In rat intestinal lymph there have been 
found to be two DC subsets can be defined by expression or lack of SIRPα 
(Liu et al., 1998). SIRPα has also been used to identify subsets of DCs within 
porcine intestinal tissues using immunohistochemistry techniques. These 
subsets can also be defined by their expression of SIRPα as well as CD11b 
(Bimczok et al., 2005). SIRPα, when bound to its ligand CD47, produces a 
negative effect on phagocytosis of host cells by APCs (Yamao et al., 2002). 
Mononuclear phagocytic cells in cattle show SIRPα expression, specifically 
monocytes, neutrophils, eosinophils, myeloblasts and macrophages (Ellis et 
al., 1988). SIRPα expression in bovine cells has been identified in tissues of 
the lymph nodes, spleen and skin (Brooke et al., 1998).  
CD1b is a cell surface glycoprotein which is also involved in the presentation 
to T cells; however the molecules which it is thought to present are lipid or 
glycolipid in nature (Porcelli et al., 1998). A small sub-set of ALDCs draining 
the skin of cattle express this molecule. CD1b has been used, in conjunction 
with CD14, to identify sub-sets of ALDCs in Sheep (Ryan et al., 2000). CD1b 
was found on few cells within ovine intestinal and lung tissues using 
immunohistochemistry techniques (Akesson et al., 2008; McNeilly et al., 
2006). 
CD40 is a membrane protein expressed by B cells and antigen presenting 
cells and functions as a co-stimulatory molecule.  It is a part of the TNF 
receptor family and binding by its ligand can induce proliferation or 
activation of APCs (Banchereau et al., 1994). 
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CD11c is an integrin expressed by DCs involved with cell adhesions. Studies 
of ovine lymph DCs have found ubiquitous CD11c expression of these cells 
(Gupta et al., 1995) while within ovine intestinal cells CD11c has been 
localised to dendritic cells within the Peyer’s patches (Gupta et al., 1993).  
Expression by murine DCs of CD11c is often used as a specific marker for 
DCs in this species, although, may not be as specific as widely thought. 
CD11c was originally generated against murine macrophages (Shortman & 
Liu, 2002). CD11c has also been identified on bovine ALDCs draining the 
skin (McKeever et al., 1991). 
CD14 is commonly a marker of macrophages and monocytes and functions 
as a pattern recognition receptor (PRR). Its primary ligand is bacterial LPS 
and it works alongside TLR4 during binding. CD14 has been found on 
ALDCs in sheep at low levels (Ryan et al., 2000) and also on porcine and 
bovine BMDCs (Carrasco et al., 2001; Hope et al., 2000b). CD14 may recognise 
other pathogen associated molecular patterns (PAMPS) as well as 
endogenous particles and apoptotic cells (Anas et al., 2010; Kitchens, 2000; 
Tapping & Tobias, 2000). 
In a similar study to the one described in this chapter, which made use of 
ovine intestinal tissues, a large proportion of cells displaying dendritic 
morphology within the rectal mucosa were MHC II + and co-expressed 
CD11c and CD205.  Only sparse staining of CD1b was observed (Akesson et 
al., 2008). Studies into similar molecules within tissues of the ovine 
respiratory tract showed staining profiles that were related to anatomical 
location. MHC II staining was widespread within the tissues including 
airways and lung parenchyma. CD1b was found expressed by a small 
number of DCs in all anatomical locations studied.  SIRPα was found on a 
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population of DCs within the airways but was absent from tissues of the 
lung. Likewise the CD205+ DCs were more abundant within the airways and 
less often observed in the lungs (McNeilly et al., 2006). 
Although the FAE and follicular tissues have been characterised in the cow, 
and a great deal of work has been carried out on ALDC returning from 
peripheral tissues, distinct populations of DCs within the tissues of the 
bovine intestine have not been studied in situ. The aim of this work was to 
identify and characterise DC populations within the bovine intestinal tract. 
 
 
The aims of this chapter were: 
1. To identify DC populations within the tissues of the bovine intestine 
using immunohistochemistry for immune cell molecules. 
2. To investigate any differences between the cell populations identified 





2.2 Materials and Methods 
 
2.2.1 Post-Mortem Cattle Tissue 
Post-Mortem tissue was obtained from six male Holstein-Friesian calves 
which were approximately six months old. Four different intestinal sites 
were sampled: proximal colon, distal colon, proximal rectum and terminal 
rectum (Fig. 2.1). Sections of approximately 1 - 1.5 cm2 were collected using a 



















Fig. 2.1 Representation of the bovine gastrointestinal tract indicating the locations of 
post-mortem tissue sampling used in this study. A: Terminal Rectum; B: Proximal 
Rectum; C: Proximal Colon; D: Distal Colon. The terminal rectum was sampled no more 
than 5 cm proximal to the recto-anal junction (RAJ). The proximal rectum was sampled 
approximately 15-20 cm from the RAJ. The proximal colon was sampled from the sigmoid 
flexure close to the caecum (E). Distal colon sampling was carried out at an area where the 
centrifugal turns of the spiral colon straighten out towards the distal loop and transverse 
colon (Image adapted from Dyce et al 2nd ed. 1996). 
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2.2.2 Preservation and Fixation of Tissues 
Two preservation methods were used for the tissue: snap-freezing in liquid 
nitrogen, fixing in formal saline and fixing in zinc salts fixative (ZSF, 
Appendix A.4.5.2). Three methods were chosen to give a wide range of 
tissues for IHC while maintaining tissue morphology. The efficacy of some 
antibodies was affected by fixation technique but the frozen tissues were 
difficult to section and resulted in poorer morphology. Tissues were placed 
in ZSF for 6-8 hours and then trimmed to approx 5-10 mm2 and placed in 
fresh ZSF for a further 24 – 72 h. The formalin and ZSF tissue were mounted 
in paraffin wax blocks. These tissue sections were placed in plastic cassettes 
and placed in 70% ethanol for 30 min before mounting in paraffin wax using 
an automated procedure (80% ethanol, 45 min; 95% ethanol, 75 min; 99% 
ethanol, 3×75 min; iso-propanol, 2×90 min; isopropanol/xylene [1:1 v:v], 90 
min; xylene, 2×90 min; medium temperature melting [56–58°C] paraffin-wax, 
2×105 min) (Gonzalez et al., 2001).  The frozen sections were embedded in 
O.C.T. compound (Tissue-Tek, Sakura-Finitek, The Netherlands) before 
snap-freezing in liquid nitrogen. These samples were stored at -80°C until 
required for analysis. Sections 5 μm thick on treated glass slides (Superfrost 
plus®™, Menzel-glaser, Germany) were used for IHC. All the 
immunohistochemistry results presented in this thesis were carried out on 
the frozen sections or the Zinc salt fixed sections. 
 
2.2.3 Single labelling Immunohistochemistry protocol 
Both the single and double staining methods were adapted from published 




Frozen sections were removed from -80°C and air dried under a fume hood 
for 10 min (forced air). These slides were then fixed in -20°C chilled methanol 
for 10 min. Further air drying in Bio MAT2 Class II Microbiological safety 
cabinet for 10 min was followed by two washes with PBS. Paraffin embedded 
tissue sections were re-hydrated using a Thermo-Shandon Varistain 24-4™ 
automatic stainer which placed the slides in graduated alcohols to take them 
to water. At this stage the method proceeded similarly for the paraffin 
embedded and the frozen tissues. All slides were then placed in PBS 
containing 0.5% Tween 80 (PBST80) to wash for 5 min. The slides were then 
incubated in PBST80 0.3% H2O2 v/v in a glass staining dish or coplin jar for 20 
min at room temperature. The slides were washed twice, 5 min for each, in 
PBST80. The slides were then loaded into a Sequenza™ immunostaining 
centre (Shandon; Runcorn, UK) rack using PBS to rinse each slide as it was 
loaded. Each slide was then washed once with PBS, where a wash 
corresponds to one fill of the reservoir chamber for each slide. The slides 
were incubated in 25% v/v Normal Goat Serum (NGS; Vector) and PBST80 
for one hour at room temperature. The slides were incubated overnight at 
4°C in primary antibody diluted to appropriate concentration in 10% 
NGS/PBST80. The negative control used was incubation with mouse/rat IgG 
at 2 µg/ml in 10% NGS/PBST80, to correspond with the species of the 
primary antibody used (see Appendix A.1 for antibodies used and 
concentrations). After overnight incubation in primary antibody the slides 
were washed twice with PBS before incubation in Dako goat anti-mouse 
labelled polymer-HRP (included in EnVision kit) for 30 min at room 
temperature. Two further washes in PBS were carried out before the slides 
were incubated in Dako DAB substrate. After a final wash with distilled 
water the slides were removed from the Sequenza™ immunostaining centre 
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and placed into distilled water before haematoxylin counterstaining. The 
counterstaining was carried out using a Thermo-Shandon Varistain 24-4™ 
automatic stainer. The programme places slides automatically in 
haemotoxylin for 1 min, followed by 2 separate water rinses of 30 sec each. 
The slides are then placed in Scott’s tap water for 30 sec before a further 
rinse. The slides were then protected by a cover slip using mounting medium 
(DPX, BDH Laboratory Supplies Poole, UK). Slides were left to set for at least 
1 h before visualisation on an Olympus BX50 microscope. Images were 
captured using an Olympus DP70 digital camera and Cell F imaging 
software. 
 
Numbers of positively stained cells in each section (one section for each 
animal at each anatomical location) were assessed subjectively and described 
using the key shown in Table 2.1. This is a published method employed by 
Dagleish et al.. 





Table 2.1 Immunohistochemistry: positive staining scoring system used for sections 
of bovine intestinal tissues. This method is an objective way of assessing the staining. The 
scoring refers in the main to numbers of positive cells per section and also takes into account 
the strength of staining. This method is used in order to produce a numerical output which 




Statistical analyses were carried out to determine if there were any 
differences between the staining patterns observed at the four anatomical 
sites. A Kruskal-Wallis one way analysis of variance test was used within the 
Minitab (v13) programme for Microsoft Windows because the data sets did 
not conform to normal distribution. A p value of less than 0.05 was 
considered significant. 
 
2.2.4 Dual immunohistochemistry fluorescence staining protocol 
Slides were removed from -80oC and treated as for the initial part of the 
method above. They were air dried under a fume hood for 10 min using 
forced air. They were fixed in chilled methanol at -20oC for 10 min and air 
dried in a laminar flow tissue culture hood for 10 minutes. Two rinses in PBS 
were followed by a 5 min wash in PBS + 0.5% Tween 80 (PBST80). The slides 
were then incubated in PBST80 + 0.3% H2O2 in a coplin jar for 20 min and 
washed with 2 x 5 min rinses in PBST80. All slides were then loaded into the 
Sequenza rack using PBS and washed once using PBS.  Incubation in 25% 
normal goat serum (NGS; Vector)/PBST80 was carried out for 1 h. Following 
this blocking step the slides were incubated overnight at 4oC in either 
primary antibody in 10% NGS/PBST80 or mouse IgG (2 µg/ml). Two rinses in 
PBS were then followed by 30 min incubation in Dako goat anti-mouse 
polymer at ambient temperature. Two washes in PBS were followed by an 
incubation for 10 min in Alexa Fluor-568 tyramide substrate (Molecular 
probes) in the dark. The tyramide substrate was made up according to the 
manufacturer’s instructions immediately before applying to the sections. All 
subsequent incubation stages were now carried out in the dark and all 
fluorescent antibodies were briefly pulsed in the centrifuge to remove 
residues. Two washes in PBS were followed by a further serum blocking 
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step. The slides were incubated in 10% normal mouse serum (NMS, 
Sigma)/PBST80 for 1 h at RT. The slides were then incubated for 1 h at RT in 
either SW73.2 mAb, to detect MHC II, or rat IgG (2 µg/ml) diluted in 10% 
NMS/PBST80. A further two washes in PBS were followed by an incubation 
for 30 min at ambient temperature with rabbit anti-rat FITC (Vector, FI-4001) 
diluted 1:500 in NMS/PBST80. Again, 2 washes in PBS were carried out 
before an incubation for 30 min at ambient temperature with donkey anti-
rabbit LC Alexa Fluor-488 (1:1000 i.e. 2 µg/ml). Two final washes in PBS were 
carried out before the slides were mounted in Mowiol (Calbiochem). The 
slides were left for at least 1 h for the Mowiol to set and the slides were 
stored, protected from light, at 4˚C prior to visualisation. The slides were 
visualised on a Zeiss Axiovert 200 and images were captured using Axiocam 
MRm and Axiovision Rel 4.7.2. multidimensional acquisition software.  
 
2.2.5 Cell counts of positively stained cells and data analysis 
Counts of positively stained cells were made using ImageJ software. ImageJ 
is a public domain Java image processing program inspired by NIH Image 
(Rasband W.S. & Bright D. S., 1995). Downloadable distributions are 
available on the internet at http://rsbweb.nih.gov/ij/download.html.  400 to 
600 positively stained cells were counted and the number of these cells that 
were single- and double-stained were noted. The percentage of co-expressing 
cells in each anatomical location could then be calculated. Data was analysed 
using a Kruskal-Wallis test for populations with unequal variance within in 






In this study the bovine intestine was subjected to immunohistochemical 
staining for cell surface molecules. Four intestinal sites were selected for 
investigation: the distal colon, the proximal colon, the proximal rectum and 
terminal rectum (See Fig. 2.1). Post-mortem samples were collected from six 
male Holstein Friesian calves and immunohistochemistry was carried out as 
described in section 2.2.  Representative formal saline fixed samples were 
H&E stained and no significant histopathological changes were observed 
(Fig. 2.2). 
2.3.1 Single Immunohistochemical Staining 
The presence of MHC II, CD205, SIRPα, CD1b, CD40, CD11c and CD14 in the 
tissue sections was analysed by immunohistochemistry. MHC II, CD205, 
CD40 and CD14 staining was carried out with zinc salt fixed tissues. SIRPα, 
CD1b and CD11c staining was carried out with frozen tissue sections. The 
numbers of positively stained cells were objectively analysed and categorised 
as shown in Table 2.1.  This allowed statistical analysis to be carried out to 
determine any differences in staining at the four intestinal sites. The results 
of the immunohistochemistry for the six animals studied are shown in Table 
2.2 and Fig. 2.4. All animals were examined for each molecule of interest at 
four intestinal locations where numbers of sections allowed. A Kruskal-
Wallis test was used to assess differences in positive staining at the terminal 
rectum, proximal rectum, proximal colon and the distal colon. All control 



















Fig. 2.2 Representative Haematoxylin and Eosin stained sections of formal saline 
fixed calf intestine at sites utilised for immunohistochemistry analysis. (A) Proximal 
Colon, (B) Distal Colon, (C) Proximal Rectum, (D) Distal Rectum. LF: Lymphoid Follicle, LP: 
Lamina Propria, LM: Lamina Muscularis, TS: Tela Submucosa, TM: Tunica Muscularis.  
These sections are representative of the normal intestinal morphology. Panels (A) and (D) 
make clear the abundance of lymphoid tissues within the proximal colon and the terminal 
rectum, and the relative lack in corresponding tissues of the distal colon and proximal 
rectum. Panel (B) is annotated to show the anatomical layers, which are similar for all 
sections. Lymphoid follicles can be seen within the tela submucosa, often extending through 
the lamina muscularis into the lamina propria, and directly up to the epithelium.   















Fig 2.3 Representative isotype control sections of calf intestine.  (A) Rat IgG isotype 
control, distal colon epithelium. (B) Mouse IgG isotype control, proximal colon 






















Table 2.2 Individual animal data for immunohistochemistry of intesitinal sections. Intensity of staining scored 0 – 5 where 0 = no significant 
immunolabelling and 5 = most severe. n.d. = not determined, due to lack of tissues or tissues where the morphology was too poor to assess staining 
accurately. Severity of staining correlates to numbers of positive cells as well as intensity of stain. DiC: Distal Colon, PC: Proximal Colon, PR: 
Proximal Rectum, TR: Terminal Rectum. Positive staining was observed for all the molecules of interest. There was some variation noted between 
the six animals studied. Significant differences between intestinal sites were observed for MHC II, CD1b and CD205 (p<0.05). For each of these 
molecules a greater number of positive cells was observed at the terminal rectum (CD1b), or the terminal rectum and proximal colon (MHC II & 
CD205) compared with the remaining anatomical locations.  
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Fig. 2.4 Histogram showing 
anatomical distribution of molecules 
detected by immunohistochemistry 
in the bovine intestine. Histogram 
shows the pooled data presented in 
table 2.2. Significant differences in 
staining between intestinal sites were 
observed for MHC II, CD1b and CD205 
(p<0.05 *). Data is pooled from six 
animals where morphology of tissues 
allowed (Table 2.2 details the tissues 
from which results could not be 
obtained). Error bars represent the 




2.3.1.1 MHC II Expression 
Labelling of MHC II was observed throughout the intestinal tract. 
Representative results of the immunohistochemistry are shown in Fig. 2.5. 
Many positive cells were observed in the lymphoid follicles at both the 
proximal colon and the terminal rectum, to the extent that very little counter 
stain was visible in these areas. Small groups and single MHC II+ cells were 
observed in epithelial areas and within the lamina propria. Higher numbers 
were present just below the epithelial layer at all sites, often at the tips of the 
villi. Individual MHC II+ cells were observed less frequently in the lamina 
propria than in villous areas along the whole large intestine. In general fewer 
positive cells were observed at the proximal rectum (Fig 2.5 E & F) and distal 
colon (Figure 2.5 C & D) compared with the proximal colon (Fig 2.5 A & B) 
and terminal rectum (Fig. 2.5 G & H).This finding was statistically significant 
(p<0.05). Most of the positive cells within the follicles exhibited 
pleomorphism when observed at higher magnification (OM x 400), with an 
irregular shape and the elaboration of dendritic type structures (Fig. 2.5 H). 
A much smaller population of large, strongly staining, rounded cells, likely 
to be B cells, was also present (Fig. 2.5 F). In the epithelium and lamina 
propria the positive cells again appeared to fall into these two main 
populations in roughly similar proportions. 
2.3.1.2 CD205 expression 
The results of CD205 staining can be observed in Fig. 2.6. Widespread 
staining was observed for CD205.  Positive cells were observed frequently 
within the epithelial layer, along the basement membrane and bordering the 
intestinal lumen (Fig. 2.6 D, F & H). Positive cells were noted individually 
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and in small groups throughout the lamina propria (Fig. 2.6 B, C & E). 
Follicles were positively stained in their entirety (Fig. 2.6 A & G). More 
staining was observed at the terminal rectum and the proximal colon due to 
strong and widespread staining of the follicles in these areas (p<0.05). Cell 
phenotypes observed included a population of large irregular cells which 
were likely to be DCs, other cells with a flattened morphology and a sizeable 
population of rounded cells which were likely to represent T and B cell 
populations. 
2.3.1.3 SIRPα expression 
Positive staining for SIRPα was observed at all intestinal locations in all the 
animals studied. Representative results are shown in Fig 2.7. Staining for 
SIRPα was widespread, with large numbers of positive cells within the 
lamina propria and particularly sub-epithelially (Fig. 2.7 C & F). Occasionally 
individual SIRPα+ cells were observed within the epithelial layer between 
two epithelial cells making up the luminal edge of the tissue (Fig. 2.7 D). 
Aggregations of positive cells were observed around the edges of the 
follicles, almost forming a ring of strongly positive staining surrounding the 
follicle (Fig. 2.7 F, G & H).Very few strongly positive cells were noted within 
the follicular areas themselves, although a very weak stain was observed 
over the cells in the very centre of some follicles. The majority of the positive 
cells were large with an irregular morphology. A small number of the 
positive cells were more rounded in appearance (Fig. 2.7 D, G & H). There 
was a trend towards a larger number of positive cells within the tissues of 






2.3.1.4 CD1b Expression 
Positive staining for CD1b was observed in all animals tested and at all sites. 
The results are shown in Fig. 2.8. There were many fewer CD1b-positive cells 
than MHC II-positive cells, although CD1b-positive cells stained more 
strongly. There were significantly more CD1b-positive cells recorded at the 
terminal rectum than at other sites (p<0.05). There were few positively 
stained cells noted in the epithelial layers and none within the centre of the 
follicles. Positive cells could be found individually throughout the lamina 
propria at all sites. Darkly staining cells were observed individually and in 
small groups, in moderate numbers surrounding the edges of lymphoid 
follicles (Fig. 2.8 D). All of the positively stained cells were large with an 
irregular appearance and dendrites were often identifiable (Figure 2.8 E). 
2.3.1.5 CD40 Expression 
The results of CD40 staining are shown in Fig. 2.9. Positive staining for CD40 
was observed in all animals and at all of the intestinal sites. Staining for 
CD40 was fairly widespread and intense, being scored as severe in most 
sections. A large number of the positive cells were grouped together under 
the epithelium near the basement membrane. Individual positive cells were 
scattered through the lamina propria (Fig. 2.9 C, D & E). No cells were 
observed between the epithelial cells contacting the lumen (Fig. 2.9 B, D & F). 
The lymphoid follicles were strongly positively stained throughout making it 
difficult to identify any negative cells in this location (Fig. 2.9 A & G). The 
positive cells within the follicles were largely irregular in shape (Fig. 2.9 H). 
CD40+ cells with a flattened, elongated morphology were observed directly 
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below the epithelium. There was no significant difference between the 
anatomical sites for levels of positive staining observed (p= 0.083). 
2.3.1.6 CD11c Expression 
The results of CD11c staining are shown in Fig. 2.10. CD11c staining was 
generally weak although a small proportion of larger, more strongly-stained 
cells were present. There were no significant differences in CD11c expression 
at different anatomical locations (p=0.607), however a smaller sample size for 
some of the locations may have contributed to this. CD11c staining was 
carried out on frozen tissues and in some sections the morphology was not 
preserved sufficiently to accurately assess the staining pattern or cell 
morphology. Positive cells were observed at all sites and in all animals. 
However there was section to section variation, which could be due to the 
weaker nature of the positive staining with these reagents or variation in 
cryosectioning techniques. Positive cells were generally found within the 
lamina propria as large individual, irregularly shaped cells (Fig. 2.10 E) and 
sometimes in small aggregations (Fig. 2.10 B & D). Few positive cells were 
noted within the follicles. 
 
2.3.1.7 CD14 Expression 
The results of CD14 staining are shown in Fig. 2.11. Mild CD14+ staining was 
observed in all animals and at all of the intestinal sites.  The positive staining 
was generally weaker than that observed for the other molecules. Individual 
cells were observed throughout the epithelium and lamina propria. The 
CD14+ cells tended to have a more flattened or elongated morphology (Fig. 
2.11 D). However, infrequent, more strongly staining cells with a round 
morphology were also observed (Fig. 2.11 F). Positive staining was observed 
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in follicular areas and surrounding the follicles but was not pronounced. No 
significant difference was found between the staining patterns observed at 
the four intestinal sites (p= 0.082). A variation in staining patterns between 
the animals studied was observed and could be caused by several factors. It 
could be that heterogeneity of CD14 expression exists within the cattle 
population and this technique reflects these animal differences; or it could 
also be due to limitations of the technique. The generally weak nature of 
CD14 staining could indicate that the combination of tissue, fixation 
technique and reagents employed here may be close to the threshold of 
detection for CD14, and therefore in some sections positive staining is not 









































Fig. 2.5 Representative MHC II staining of bovine intestinal tissues. (A) & (B) Proximal 
Colon, (C) & (D) Distal Colon, (E) & (F) Proximal Rectum, (G) & (H) Terminal Rectum. 
Widespread staining of all tissues was observed. (A) Lymphoid follicles were stained 
strongly (B) positive cells were observed between the epithelial cells, contacting the 
intestinal lumen. (C) aggregations of positive cells were observed at the apical villi. (D) 
pleomorphic cells near the lamina muscularis. (E) Fewer positive cells were noted within the 
tissues of the proximal rectum. Aggregations of cells noted at the apical villi. Individual 
positive cells were scattered throughout the tela submucosa. (F) Pleomorphic cells at the 
apical villi and a positive cell within the epithelium. (G) Numerous positive cells within a 
lymphoid follicle of the terminal rectum. (H) Positively stained cells with a dendritic 
























Fig. 2.6 Representative CD205 staining of bovine intestinal tissues. (A) & (B) Proximal 
Colon, (C) & (D) Distal Colon, (E) & (F) Proximal Rectum, (G) & (H) Terminal Rectum. 
Widespread staining of all tissues was observed. (A) Intense staining of the lymphoid 
follicles of the proximal colon (B) Many positive cells were observed between the epithelial 
cells, contacting the intestinal lumen; a lymphoid follicle observed below the lamina 
muscularis (C) Fewer positive cells are noted within the tissues of the distal colon, mainly 
scattered through the lamina propria. (D) Mainly rounded or elongated cells were found 
near the apical villi. (E) Aggregations of cells noted at the apical villi. Individual positive 
cells were scattered throughout the tela submucosa. (F) Pleomorphic cells within the lamina 
propria, several positively stained cells were found within the epithelial layer (G) Abundant 
positive cells within the lymphoid follicles of the terminal rectum. (H) Numerous positively 
stained cells within the epithelial layer. Many large round cells, other morphologies noted, 
























Fig. 2.7 Representative SIRPα staining of bovine intestinal tissues. (A) & (B) Proximal 
Colon, (C) & (D) Distal Colon, (E) Proximal Rectum, (F) (G) & (H) Terminal Rectum. 
Moderate staining of all tissues was observed. (A) & (B) Staining of the lamina propria of the 
proximal colon showing some variation in the strength of positive staining (C) Staining of 
the distal colon shows that positive cells occur in aggregates at the apical villi and scattered 
through the lamina propria and tela submucosa. (D) Rounded and elongated cells were 
observed as well as cells with a more dendritic morphology. (E) Few positive cells within the 
proximal rectum. (F) Numerous strongly staining cells within the lamina propria of the 
terminal rectum, Positive cells were observed throughout the villi in groups as well as 
scattered throughout the tela submucosa. Positively stained cells surround the lymphoid 
follicles and are generally excluded from the centre. (G) Abundant positive cells within the 
tela submucosa surrounding a follicle at the terminal rectum. (H) Cells surrounding the 























Fig. 2.8 Representative CD1b staining of bovine intestinal tissues. (A) Proximal Colon, 
(B) Distal Colon, (C) Proximal Rectum, (D) & (E) Terminal Rectum. Mild staining of tissues 
was observed. (A) Staining of the proximal colon showing few strongly stained cells in the 
lamina propria and at the periphery of a lymphoid follicle. No positive staining was 
observed in the centres of the follicles (B) Sparse, strongly staining cells at the apical villi (C) 
Staining of the proximal rectum shows that a few positive cells occur scattered through the 
lamina propria (D) Positive cells within tissues of the terminal rectum surrounding the 
lymphoid follicles, and absent from the follicle centres. Strongly staining cells with dendritic 
morphology can be seen within the lamina propria, and also scattered between the 
lymphoid follicles within the tela submucosa. (E) Strongly staining dendritic – type cells 



























Fig. 2.9 Representative CD40 staining of bovine intestinal tissues. (A) & (B) Proximal 
Colon, (C) & (D) Distal Colon, (E) & (F) Proximal Rectum, (G) & (H) Terminal Rectum. 
Widespread staining of all tissues was observed. (A) Strong staining of lymphoid follicles 
and apical villous areas (B) Numerous positive cells throughout the lamina propria, very few 
positive cells observed within the epithelial layer. (C) Aggregations of positive cells at the 
apical villi. (D) pleomorphic cells within the lamina propria, no positive cells observed 
within or penetrating the epithelium. (E) Fewer positive cells are noted within the tissues of 
the proximal rectum. Small groups of positive cells within the lamina propria and individual 
positive cells scattered throughout the tela submucosa. (F) Pleomorphic cells at the apical 
villi and a positive cell within the epithelium. (G) Profuse staining of lymphoid follicles of 

























Fig. 2.10 Representative CD11c staining of bovine intestinal tissues. (A) Proximal 
Colon, (B) Distal Colon, (C) Proximal Rectum, (D) & (E) Terminal Rectum. Weaker staining 
of tissues, with a varied distribution was observed. (A) Staining of the proximal colon 
showing very few weakly stained cells in the lamina propria near the base of the intestinal 
glands (B) Groups of moderately stained cells at the apical villi (C) Staining of the proximal 
rectum shows weaker staining pleomorphic cells at the apical villi (D) Positive cells within 
tissues of the terminal rectum were slightly stronger staining, here pleomorphic cells are 






























Fig. 2.11 Representative CD14 staining of bovine intestinal tissues. (A) & (B) Proximal 
Colon, (C) & (D) Distal Colon, (E) Proximal Rectum, (F) (G) & (H) Terminal Rectum. 
Moderate staining of all tissues was observed. (A) Diffuse, weak staining of the follicles of 
the proximal colon (B) Positively stained elongated cell in the lamina propria and diffuse, 
weak stain of the follicle tissue below the lamina muscularis. (C) Staining of the distal colon 
shows that positive cells occur in aggregates at the apical villi and scattered through the 
lamina propria and tela submucosa. (D) Elongated cells observed within the lamina propria 
of the distal colon. (E) Little positive staining within the tissues of the proximal rectum (F) 
Sparse positive cells within the lamina propria were elongated or rounded in shape. (G) 
Weak staining of the lymphoid follicles of the terminal rectum. (H) Moderately stained cells 
were generally of an elongated or rounded phenotype within the lamina propria. A weak 
stain can be seen on cells within the lymphoid tissue below the lamina muscularis. 
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2.3.2 Double immunohistochemical staining 
The results described in section 2.3.1.1 and Fig. 2.5 identified widespread 
populations of MHC II+ cells associated with the epithelium and lymphoid 
tissues of the bovine intestine. Further staining revealed other cell surface 
molecules in similar anatomical locations to the MHC II+ cells (sections 2.3.1.2 
– 2.3.1.7 and Fig. 2.6 – 2.11). A selection of these molecules was chosen for 
further investigation by double immunofluorescence, co-staining with MHC 
II as described in section 2.2.4. The molecules of interest selected were SIRPα, 
CD205 and CD1b. The same six animals and the same intestinal sites were 
used as for the single staining protocols. Approximately 500 (range 400-600) 
MHC II+ cells per tissue section were counted and the number of these cells 
that were dual stained was recorded. The areas selected for analysis were the 
epithelium and lamina propria because the large numbers of positive cells 
within the follicles would make it difficult to identify individual cells. This 
study was directed towards identifying DC populations within the tissues 
and, as such, these cells would be large irregular cells which express MHC II 
in addition to other cell molecules. Calculation of the percentage of cells 
which are dual stained from the total MHC II+ population can potentially 
indicate prevalence of DC subsets. However, not all SIRPα+, CD1b+ or CD205+ 
cells were MHC II+ and it was appropriate to also consider these cells. It was 
important to take into account that this method of statistical analysis does 
not indicate actual numbers of dual stained cells per section, only the 
proportions of cells single or double stained for various molecules and how 
these proportions may relate to anatomic locations. The relative numbers of 




Firstly, this numerical system enabled the calculation of the percentage of the 
total MHC II+ cell population (FITC stained – green fluorescence) which co-
expressed each molecule (yellow fluorescence). Calculation of the percentage 
of CD205+, SIRPa+ and CD1b+ cells  (Tyramide stained – red fluorescence) 
which were also MHC II+ (yellow fluorescence) was also performed. 
Representative images obtained for the double staining are shown in Fig. 
2.12. All controls slides were clear (data not shown). The percentage of the 
total number of MHC II + cells which also expressed each of the molecules of 
interest is shown in Table. 2.3. SIRPα was expressed on a small percentage of 
MHC II + cells (<5%) at each site along the intestine. CD205 was widely 
expressed by the MHC II+ population in the intestine with variations that 
were site specific (p<0.05). The largest percentage of CD205+ cells which were 
also MHC II+ were observed within the tissues of the colon (73%). The 
percentages at the proximal rectum and proximal colon were similar at 43-
45% and the smallest percentage of co-localisation was observed at the 
terminal rectum (35%). 
 
There was great anatomical variation in the percentage of MHC II+ cells 
which expressed CD1b. The smallest percentages were found at the proximal 
rectum (8%) and the terminal rectum (12%). The colon tissues contained 
higher percentages of MHC II+ cells which also expressed CD1b; 28% at the 
proximal colon and 58% within the distal colon.  
 
Next, the counts of positive cells recorded for each section were used to 
calculate the percentages of each of the individual cell surface molecules 
(CD1b, CD205 and SIRPα) which also expressed MHC II. This data showing 
the percentage co-localisation of MHC II with each molecule is shown in 
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Table. 2.4. This provided different information about the positively stained 
cells in the intestinal tissues.  Co-localisation of SIRPα and MHC II was 
observed in all the animals and at all the intestinal sites at low levels; 15 - 
20% of SIRPα+ cells were also MHC II+ at all sites except the colon. At the 
colon, less than 10% of SIRPα+ cells were co-localised. These findings indicate 
that 80 – 90% of SIRPα+ cells were not found to co-express MHC II when 
using this method in these tissues. The majority of CD205+ cells also 
expressed MHC II. Greater than 50% of CD205+ cells also expressed MHC II 
at all intestinal sites except the terminal rectum. The percentage of CD205+ 
cells co-localising within the tissues of the terminal rectum were lower at 
33%. It was found that 50 – 70% of CD1b+ cells also expressed MHC II and 

























Fig. 2.12 Representative fluorescent stained sections of calf intestine. Green 
fluorescence in all images corresponds to MHC II expression. Red fluorescence: (A) & (B) 
CD205; (C) & (D) SIRPα; (E) & (F) CD1b. Yellow fluorescence indicates co-localisation of 
molecules. All sections are from rectal tissues. (A) Staining for MHC II and CD205 at the 
bovine terminal rectum. Numerous MHC II+ cells (green) within the lamina propria, Many 
CD205+ cells also expressed MHC II (yellow). Few CD205+ single stained cells. (B) Higher 
power image of proximal rectum tissue showing a few CD205+ cells (red), some large MHC 
II+ cells (green) and two double stained cells (yellow). (B) Tissue of the proximal rectum 
stained for MHC II (green) and SIRPα (red). Many MHC II+ cells present, several SIRPα+ cells 
and occasional larger double stained cells near the apical villi. (D) Co-localisation of MHC II 
and SIRPα (yellow) in a large cell with dendritic morphology. (E) Tissues of the proximal 
rectum stained for MHC II (green) and CD1b (red) showing numerous MHC II cells in the 
lamina propria region. Fewer cells were CD1b+ and co-localised cells (yellow) were sparse. 
(F) Large cell with dendritic morphology stained positively for MHC II, with one cell which 











Table 2.3 The percentage of MHC II
+
 cells which co-express DC cell surface 
molecules: (†) A double immunohistochemical staining method was used for DC molecules 
and MHC II in the proximal colon, distal colon, proximal rectum and terminal rectum of 6 
calves. (*) Values are the mean percentages of cells expressing MHC II which also express 
SIRPα, CD205 and CD1b ± SEM. Significant differences (p<0.05) for anatomical location were 
observed for CD205  and CD1b. No significant difference for anatomical location was 









Table 2.4 Co-expression of DC cellular molecules with MHC II; the percentage of cells 
expressing the DC molecule of interest which co-express MHC II: (†) A double 
immunohistochemical staining method was used for DC molecules and MHC II in the 
proximal colon, distal colon, proximal rectum and terminal rectum of 6 calves. (*) Values are 
the mean percentages of cells positively stained for SIRPα, CD205 and CD1b which also 
express MHC II ± SEM. Significant differences (p<0.05) were observed at anatomical 
locations for CD205. There were no significant differences between intestinal sites observed 




For this chapter, immunohistochemical techniques were used to characterise 
dendritic cells in bovine intestinal tissue and to investigate any differences in 
the population of cells within selected locations within the tissues of the large 
intestine, including the terminal rectum. 
Widespread staining of MHC II within the tissues of the terminal rectum 
suggests there are numerous immune cells in this area. The additional cell 
surface molecules investigated, the co-localisation of selected molecules with 
MHC II, the locations of the positively stained cells and their morphology 
make it quite clear that there are numerous DCs within all bovine large 
intestinal tissue including the terminal rectum which is the principal site of E. 
coli O157:H7 colonisation. 
There were significantly more positively stained cells found associated with 
the lymphoid follicle areas within the proximal colon and terminal rectum 
than found within the tissues of the proximal rectum and the distal colon. 
This was evident by visual inspection and confirmed by statistical analysis of 
data derived from the stained sections. 
There was widespread staining of MHC II, CD205 and CD40 within the 
follicles. The results of the single colour IHC indicates that there is a 
population of cells within bovine intestinal tissues that are likely to be MHC 
II+, CD205+ and CD40+, suggested by the profuse staining for these three 
epitopes within the tissues of the lymphoid follicles. This does not fully 
define these follicular cell populations, however, and multiple-colour IHC 
could more accurately identify the molecules which are co-expressed by 
these cells. Additionally, if the cells could be extracted from this area, 
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multiple colour FACS analysis would assist further characterisation. The 
possibility of characterising ex vivo DCs in this way is investigated in more 
depth in Chapter 3. 
The staining pattern observed for SIRPα and CD1b, where few positive cells 
were observed within the follicles but were clustered around the follicular 
margins and scattered within the lamina propria, suggests these populations 
of cells take up similar anatomical locations. Although there were many 
fewer CD1b+ cells than SIRPα+, it is possible that some of these cell are either 
co-expressing or are in close proximity. The morphology of these cells is 
strongly suggestive of DCs. Further techniques such as three colour 
immunofluorescence would be required to confirm any co-localisation of 
these epitopes with MHC II. Within ALDCs draining the skin of cattle, a 
subset of SIRPα+ cells have been shown to co-express CD1b (Howard et al., 
1999). The SIRPα staining pattern, (strongly stained cells with dendritic 
morphology surrounding the lymphoid follicles) was interesting and is 
similar to findings in bovine mediastinal lymph node and spleen, where 
SIRPα+ cells were identified but were excluded from the B cell germinal 
centres of these tissues (Brooke et al., 1998). 
CD11c staining, although weak, was observed in anatomical positions where 
MHC II+ cells were located and dendritic morphology was observed, 
suggesting a small subpopulation of bovine DCs could be CD11c+. Double 
staining with MHC II could verify this. CD11c has been found to be 
expressed by SIRPα+ bovine DCs in blood and the thymic medulla 
(Miyazawa et al., 2006).  
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Macrophage populations, represented by CD14 staining, indicated two 
populations of cells within the intestinal tissues. Weak staining of the follicle 
tissues suggests that cell types in this location weakly express CD14. More 
strongly staining cells within the lamina propria were either very elongated, 
or more rounded in appearance, neither of which are a classic dendritic 
morphology. Although some DCs may be weakly expressing CD14 within 
the follicles, the majority of the CD14 cells are likely to represent 
macrophages. 
 Double staining allowed the calculation of the percentages of MHC II+ cells 
which co-expressed DC molecules at each intestinal location. 
When comparing the results of the double staining with the study by 
McNeilly et al (2006), which examined tissues of the respiratory tract, many 
similarities can be drawn. The percentage of MHC II+ cells co-expressing 
SIRPα was similar for intestinal and airway tissues at 5% or less. This 
suggests that a significant population of SIRPα- DCs are likely to be present 
in the tissues. It has been shown that SIRPα- DCs from both sheep mucosae 
and rat intestine contain apoptotic bodies and are likely to be tolerogenic in 
function, and are therefore an important DC sub-population (Epardaud et al., 
2004; Huang et al., 2000).   CD205 expression by MHC II+ cells in the intestine 
was also similar to that found in the airway tissues: around 60% for the 
airways and between 43% and 73% for the intestinal tissues. No cells co-
expressing SIRPα were found within the lung tissue and less than 10% of 
MHC II+ cells were also CD205+ in this area. It is possible that this may reflect 
the reduced antigen challenge within the lung tissues compared with the 
airways and intestine. There were marked differences in the percentages of 
MHC II+ cells co-expressing CD1b depending on anatomical location. Within 
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all the respiratory locations the percentage was less than 10%, which was 
similar to the values calculated for the proximal and terminal rectum (8% 
and 12% respectively). This study found a much greater percentage of CD1b+ 
cells co-expressing MHC II in the tissues of the proximal and distal colon 
(28% and 58% respectively). The sheep pulmonary study (McNeilly et al., 
2006) found that 96% - 100% of SIRPα+ and CD205+ cells in the airway also 
expressed MHC II but that around 87% of CD205+ cells in the lung 
parenchyma did not co-express MHC II. Although this study also shows that 
CD205+ cells co-expressing MHC II is significantly varied with anatomical 
site such as found by McNeilly et al., in contrast to the airway findings this 
study suggests that 16 – 64% of intestinal CD205+ cells were MHC II-. These 
cells are likely to be B and T lymphocytes. Furthermore, upward of 80% of 
SIRPα+ cells in this study appeared not to express MHC II. SIRPα is 
expressed by bovine DCs, monocytes, macrophages and granulocytes 
(neutrophils and eosinophils) (Ellis et al., 1988; McKeever et al., 1991). Of 
these cells only the granulocytes do not express MHC II in resting states, 
however both neutrophils and eosinophils can be stimulated to express MHC 
II (Celestin et al., 2001; Hansch & Wagner, 2003). A study by Stamm et al. 
(Stamm et al., 2008) also found a population of SIRPα+, MHC II- cells within 
the lamina propria of the bovine colon and the authors concluded that these 
cells were intestinal macrophages, despite the fact that macrophages would 
also be expected to show some level of MHC II expression. It is unclear 
whether the SIRPα data here represents an actual finding or is a result of the 
more intense SIRPα staining compared with the moderate MHC II staining 
when using the fluorescent antibodies. The imaging software was 
occasionally hampered by the varied levels of fluorescence when producing 
a multidimensional image. It is also possible that the dual staining protocol 
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blocked some of the MHC II sites due to the SIRPα, CD1b or CD205 mAbs 
being incubated with the tissues before MHC II. A further possibility is that 
the SIRPα+ cells were expressing MHC II at a low level which was below the 
level of detection by these methods, and these cells could represent a 
population of immature peripheral DCs.  
 
 50 to 70% of CD1b+ cells co-expressed MHC II in the bovine intestine, which 
is only marginally lower than the results for ovine respiratory tract where 60 
– 90% of CD1b+ cells co-expressed MHC II. 
In summary, this study found similar populations of DCs in the bovine 
intestine to those found within the ovine respiratory system with widespread 
MHC II+ cells throughout the tissues. DC populations expressing CD205 
were widespread with smaller sub-populations of SIRPα+ and CD1b+ cells. 
However this study identified a population of cells that was SIRPα+, MHC II- 
which was not observed by McNeilly et al. in ovine tissues. CD205+, MHC II- 
cells were observed in ovine lung parenchyma (87%) but very infrequently 
within the upper airways, thus showing an anatomical variation. In this 
work too CD205+, MHC II- cells appeared to be significantly linked to the 
anatomical location sampled (p<0.05). 
Within the intestinal tissues 40-60% of CD1b+ cells did not express MHC II. 
As MHC II expression is characteristic of DCs, it is probable that these cells 
are not DCs and as discussed in McNeilly et al. (2006), it is possible that they 
represent cortical thymocytes.  
In contrast to the McNeilly study, where SIRPα staining of the ovine DCs 
was relatively weak, SIRPα staining was strong in the bovine cells. This 
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could represent a genuine increase in SIRPα expression by the bovine cells 
compared to ovine, or could be due to differences in protocols or reagents, 
and may have affected the dual staining results as discussed above. The 
monoclonal antibody used by McNeilly was ILA-24 whereas this study used 
CC149. Both antibodies have been investigated by Brooke et al (1998), and 
they were each found to recognise a different epitope of SIRPα which could 
account for the differences in staining observed here. In addition, although 
both mAbs functioned to inhibit binding of T cells to SIRPα, CC149 did this 
with higher efficacy than ILA-24 (Brooke et al., 1998). 
The lower numbers of SIRPα+ cells in the intestinal tissue possibly suggests 
that a SIRPα- population is more widespread here than SIRPα+. This is 
similar to the situation found in sheep where SIRPα- cells were more 
commonly found in lymph draining the mucosal surfaces of the head 
compared to the skin (Epardaud et al., 2004). 
The work on ALDCs in ruminants has identified differences in the DC 
populations draining different anatomical locations. The original bovine 
studies were carried out on lymph draining the skin, and this is where the 
majority of the information on bovine DCs, their function and phenotype has 
originated (Gliddon et al., 2004a; Gliddon & Howard, 2002; Hope et al., 2001; 
Howard et al., 1996; Howard et al., 1997; Stephens et al., 2003). More recent 
work has been carried out on lymph draining the ovine head and has shown 
that SIRPα- cells may be more common within mucosal tissue than the skin.  
This could be reflected in this study, as SIRPα+ cells were only a small 
population within the DCs of the intestinal mucosa. 
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There are differences between the cellular expression of SIRPα and CD1b in 
the tissues of the intestine found in this study when compared to ALDC 
expression levels. A greater proportion of cells within bovine lymph express 
both SIRPα and CD1b. This could be due to anatomical variation as the 
majority of ALDC work employs DCs migrating from the skin. The results 
shown here could indicate genuine differences in the populations within 
intestinal tissues compared to the skin. These findings could also relate to 
state of maturity of the cells involved. DCs within peripheral tissues, such as 
the intestine or the skin or the lungs, are widely accepted to be immature, 
with maturation occurring upon uptake of antigen and during migration to 
the draining lymph node (Banchereau et al., 2000). Therefore, afferent lymph 
cells have begun their migration, are likely to be carrying antigen, will have 
undergone some initial maturation characterised by changes in cell surface 
molecule expression and may not accurately represent the DC populations of 
the peripheral tissues which they have left.  Finally, work carried out on 
ALDCs has for the most part utilised flow cytometry, a technique which may 
have inherent differences in sensitivity to the IHC techniques used here. This 
could account for some of the observed differences in cellular expression. 
Positively stained MHC II cells appeared occasionally to be within or 
between adjacent epithelial cells, in direct contact with the intestinal lumen. 
This finding may indicate that the sampling method used by DCs, in which 
they extend dendrites into the intestinal lumen to collect antigens, does occur 
in cattle as has been reported in murine hosts (Chieppa et al., 2006; Collan, 
1972; Rescigno et al., 2001b). A higher number of CD205+ cells were found to 
be in contact with the intestinal lumen than any of the other molecules. Since 
not all of these cells were co-localised for MHC II it is possible that they may 
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not be DCs. However, these cells could be immature DCs expressing MHC II 
at levels below the threshold for detection by this technique. However, a 
proportion of the cells within the epithelial layer were MHC II positive and 
are likely to represent DCs in a location ideal for sampling antigens directly 
from the intestinal lumen. 
 
This study was performed on tissues from six month old calves and thus 
may not be representative of adult animals. It is also possible that there could 
be age, breed, management or age related changes. A similar study observed 
no age-related differences in the distribution and expression of DC markers 
in ovine intestinal tissues (Akesson et al., 2008), and so it possible that this 
situation is mirrored in other ruminant species. However, there have been 
differences noted in immune cell locations within the ileal immune follicles 
when comparing newborn or neonatal calves with animals of 2 months old 
(Lwin et al., 2009). Investigations into dendritic cell subsets within Peyer’s 
patches of rats did reveal age-related differences in DCs; differences reached 
a steady state at approximately 11wks post partum, corresponding with the 
time of adult maturity in rats. Differences were observed at times of major 
dietary change such as weaning (Zhou et al., 2009). The calves in this 
experiment were weaned and fed a solid diet. Their intestinal maturity 
would more closely resemble that of an adult than a neonatal animal on a 
purely milk diet, so it is reasonable to assume that the results obtained here 
reflect the situation in adult animals. A similar study on fully mature bovine 
intestinal tissues would be necessary to confirm this. 
 
Several antibodies were trialled with the calf tissues to attempt to visualise B 
cell populations in order to determine their anatomical locations and to 
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confirm that these are distinct from those of DCs. Antibodies for IgG, IgA, 
IgM and CD79 were used on ZSF and frozen tissues. CD79, IgG and IgA 
antibodies showed non-specific or no staining, or patterns of staining that 
varied greatly between sections. Staining for IgM was successful and stained 
up the mucosal edges of epithelial cells, cells within the lamina propria and 
the centre of follicles but not the interfollicular areas. Individual positively 
stained cells that were observed were large and round and strongly stained 
(data not shown). These results made it difficult to definitively identify B cell 
populations; however the morphologies of the positively stained cells and 
the co-localisation observed using the antibody panel in sections 2.3 - 2.9 
make it likely that DCs have been positively identified in this work.  
 
In conclusion, this work shows that the bovine large intestine contains many 
immune cells. DCs are found in all tissues of the large intestine, in particular 
within the lymphoid follicles of the terminal rectum. These DCs are defined 
primarily by their morphology and expression of MHC II. Their cellular 
morphology displays numerous cytoplasmic processes and large eccentric 
nuclei. Expression of various other cell molecules including SIRPα, CD1b, 
CD205 & CD11c can help to identify DC subsets. SIRPα+ DCs were a smaller 
subset found at all intestinal sites; no significant differences between the 
anatomical sites were detected. CD205+ DCs were more widespread and 
showed a distribution significantly linked to anatomical location. CD1b was 
expressed by a moderate subset of intestinal DCs, and some site specific 
differences were noted. The work presented here also highlights the 
importance of recognising the limitations of any technique when interpreting 
any resulting data. Further techniques such as three colour IHC or flow 
cytometry of ex vivo cells would provide additional characterisation 
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information for the DC populations within the intestine to support the 










Chapter 3 Development of a protocol to isolate 











3.1 Introduction  
The results from Chapter 2 give a clear indication that there are potentially 
numerous DCs within the tissues of the terminal rectum of cattle. To assess 
any possible interactions between E. coli O157:H7 and DCs, it would be 
useful to extract these local DCs for further investigation in vitro.   
 
Dendritic cells from diverse anatomical locations and which encounter 
different micro-organisms are likely to respond uniquely to their 
surrounding environment. These different responses are likely only to be 
able to be studied accurately in vitro with cells extracted from their specific 
anatomical location.  
 
Many studies have been carried out on cells generated from blood, but it is 
argued that these may not behave as specifically as ex-vivo tissue cells. The 
role cytokines play in producing DCs in vitro has been reviewed and the 
extent to which this may reflect the in vivo situation. It has been postulated 
that the GM-CSF stimulated cells represent not the normal state DCs but are 
more likely to correspond to DCs present during inflammatory processes 
(Conti & Gessani, 2008).   
One aim of this study was to look at the possibility of extracting DCs from 
the bovine terminal rectum as the site of localisation of E. coli O157:H7. It was 
presumed that viable DCs could be extracted in sufficient numbers to 
perform downstream assays including their phenotypic characterisation as 
well as assessing their interactions with E. coli O157:H7 and its components. 
DCs have been generated in vitro from bone marrow in mouse (Inaba et al., 
1992), rat (Talmor et al., 1998), human (Reid et al., 1992) and bovine systems 
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(Hope et al., 2000b). Stem cells from cord blood have also been used in this 
way (Zheng et al., 2000).  
A common method to generate DCs in vitro has emerged with the use of 
blood monocytes as precursor cells in humans (Sallusto & Lanzavecchia, 
1994), rats (Richters et al., 2002), mice (Schreurs et al., 1999), pigs (Carrasco et 
al., 2001; Paillot et al., 2001) as well as cattle (Hope et al., 2000a; Werling et al., 
2002). These methods involve extended culture of cells in the presence of 
cytokines.  
DCs from the tissues of interest have also been studied directly, including 
spleen, liver, lymph node, lungs and skin, using various techniques. DCs 
from the thymus and spleen of rats have been collected for study by 
enriching for dendritic cells using metrizamide and plastic adherence 
techniques subsequent to collagenase tissue digestion (Josien et al., 1997). 
Cells are more readily released from lymph nodes than intestinal or other 
organ tissues and lend themselves well to producing a single cell suspension.  
However, all these methods described involve many laboratory practices 
including extensive culturing, wash steps, separation techniques and other 
manipulations, all of which may give rise to cells which do not closely 
resemble the in vivo counterparts which are the cells of interest. 
One method for the study of ex vivo DCs is the afferent lymphatic 
cannulation model, whereby lymph DCs returning from the tissue of interest 
to the draining lymph node are collected. This has been achieved by removal 
of local lymph nodes and cannulation of lymph ducts in various species. 
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These techniques lend themselves necessarily to anatomical sites which are 
accessible using surgical techniques.  
DC populations in rodents have been collected and studied following lymph 
duct cannulation. Rat intestinal lymph DCs are shown to belong to several 
sub-groups with varied cell surface molecule expression and functional 
activity (Yrlid & MacPherson, 2003). Two main subsets have been identified: 
SIRPα-, CD4- and SIRPα+, CD4+. These two subsets have been characterized in 
terms of their phenotype, anatomical distribution, T cell stimulatory 
functions and in vitro viability. The SIRPα+ cells have been shown to have 
superior immunostimulatory capabilities in vitro compared with the SIRPα- 
cells as well as superior viability in culture conditions. This has been 
demonstrated using mixed leukocyte reactions (MLR) and naïve CD8+ T cell 
proliferation assays (Liu et al., 1998; Voisine et al., 2002).  The SIRPα- cell 
subset constitutively endocytose apoptotic enterocytes and migrate to T cell 
areas indicating a role for these cells in self-tolerance in the intestine (Huang 
et al., 2000). SIRPα- cells have been localised to the T cell areas of the 
mesenteric lymph node while the SIRPα+ were not observed in this location, 
further supporting a role for the tolerogenic nature of SIRPα- and a 
stimulatory role for the SIRPα+ cells (Liu et al., 1998).  
Porcine DCs have been studied by both cannulation and 
immunohistochemistry methods.  Four main populations of cells were found 
using IHC on porcine intestinal tissue however, only two of these were then 
found in the lymph draining this tissue. The sub-sets found in the lymph 
corresponded to DCs found in the lamina propria and not other anatomical 
locations within the intestine. This could suggest that either migration from 
tissues occurs mainly from the lamina propria or that DCs alter in their 
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expression of cell surface molecules in response to migration (Bimczok et al., 
2005).  
The removal of the bovine pre-scapular lymph node and cannulation of the 
resulting pseudo afferent lymph duct is a well documented technique and 
has provided valuable information about DCs phenotype and function in this 
species (Hope et al., 2006). Again, these cells are not found to be 
homogeneous, and two main sub-groups have been identified based on cell 
surface molecule expression, although there is an indication that there could 
be yet further sub-groups within this definition that are yet to be identified 
(Howard et al., 1999). As for rodent afferent lymph DC subsets, bovine cell 
subsets defined on the basis of phenotypic differences were found to be 
functionally divergent with different capacity to interact with T cells. The 
two broad groups of cells in afferent lymph could be identified by their 
expression of SIRPα. The SIRPα+ cells were found to induce proliferation of 
both CD4 and CD8 T cells at a greater level than the SIRPα- cells. SIRPα- and 
SIRPα+ subsets were able to present soluble protein antigen (OVA) equally. 
There was, however, a tenfold difference in response to viral antigen. SIRPα- 
and SIRPα+ subsets which had been incubated with RSV virus in culture 
were used to stimulate CD4 cell proliferation and the SIRPα+ cells produced 
the greater response (Howard et al., 1997).  
DCs from other ruminants too have been studied in this way. Lymph 
returning from the mucosal surfaces of the head and neck has been 
successfully collected from sheep following removal of the cervical lymph 
nodes. The cell types have been investigated as potential vaccine targets 
(Schwartz-Cornil et al., 2005). As the DCs are important for generating 
tolerance or immune responses to encountered antigen they may be able to 
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present vaccine to naive T cells. DCs could potentially act as vehicles, taking 
vaccine from mucosal surfaces to inductive sites in lymph nodes. Both 
cannulation methods (prescapular and cervical) have been used in sheep to 
investigate the role of the mucosal environment on DC phenotype and 
migration (Epardaud et al., 2004). These methods too have revealed 
significant heterogeneity in the DC populations recovered. Although cells 
from both anatomical locations express MHC II and co-stimulatory 
molecules (CD40, CD80 and CD86) at similar levels there were a greater 
number of CD26hi, SIRPα- cells found in the lymph returning from the head 
mucosa than the skin. These CD26+ cells are thought to be tolerogenic within 
the mucosa as they can take up apoptotic cellular fragments. When 
considering that these cells transport apoptotic DNA during their migration 
to lymph nodes it is possible that this cellular subset continually samples and 
migrates, presenting self antigen to T cells with the purpose of maintaining 
tolerance to self. Additionally in this study it was found that a lower number 
of total DCs circulating from the mucosa were recovered than from the skin 
(Epardaud et al., 2004). A subset of bovine SIRPα- DCs have been shown to be 
CD26+ and have also been found in lymph node tissues and afferent lymph 
draining the skin (Gliddon & Howard, 2002). 
From the published work in these veterinary species and the 
immunohistochemistry carried out in Chapter Two several molecules were 
chosen for study in this chapter. They were selected for their capacity to 
indicate dendritic cell populations and stages of maturity. See Chapter Two 
for a more in-depth description of each molecule, its function and relevance 
to bovine dendritic cell subsets. 
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The advantage of studying ex vivo cells in this way reduces the possibility of 
cellular modification following culture, separation, enrichment or other 
potentially altering laboratory techniques. The DCs isolated represent most 
closely their in vivo counterparts. However, cannulation is not a viable 
technique for many tissue compartments. For example, in sheep it has been 
possible to cannulate the lymphatic system draining the small intestine (Hein 
et al., 2004; Pernthaner et al., 2002), but this would be very difficult in cattle 
due to the complexity of the procedure, and has not yet been attempted. 
Lymphatic drainage from the bovine abdominal organs is inconsistent, in 
that not all lymph nodes are found in all animals. The predominant lymph 
nodes draining the organs in the pelvic area are the medial iliac and sacral 
nodes, which are found around the bifurcation of the aorta, just caudal to the 
kidneys (Dyce et al., 1996). These nodes do not lend themselves easily to 
surgical techniques due to their deep location. In addition, these nodes are 
likely to receive lymph from other pelvic organs such as the reproductive 
organs and vessels as well as bladder etc. and therefore do not contain cells 
which are solely intestinal in origin. However, there are scattered anorectal 
and caudal mesenteric nodes found on the surface of the terminal intestine. It 
is likely that these smaller, more variable nodes will first receive the 
circulating DCs coming from the terminal rectum. Unfortunately these nodes 
will be very difficult to surgically remove, even at post mortem, and 
cannulation would in all probability be impossible. To even attempt these 




Thus, DCs have been extracted from many different tissues in different 
species, but intestinal DCs in cattle have not yet been collected successfully 
and subsequently used for downstream applications.  
Cells have been elicited from intestinal tissue in various species and DCs 
specifically have been collected for use in downstream assays. Murine 
colonic DCs have been extracted using digestion followed by density 
gradient centrifugation and filtering/sieving techniques. These cells were 
then characterised based on expression and functional profiles (Pavli et al., 
1990; Takenaka et al., 2007). It is from this work that the possibility of 
developing a protocol for collecting bovine DCs local to the site of interest 
was investigated. 
Similar digest methods have been used to elicit cells from intestinal tissues in 
rats.  DCs from intestinal tissue were compared with lymph DCs in their 
ability to stimulate a mixed leukocyte reaction. It was noted that culturing of 
the intestinal cells altered their stimulatory capabilities when compared with 
freshly isolated cells. Culturing of cells appeared to increase their stimulatory 
capacity which was proposed to correspond to a functional maturation of 
these cells (Liu & MacPherson, 1995). 
Human DCs also have been isolated from intestinal tissues in several studies, 
mainly making use of surgical biopsy samples and digestion techniques (Bell 
et al., 2001; Pavli et al., 1996).   
If DCs could be isolated from the terminal rectal tissue of cattle it would 
facilitate investigations of potential DC and E. coli O157:H7 interactions in 
vitro. This would negate the need for using blood-derived cell models which 
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may not accurately reflect in vivo responses. If it is possible to collect 
intestinal tissue DCs it would enable the comparison of the responses of 
these tissue DCs with the moDC in cattle. This comparison should be able to 
go some way to assessing the suitability of the widely used moDC model for 
E. coli O157:H7 colonisation studies. The use of post-mortem tissue would 
also remove the need for carrying out complex surgical techniques on live 
experimental animals. Furthermore, collection of these cells will enable more 
comprehensive characterisation of terminal rectal cells by methods such as 
flow cytometry for cell surface molecule expression, and functional assays; 
which would yield more detailed information than immunohistochemistry 
and other in-situ techniques will allow. 
In this study post-mortem terminal rectal tissue from cattle was used to 
attempt to develop a Dendritic Cell recovery protocol. Three main methods 
were employed, extrapolated from published protocols for other tissues and 
species.  
The aims of this chapter were: 
1. To develop a method of extracting TRDC (Terminal Rectal Dendritic 
Cells)  
2.    To characterise TRDCs by IHC and FACS analysis 
3.    To carry out a phenotypic comparison of TRDC with moDC 
4.    To use extracted TRDCs and investigate interactions with E. coli 
O157:H7 in vitro. 
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3.2 Materials and Methods  
 
3.2.1 Method 1: Tissue Digestion 
The initial part of this method is adapted from the technique developed by 
Dr. A. Mahajan to establish primary cell cultures of bovine rectal epithelial 
cells. This method had been modified from published techniques (Booth et 
al., 1995; Hoey et al., 2003). Terminal rectal tissue including the anus was 
collected from the abattoir. It had been immediately placed on ice in Hank’s 
Balanced Salt Solution (HBSS) with gentamicin (50 μg/ml) for the journey to 
the laboratory. Previous studies have revealed that up to 3 hours after 
removal, form and function of gastrointestinal tissue is essentially 
unchanged (Jackson et al., 2004). Once returned to the laboratory the luminal 
contents were flushed with PBS. Excess fat and connective tissue were 
removed, and the lumen opened along its length. The tissue was at this stage 
cut into two pieces, again along the length of the piece of intestine. Each 
piece was placed into a Falcon tube containing HBSS with Fungizone 
(Invitrogen) at (5 μg/ml) for 5 min. The mucus was gently scraped from 
mucosal surface with a glass slide and put to waste. A sterile glass slide was 
then used to scrape the mucosal cells from the underlying muscular and 
connective layers. These scrapings containing the intestinal cells were 
collected into a Falcon tube containing HBSS. The cells were washed five 
times in HBSS by gentle centrifugation at 260 x g for 2 min. After each spin 
any floating debris was then removed while being careful not to disturb the 
cell pellet. Digestion medium (Appendix A.4.2.5) was then added to the cells 
to make up to a final volume of 25 ml, and incubated in a shaking incubator 
for 1 h 30 min to 1 h 45 min at 37°C. Following the incubation the cells were 
washed in PBS once and then passed through a 100 μm cell strainer (352360 
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BD bioscience). Cells were washed again in PBS at 260 x g for 5 min. The 
sample was resuspended in 20 ml PBS, underlaid with 10 ml histopaque 1083 
and centrifuged (35min, 1200 x g, no brake, 20°C). The resulting cells at the 
interface were collected into a fresh Falcon tube. Following a final wash in 
PBS, the cells were strained again if required before proceeding with viable 
cell counting in Nigrosin, (Sigma) using a disposable chamber slide (Fast-
read 102, ISL, Devon). The cells were then resuspended to desired 
concentration for downstream applications including immunohistochemistry 
and flow cytometry. 
 
3.2.2 Method 2: GM-CSF Migration 
This method was developed from the technique used at IAH, Compton to 
extract DCs from tracheal tissue which in turn was modified from a 
published technique (Ortner et al., 1996) (Personal Communication, Dr. J. 
Hope, 2008). Terminal rectal tissue from the abattoir was stored on ice until 
returned to the laboratory. The epithelial layer was dissected out and was 
stored in TCM (Appendix A.4.2.3) for approximately 10 min at ambient 
temperature. The epithelium was cut into small pieces approx 1 cm x 1 cm 
using scissors or scalpel. The tissue pieces were transferred into a 9 cm Petri 
dish containing approximately 30 ml TCM with GM-CSF. (1:100 v/v, IAH, 
Compton) The tissue was incubated in the medium containing GM-CSF for 
approximately 24 h in Humidified incubator at 37°C with 5% CO2. After 
incubation the TCM containing any cells were removed into a Falcon tube. 
Any remaining cells were washed from the dish using PBS pre-warmed to 
37°C and add to the Falcon tube. These cells were pelleted by centrifugation 
at approximately 480 x g for 5 min, washed by adding approximately 20 ml 
PBS and a repeat of the pelleting step. The cells were then resuspended in 10 
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ml TCM, underlaid with 5 ml Histopaque and centrifuged (1200 x g for 30-40 
min, no brake, 20°C). Cells were removed from the interface using a 
graduated pipette and placed into a fresh universal. The cells were washed 3 
times, initially pelleted at 480 x g for 10 min at 4°C followed by two wash 
steps at 260 x g for 8 min at 4°C. Viable cell counts were made in TCM using 
a disposable cell counting chamber and Nigrosin stain as before. Cells were 
then resuspended as required for downstream procedures. 
 
3.2.3 Method 3: Mechanical Disaggregation  
This method was developed from a published method of retrieving viable 
cells from intestinal tissue from human biopsy samples (Olsen, 2009) Two 
pieces of terminal rectal tissue, including the anus, were collected from male 
Friesian cattle, following slaughter at Moredun Research Institute (MRI). The 
luminal contents were washed out using tap water. Excess connective and 
fatty tissue was removed and the pieces of intestine were opened along their 
length. Small samples of the terminal rectal mucosa, approx 1 cm2, were 
dissected out using a sterile scalpel blade and rat-toothed forceps. Three 
samples from each animal were put into separate Petri dishes containing 
TCM with 5 μg/ml Fungizone, Penicillin 100 U/ml and Streptomycin 30 
μg/ml added. These samples were incubated overnight at 37°C and 5% CO2. 
The following day the samples were dissected further to approx 3mm3. Three 
of these pieces were placed inside a BD Medimachine Medicon (BD 
MedimachineTM Medicon, 50 μm Sterile) with 1 ml of PBS. Disaggregation of 
the tissue was carried out by running the Medicon inside the Medimachine 
for 120 sec. A sterile syringe was then used to collect any cell suspension. If 
larger tissue particles remained inside the Medicon, fresh PBS was added 
and the disaggregation repeated until no visible tissue was left inside the 
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Medicon. The resulting cells in suspension were washed twice by 
centrifugation at 480 x g for 5mins in PBS. The cells were then filtered 
through a 100 μm FilconTM (BD) to remove any debris. The cells were 
resuspended in 20 ml PBS, underlaid with 10ml histopaque and centrifuged 
(1200 x g for 35 min, no brake, 20˚C). The cell layer resulting at the interface 
was collected using a graduated pipette. Three washes were then carried out; 
one at 480 x g for 10 min and then two washes at 210 x g for 8 min; each at 
4°C. At this stage any resulting cells were counted using Nigrosin stain and a 
disposable counting chamber, and resuspended in the appropriate media for 
downstream applications. 
 
3.2.4 Slide preparations 
Treated glass slides (superfrost plus®™, Menzel-glaser, Germany) were 
assembled with Cytospin filter paper on the charged surface and held 
together with bulldog clips along the long edge. These were used for making 
the slide preparations on the laboratory bench without the use of the 
Cytospin machine. 50 μl of cell suspensions at 5 x 105 or greater were 
dropped into the holes in the Cytospin paper. The liquid was wicked away 
into the filter paper and this left the cells on the surface of the slide, without 
the need for centrifugation. These preparations were then allowed to air dry. 
Once dried, the slides were kept at -20°C until required for staining 
protocols. 
 
3.2.5 Giemsa Staining of Slide Preparations 
Giemsa Stain (Sigma) was diluted 1:10 with Sorensen’s Buffer (Appendix 
A.4.5.1). The slides were flooded with Giemsa stain and incubated at room 
temperature for 30 min on a staining rack. Following the incubation the 
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slides were washed with Sorensen’s buffer and then fully dried under a fume 
hood. The slides were then coverslipped with Shandon Consul-mount 
(Thermo-scientific). The slides were observed and imaged using the same 
microscope and camera set up as described in section 2.2.1. 
 
3.2.6 Immunohistochemistry 
All slides were stained as previously described (See section 2.2.1). 
 
3.2.7 Flow Cytometry 
Primary mouse anti-bovine monoclonal antibodies (mAbs) and secondary 
anti-mouse FITC conjugated antibodies were used to indicate the presence of 
cellular markers. MoDCs were seeded at 5 x 105 cells per well of a 96 well 
microtitre plate (sterilin) in 50 μl TCM. Primary mouse anti-bovine 
monoclonal antibodies (mAbs) and secondary anti-mouse FITC conjugated 
antibodies were used to indicate the presence of cellular molecules. 
(Appendix A.4 mAbs used and concentrations) Antibodies were diluted in 
PBS with 0.1% NaN3 and 1% BSA (PBS/BSA/Azide). Antibodies were added 
to cell suspensions, agitated on a plate shaker (Fisherbrand® Vortex 
Whirlimixer) and incubated for 10-30 min at room temperature, covered to 
prevent drying. To wash the cells, 100 μl PBS/BSA/Azide was added to each 
well and cells were pelleted for 1 min at 480 x g, with supernatant flicked to 
waste. The secondary antibody was added and plates were agitated, 
incubated and washed as before. After the cells were stained they were fixed 
in 100 μl per well of 1% paraformaldehyde solution and stored at 4°C for a 
maximum of 14 days before FACS analysis. For analysis the fixed cells in 1% 
paraformaldehyde were resuspended in approx 250 μl of FACSFlow (BD) in 
a suitable tube. The samples were assayed on a FACSCalibur (Becton-
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Dickinson, San Jose, CA) or a Dako CyAn and data was analysed using FCS 
Express software. (DeNovo Software, Ontario, Canada) The limit was set at 
10,000 gated cells for each preparation, although in some cases there were 
not sufficient cells for this (see Results section 3.3). 
 
3.2.8 Data Analyses 
 Dot plots of forward scatter against side scatter (Fig. 3.1 A and C) were used 
to gate out dead cells and debris, the resulting cells were then used for 
further gating. Next, dot plots were used to plot forward scatter against 
fluorescence for the molecule of interest and its corresponding isotype 
control samples. These plots were used to gate for MHC II+ cells (Fig. 3.1 B & 
D). Within the positive population (gate 3), were cells expressing higher 
levels of MHC II; (gate 4) this population of cells were then gated and this 
final gate (gate 2) was applied to the original dot plots of forward and side 
scatter (Fig. 3.1 E) to indicate the location of the MHC II cells within the total 
population. It was this population of cells (gate 4), which were used for all 
analyses. Histograms were used to obtain mean fluorescence intensity (MFI) 
data and a marker was drawn to calculate the percentage of positively 
stained cells for each molecule of interest (Fig. 3.1 F and G). The MFI data for 
each cell surface molecule was calculated after subtracting the MFI for the 
specific isotype control. Graphs were plotted in Microsoft Excel. Statistical 
analyses were carried out in Minitab. Two sample t-tests were carried out for 
each cell surface molecule after assessing the data for equality of variance 






3.3.1 Method 1: Tissue Digestion 
3.3.1.1 FACS analysis of tissue cells 
Bovine terminal rectal tissue was digested and the resulting cells were 
analysed by flow cytometry. Each preparation was very different reflecting 
large animal to animal variation. Some preparations had numerous cells in a 
single cell suspension and were able to be analysed by flow cytometry. Other 
preparations contained many aggregations of cells which stopped the flow 
cytometer running. With some of these preparations, filtering the cell 
suspension through sterile lens tissue would enable reading of the sample. 
However for some preparations this was not sufficient and incomplete FACS 
datasets were generated. Due to the great differences in cell numbers 
retrieved, not all cell surface molecules were assessed in each preparation. 
From 11 cows sampled only 6 cows provided complete data sets of staining 
profiles for comparison of DC cell surface molecule expression by FACS.  
This digest technique was very inconsistent with much between animal and 
preparation variation. Within the gated population selected for analysis there 
was a greatly varied number of cells that were MHC II+. The percentage of 
MHC II + cells ranged from 18.4% to 42.04%. A representative example of the 
plots and gates used for analysis from one animal are shown in Fig. 3.1. This 
gating method was chosen to try to locate dendritic cells within the 
population of cells that were collected as it was assumed due to the nature of 
the technique, and early observations of slide preparations, that the 




From the first animal studied (individual data not shown) results suggested 
that the cells recovered from the abattoir terminal rectal tissue expressed a 
similar set of surface expressed molecules to the monocyte derived cells. A 
similar percentage of MHC II+ cells were found and these were shown to be 
at a similar level of maturity (based on CD40, 80 and 86 expression) although 
fewer of these cells were positive for both CD1b and SIRPα which appeared 
to correspond with findings on tissue DCs draining the mucosa of ovine 
tissues where the more prominent subset is SIRPα-. (Eperdaud, 2004) 
However, each time that this technique was repeated the more diverse the 
results were and no data sets were the same. (See Table 3.1 for ranges of 
results) The final data presented here is an average (+/- standard error) of six 
animals (Fig. 3.2). 
 
The monocyte derived DC data used for comparison is pooled from 7 
animals, four housed at IAH, Compton and three which were kept at MRI. 
The cell surface molecule expression profiles for these separate groups of 
animals was similar and so it was deemed reasonable that this data was 
representative of this widely used model and thus used for comparison. The 
moDC data is displayed fully and discussed further in Chapter Four.  
 
The percentage of cells expressing each cell surface molecule was lower for 
the tissue cells than the moDCs (p<0.05), with the exception of CD205 and 
CD86 which were similar (CD205, p=0.87; CD86, p=0.140). The most 
significant difference observed was for SIRPα (p<0.001) (Fig. 3.2 A) 
 
Mean fluorescence intensity (MFI) data for this terminal rectal tissue 
indicated that the level of cellular expression of the co-stimulatory molecules 
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CD40 and CD80 on these positive cells was lower (p<0.05) than the moDC 
suggesting a more immature DC type. (Fig. 3.2 B) However, the level of 
expression found was similar for MHC II, CD86 and CD205 (MHC II, 


































































Fig. 3.1 Flow cytometry of terminal rectal tissue cells showing gating strategy. Dot 
plots of cells retrieved from terminal rectal tissue showing the gated populations used for 
analyses. A & B – Dot plots of terminal rectal cells labelled with an isotype control. The live 
cells were gated for analysis (gate 1). Gate 3 was used to locate the cells positively stained for 
MHC II. C & D – Dot plots of terminal rectal cells labelled with MHC II. Gate 1 and 3 as 
above, Gate 4 contains the population of live cells highly positive for MHC II. E – Dot plot 
showing population of cells used for analysis (gate 2); these cells were gated through gate 4, 
F & G - Histograms  of MHC II expression (red) and isotype matched control (black) of the 
terminal rectal tissue cells selected for in Gate 1 showing the marker used to calculate the 
percentage of positively stained cells. The histogram without the marker was used for 
analysis of mean fluorescence intensity (MFI). Great variability in cell number was observed 

































































Fig 3.2 Flow cytometry of terminal rectal cells : method 1 
(A) Cellular expression of molecules on bovine moDC compared with cells recovered from bovine terminal rectal tissue using a tissue digestion 
method. MoDC: average of 7 animals, tissue cells (TRDC): 6 animals. Error bars represent standard error of the mean. Cells were gated through gate 
4 as described. (Section 3.2.8. & Fig. 3.1.). The percentage of tissue cells and moDC that were CD205+ were very similar (p=0.87). Numbers of cells 
expressing CD86 were also close to the moDC (p=0.14). A greater percentage of the moDC expressed MHC II, CD40, CD80, CD1b and SIRPα than 
the tissue cells, (* p<0.05).  
(B) Mean Fluorescence Intensity (MFI) of cell surface molecules on moDC compared with cells recovered from bovine terminal rectal  tissue 
using a digestion method. MoDC: average 7 animals, Tissue Cells (TRDC): average 6 animals. Error Bars represent standard error of the mean. Cells 
were gated through gate 4 as described. (Section 3.2.8. & Fig. 3.1.). Mean Fluorescence intensity for CD40, CD80, CD1b, SIRPα  molecules was much 
lower for the TRDCs than the moDCs (* p<0.05). MFI for MHC II, CD86 and CD205 was not significantly different in the tissue cells compared to the 



















Table 3.1. Range of results for percentage of positive cells and MFI of tissue cells 
collected using a digest technique. The range of results collected was broad. Each animal 
gave differing results; this technique did not provide consistent results. 
 
This was an interesting finding and the reduced number of cells expressing 
each molecule could be due to an impure cell population even with the 
efforts to gate for dendritic cells. It is also probable that there are different 
subsets of dendritic cells within the tissues of the terminal rectum and 
comparing with the moDCs which are a more homogeneous cell population 
will show differing results when analysed in this way. Also different subsets 
in the tissues would not be able to be identified by the single colour FACS 
staining carried out here. The similar levels of expression of the MHC II and 
the CD205 suggest however that some dendritic cells have been collected and 
positively stained, and suggest that the cells recovered are not monocytes as 
CD205 is not expressed by ruminant monocytes (McNeilly et al., 2006). It was 
hoped that experimental repeats and modification of the technique would be 
able to confirm and increase the significance of these findings as well as 
further reducing the numbers of contaminating non-DC cells.  
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The first tissue to be used for the digest method produced a large number of 
cells enabling numerous cell surface molecules to be studied. From this large 
panel there were five molecules expressed by more cells in the TRDCs than 
the moDCs, and at higher levels (data not shown). These molecules were 
CD1w3, CD3, CD5, CD13 & CD26. These molecules have been found to be 
expressed on epithelium (CD13, CD26) (Hansen et al., 1994; Stange et al., 
1996), T cells (CD3, CD5, CD13, CD26) B cells (CD5, CD1w3) (Stabel & 
Khalifeh, 2008; Werner-Favre et al., 1989) and vascular endothelium (CD1w3) 
(Jorundsson et al., 2000). Subsequent experiments did not yield sufficient cell 
numbers to study such a wide panel of molecules and so CD1w3, CD13 & 
CD26 were not selected for further work. CD5 and CD3 expression are 
investigated further in Chapter 4. This preliminary data could indicate that 
the cell population retrieved was not purely dendritic cells as both numbers 
of cells expressing each molecule and levels of expression was greater for the 
tissue cells when compared with moDC. However this could also point to the 
presence of dendritic cell subsets within the tissues of the terminal rectum. 
When looking at the published data available, it is known that ruminant 
mucosal dendritic cells express CD26 (Epardaud et al., 2004; Gliddon & 
Howard, 2002) and CD13 (personal communication Dr. J. Hope) and 










3.3.1.2 Giemsa staining of ex vivo terminal rectal tissue cells 
Staining of slide preparations of these cells was carried out using Giemsa 
stain to look for DC morphology and assess the quality of the slide 














Fig. 3.3 Giemsa Stain of terminal rectal tissue cells collected using a digest method. 
DC morphology was observed on several of the cells including eccentric nuclei and 
dendrites. The slide preparations contained some considerable mucus and cellular debris. 
(arrow = dendrite) 
 
Immunohistochemistry was carried out on slide preparations for several 
molecules known to be expressed by DC; MHC II, SIRPα and CD1b as well 
as isotype matched controls. The slide preparations were very variable in 
numbers of cells present. Some had numerous cell aggregations and mucus 
despite efforts to eliminate this in the technique. Varying cell types were 
observed indicating that this method did not produce a pure DC population. 
The slides were examined independently by a veterinary pathologist and 
dendritic type cells, epithelial cells, fibroblasts, plasma cells, macrophages 

































            
 
 
Fig. 3.4 Immunohistochemistry for cell surface expressed molecules on ex vivo cells 
from bovine terminal rectal tissue. DAB Staining for MHC II (A, B), SIRPα (C,D) and 
CD1b (E,F). Brown colour is positive staining. Positive cells were observed for all the 
molecules and cells showing distinct dendritic cell morphology were observed in all 




Positive staining was observed however for MHC II, SIRPα and CD1b, which 
are all expressed on bovine DCs as well as other cell types. Some distinct DC 
morphology was noted on some of the positively stained cells, with 
dendrites and large eccentric nuclei being a common feature (Fig. 3.4). 
Several repeats of this method and variations on it did not yield the 
corroborating results that were hoped for. A GM-CSF migration technique 
was the next method to be assessed. 
 
3.3.2 Method 2: GM-CSF Migration 
GM-CSF was used to stimulate DCs to migrate from bovine terminal rectal 
tissue. These cells were assessed by flow cytometry for cell surface expressed 
molecules. Although there was animal to animal variation a generally low 
number of cells retrieved meant that a much reduced number of cell surface 
expressed molecules could be assessed and that it was not possible to carry 
out any further investigations. (See table 3.2 for range of results obtained) 
 
Cells retrieved using this method did not have similar number expressing 
MHC II or CD1b compared to the moDCs for (p<0.05) but a similar number 
of cells were positive for CD205 in the tissue cells preparation as the moDCs.  
(p=0.75) (Fig. 3.5 A) However for such a small panel of markers and number 
of cells it is less likely that a pattern will be observed, or this may indicate the 
impurity in the cell population, or could indicate that subsets of DCs were 
collected using this method. Levels of expression for MHC II and CD1b were 
much lower on the tissue cells compared with the moDCs (p<0.05). CD205 
expression levels were similar for both the moDC and the tissue cells 
obtained by this migration method. (p=0.87) (Fig. 3.5 B)  
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Fig. 3.6 shows percentage expression (Fig. 3.7 A) and MFI (Fig. 3.6 B) data for 
cells recovered by the digestion method and the migration method compared 
with the moDCs. The percentage of MHC II+ cells and MFI was different for 
each method and also when compared to the moDCs. The numbers of CD1b + 
cells and the level of CD1b expression was similar for each TRDC method, 
however these were both much lower compared to the data for the moDCs. 
CD205 was the only molecule studied which had similar percentage of 
























































Fig 3.5 Flow cytometry of terminal rectal cells: method 2 
(A) Expression profiles of terminal rectal tissue cells collected by GM-CSF migration  method of extraction compared with MoDC; MoDC: 7 
animals. Tissue DCs: 4 animals for MHC II and 3 animals for CD1b and CD205. Error bars represent standard error of the mean. Cells were gated 
through gate 4, and analysed as described (Section 3.2.8 & Fig. 3.1). A low number of cells extracted with this technique allowed only three 
molecules to be analysed. Some positive staining was observed and the percentage of cells expresing CD205 was very similar for the tissue cells and 
the moDC (p=0.75). The numbers of cells expressing MHC II and CD1b was much lower for the tissue cells than the moDC. (* = p<0.05) 
(B) Mean fluorescence intensity of cell surface molecules on terminal rectal tissue cells collected by a GM-CSF migration method of extraction 
compared with moDC; moDC: 7 animals, Tissue DCs: 4 animals for MHC II and 3 animals for CD1b and CD205. Error bars represent standard error 
of the mean. The cells were gated through gate 4, and analysed as described (section 3.2.8 & Fig 3.1).  Mean fluorescence intensity for the tissue cells 
was much lower on the tissue cells for MHC II and CD1b compared to the levels on the moDC (* = p<0.05), but the levels of expression for CD205 
vas very similar (p=0.87).  
 





















































                                                                                                                            
Fig. 3.6 Flow cytometry of terminal rectal tissue cells: method 1 and method 2 compared with moDCs 
(A) Expression profile of cells extracted from bovine terminal rectal tissue; two methods compared with monocyte derived DCs; MoDCs: 7 
animals, TDC–1: 4 animals for MHC II and 3 animals for CD1b and CD205. TDC-2: 4 animals. Error bars represent standard error of the mean. TDC-
1 = digestion method; TDC-2 = migration method. The methods used produced a different expression profile from each other and the moDCs for 
MHC II. Both methods showed a similar percentage of cells that were positive for CD1b but this was different from the percentage seen with the 
moDCs. A similar percentage of cells were positive for CD205 in both methods as well as the moDCs 
(B) Mean fluorescence intensity of cells extracted from terminal rectal tissue; two methods compared with moDC; moDC; 7 animals, TDC–1: 4 
animals for MHC II and 3 animals for CD1b and CD205. TDC-2: 4 animals. Error bars represent standard error of the mean. TDC-1 = digestion 
method; TDC-2 = migration method. MHC II expression was different for both methods and the moDCs. Both methods produced cells that had a 
similar low expression of CD1b which was different from the higher expression observed on moDCs. Both methods used produced a similar profile 















Table 3.2. Range of results for percentage of positive cells and MFI of tissue cells 
collected using a migration technique. The range of results collected was broad. Each 
animal gave few cells for analysis and differing results. 
 
 
3.3.3 Method 3: Mechanical Disruption using the Medimachine System 
This method did not yield any viable cells at all when initially used on 
tissues from two animals. A small cellular layer was observed after 
Histopaque separation. Filtration of this layer following centrifugation 
resulted in no cellular pellet suggesting that it consisted of cell debris/tissue 












Several methods were employed in attempts to extract dendritic cells from 
the terminal rectal tissues of cattle. Each method had its limitations and due 
to time and financial constraints this area of research was eventually 
abandoned.  
With all the methods used, despite some promising early results, it was not 
possible to consistently produce a cell population from the intestinal tissue 
that could be accurately identified as dendritic cells. The early data from the 
first animal studied, using the digest method, suggested that it was possible 
to collect terminal rectal cells in sufficient numbers to carry out FACS 
analysis. This data also suggested that these cells were a mixed population 
likely to contain DCs. A percentage of cells expressed similar cell surface 
molecules when compared to the monocyte-derived DC and the levels of 
expression were comparable for the tissue cells and the moDC.  Microscopy 
suggested the presence of cells with DC morphology and expressing DC cell 
surface molecules but also indicated that the cell suspension was not a single 
population of cells. For example plasma cells, macrophages, fibroblasts and 
epithelial cell types were identified in the preparations, as well as cell debris 
and mucus. DC type cells that could be identified appeared to express cell 
surface molecules at a similar level to moDCs. Many attempts were made to 
improve and even reproduce this data, and a significant amount of work 
went into trying to develop a workable protocol. Unfortunately, these 
methods have not been found to be reproducible and in fact several of the 
attempts did not manage to yield a single cell suspension suitable for 
analysis. There seemed to be great animal to animal differences as each 
preparation had greatly differing cell numbers. 
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Following these experiments it became clear that to study the interaction of 
E. coli O157:H7 and dendritic cells in the bovine host it would be necessary to 
use the monocyte-derived DC model. 
A combination of the methods described in this chapter would possibly be 
useful, for example use of digest medium following the Medimachine 
technique. Addition of an EDTA treatment step as used by Pavli et al (Pavli et 
al., 1996), prior to use of digestion medium too may be useful to try to reduce 
any contaminating epithelial cells. 
Although the GM-CSF migration technique produced some cells for analysis, 
the numbers were so small that it was not a practical option and again there 
were vast differences between the four animals studied. However if this 
method could be used following a digest step, it may be possible to elucidate 
a greater number of cells. 
There are a few other points to note that could assist with the data analysis of 
this technique. If a single cell suspension could be fairly consistently 
produced it would be helpful to carry out four colour FACS analysis if a 
sufficient number of cells could be collected. One colour for the molecule of 
interest, one for MHC II, one for CD45 which would enable epithelial cells to 
be gated out and finally a viability indicator such as propidium iodide to 
accurately analyse the live cells. FITC could also be substituted for an 
alternative conjugate such as Alexa-Fluor 488 that is brighter due to a smaller 
stokes shift. 
The gating process used for analysis should exclude monocytes as they are 
smaller and less granular than dendritic cells, however, expression of CD14 
could be used in addition to ensure monocytes are not being collected and 
126 
 
detected by these methods. Of the molecules used for analysis in this study, 
CD1b and CD205 have not been found to be expressed by 
monocytes/macrophages (McNeilly et al., 2006).  
Future work would ideally further develop a protocol to extract viable DCs 
from bovine rectal tissue. The IHC from Chapter Two suggests that there 
could be many DCs in this area and a consistent method of retrieval could be 
of benefit to many branches of intestinal research, including Crohn’s disease, 
inflammatory bowel diseases, gut allergies as well as food borne pathogens. 
Development of a protocol could be further enhanced by the work carried 
out in Chapter Two. The immunohistochemistry results could be used to 
identify a panel of cell surface molecules expressed by TRDC and the 
reagents that could be used with a FACSort system to collect these cells. 
Given the inconsistency of the methods above in producing useable DC 
populations, the remainder of the laboratory work carried out investigated 







Chapter 4 Characterisation & reproducibility of a 
bovine moDC culture system including responses of 























Dendritic cells are of great importance for generating immune responses and 
are found dispersed throughout the tissues of the body in a wide variety of 
species. Dendritic cells (DC) are professional antigen-presenting cells (APCs) 
which are understood to be the only APC with the ability to interact with 
naive T cells. This interaction can subsequently elicit primary T cell-mediated 
responses (Banchereau & Steinman, 1998). Study of DCs however, has 
proved complex due to their low frequency in tissues and circulating blood 
and the relative difficulty of extracting DCs directly from tissues. The 
discovery of several DC subsets, which exhibit tissue and species 
heterogeneity as well as the migratory nature of these cells, makes them a 
challenge to investigate. All of these factors have prompted researchers to 
find novel ways of looking at these key immune cells.  
 
DCs are common in circulating lymph where they are to be found returning 
from peripheral tissues, and a great deal of valuable information has arisen 
from the study of this cell population. However to collect these lymph DCs, 
complex surgical techniques must be undertaken which necessarily incur 
technical, ethical and cost implications. The possibility of generating DCs 
from proliferating progenitor cells or non-proliferating precursor cells was 
subsequently explored. DCs have now been successfully generated from 
bone marrow cells as well as blood and lymphoid organ cells, and these 
methods have provided valuable insights into DC populations. 
 
Initially bone marrow was identified as a source of suitable progenitor cells 
from which to derive DCs. Bone marrow DCs have been generated in vitro 
for mouse (Inaba et al., 1992), rat (Talmor et al., 1998), human (Reid et al., 
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1992) and bovine systems (Hope et al., 2000b). Subsequently PBMCs and, 
more specifically, monocytes were employed as progenitor cells to generate 
large numbers of DCs following culture in the presence of cytokine. These 
moDCs have been generated and characterised in human (Sallusto & 
Lanzavecchia, 1994), primate species (O'Doherty et al., 1997) murine 
(Schreurs et al., 1999), equine (Hammond et al., 1999), porcine (Paillot et al., 
2001), rat (Richters et al., 2002), canine (Catchpole et al., 2002; Wang et al., 
2007), ovine (Chan et al., 2002) and bovine (Hope et al., 2000a; Werling et al., 
2002; Werling et al., 1999) systems. 
 
Bovine moDC were first generated by Werling et al in 1999. This drew on a 
published technique for successful generation of human moDCs in vitro 
(Woodhead et al., 1998). Adherent bovine PBMCs were incubated with 
recombinant bovine cytokines GM-CSF (at an empirically determined 
concentration – approx 0.2 U/ml) and IL-4 (200 U/ml) for up to seven days 
with the addition of fresh media with cytokine after 3 days. By day 3 in 
culture visible changes were observed whereby the cells exhibited a more 
heterogeneous morphology and displayed dendrites. These cells were no 
longer as adherent to the culture plates and had also formed cell clusters. By 
days 6-7 of culture under the continuing culture conditions the cell clusters 
were of maximum size. When compared to bovine monocytes these cultured 
cells were found to have upregulated the cell surface molecules MHC II, 
Mannose receptor (MR), CD80/CD86, SIRPα and CD1b when examined by 
flow cytometry. Down-regulation of CD14, CD32 and CD62L on these cells 
was also observed. Morphological assessments after 6-7 days in culture, 
along with the cell surface expression pattern and their capacity for 
stimulating lymphocyte proliferation indicated that these cells were indeed 
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blood-derived dendritic cells (Werling et al., 1999). These moDCs were 
however compared to bovine ALDCs returning from the skin and were 
discovered to have higher expression of CD14 and lower expression of MHC 
II than the levels published for the ex vivo lymph DCs (Howard et al., 1997) A 
modification to the technique has been widely incorporated and replaces the 
PBMC adherence process. Instead, CD14+ cells are labelled using super-
paramagnetic particles to enable their positive selection from the PBMC 
population, and these cells are then cultured as before (Hope et al., 2000a). 
This same moDC generation method is now exploited in a variety of bovine 
research areas including Mycobacteria (Langelaar et al., 2005; Price & Hope, 
2009; Werling & Kaiser, 2006), Salmonella (Norimatsu et al., 2003; Norimatsu 
et al., 2004), bovine respiratory syncitial virus (BRSV) (Werling et al., 2002) 
and Bovine Viral Diarrhoea Virus (BVDV) (Glew et al., 2003). 
 
One interesting point of note with this technique is that different researchers 
have utilised varied culture times to suit their needs. Bovine moDCs after 3 
days in culture are generally thought to represent an immature DC 
phenotype with lower expression of MHC II and co-stimulatory molecules 
than cells cultured for longer. Seven day moDCs are indicated to represent a 
more mature phenotype. A brief comparison was carried out here, although 
as intestinal DCs are likely to be of an immature phenotype when they 
encounter E. coli O157:H7 it was decided that working with 3 day moDCs 
would be the most biologically relevant (Langelaar et al., 2005).   
Functional characteristics of these moDCs have been investigated, including 
T cell stimulatory abilities, phagocytosis of pathogens and cytokine 




In their role as antigen presenting cells DCs are important for directing 
immune responses to encountered pathogens. To aid them in this task they 
express numerous toll-like receptors (TLR) to enable recognition of motifs 
expressed by various organisms. Bovine APCs have been shown to express 
numerous TLR in vitro which recognise bacterial components such as 
flagellin (TLR5) LPS (TLR4) and CpG (TLR9) (Werling et al., 2006), and 
enable generation of appropriate immune responses. 
 
It is known that bacterial LPS is a potent stimulator of DCs in vitro (Sallusto 
et al., 1995) and in vivo (De et al., 1996). In vitro LPS challenge of moDCs 
prompts cells to up regulate expression of MHC II, CD80, CD58, CD54 as 
well as reducing pinocytosis activity within 24-48hr (Sallusto et al., 1995). 
DCs in vivo have also been stimulated to mature and migrate to tissue T cell 
areas following LPS administration. In this murine model, migration 
occurred rapidly (within 6 hr) and was accompanied by upregulation of 
MHC II and CD80/CD86 (De et al., 1996). Kaisho et al (2001) have also shown 
murine BMDC maturation in vitro in response to LPS, and found this to occur 
in a TLR4-dependent manner (Kaisho et al., 2001). Human moDCs have also 
been shown to mature in response to LPS in vitro (Benhamron et al., 2006) In 
ovine moDCs cytokine responses to LPS stimulation have been studied using 
real time PCR and this has demonstrated a difference in the responses of 
moDCs which were dependent on the time in culture. Ovine moDCs 
differentiated in culture for three days produced no cytokine response to 
LPS; however cells which underwent five days of differentiation produced 
cytokine responses as detected by mRNA transcripts. TNFα responses were 
detected around 3 h post-stimulation and the IL-12 responses were slightly 
delayed at between 3 and 6 h. This study too found there to be differences in 
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the responses of cells from individual animals (Budhia et al., 2006).  It is clear 
that LPS is an important bacterial component which is recognised by DCs. 
The responses of DCs to LPS are marked and are likely to be essential for 
host recognition of bacterial infiltration. Bovine moDCs are also known to 
respond to LPS in the same way by expressing cell surface molecules 
indicated of a more mature phenotype. (Dr. J. Hope, personal 
communication) This response to LPS by production of cytokine and 
upregulation of cell surface molecules will be used in this study to confirm 
activity of the in vitro generated bovine moDCs. 
 
Flagellin is an important pathogenicity factor of many bacterial pathogens 
including E. coli O157:H7 as it confers motility (Monday, 2003).  As a protein 
located outside the bacterial cell wall it often directly contacts host cells and 
is termed a pathogen associated molecular pattern (PAMP) recognised by 
TLR5 (Hayashi et al., 2001). H7 flagellin has been shown to be important 
during binding of EHEC to primary bovine epithelial cells in vitro (Mahajan 
et al., 2009), and has been demonstrated to produce specific serum IgA 
responses in E. coli O157:H7 challenged cattle (McNeilly et al., 2008), and so 
H7 flagellin may potentially play in important role within the bacterial-host 
interaction.  Bovine DCs in the terminal rectum are likely to contact H7 
flagellin during colonisation and so characterisation of this interaction in 
vitro would be advantageous to advance the understanding of the bovine 
immune responses to EHEC. Murine lamina propria DCs have been shown 
to produce cytokine in response to stimulation with flagellin; IL-12 
production was detected with little production of IL-10 (Uematsu & Akira, 
2009). Murine BMDCs in vitro also respond to flagellin stimulation by 
production of IL-12 with no detectible IL-10 secretion (Vicente-Suarez et al., 
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2009). Flagellin has shown effects on murine DCs in vivo. Following injection 
of mice with Salmonella flagellin, cell surface molecules CD40, CD80 and 
CD86 were upregulated by splenic DCs. Variations in the responses of DC 
subsets was observed: the CD11b+ cells responded with greater magnitude 
than CD8α+ DCs. This difference was interesting because responses 
stimulated by LPS were similar for both CD11b+ and CD8α+ cell populations. 
Flagellin injection into mice also stimulated migration of splenic CD11c+ DCs; 
within six hours of treatment the CD11c+ cells were found in the T cell area of 
the white pulp and absent from other areas. A further interesting aspect of 
this study was that when isolated and purified the CD11c+ DCs did not 
respond in vitro to flagellin, (by measurement of cytokine production and 
levels of co-stimulatory molecule expression) and it was concluded that these 
cells are activated in vivo by means of ‘bystander’ stimulation (Salazar-
Gonzalez et al., 2007). However other reports have indicated that murine DCs 
do respond in vitro to flagellin, and mirror the in vivo responses. 
Didierlaurent et al.  reported that murine splenic DCs increased expression of 
CD40, CD80 and CD86 in vivo following an injection of flagellin and also that 
murine BMDCs were found to upregulate costimulatory cell surface 
molecules and MHC II as well as produce IL-12p40 in response to flagellin 
(Didierlaurent et al., 2004). The role which DCs play in response to flagellin is 
therefore complex and not fully defined. Consequently studies into 
interactions of H7 flagellin and bovine DCs would be of value, concentrating 
in particular on the production of IL-12 and changes in expression of cell 
surface molecules highlighted by the murine studies.  
 
Verotoxin is a significant mediator of the most serious disease progression 
(HUS) in human infection with EHEC, and so quite a body of research has 
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probed the actions of this toxin in vitro with various host species. The 
structure of VT is important in relation to function. One central A subunit 
inhibits protein synthesis in eukaryotic cells by acting on the cell ribosome. 
The A subunit is surrounded by five B subunits which specifically bind to the 
galactosyl-α1,4-galactose (Galα1, 4Gal) linkage of globotriaosylceramide (Gb3 
or CD77) found on endothelial cell surface. Expression of CD77, the receptor 
for VT, by eukaryotic cells is thought to relate to VT susceptibility 
(Eisenhauer et al., 2001). VT has profound cytotoxic effects on vascular 
endothelium. Human monocytes when stimulated with Verotoxin (VT) in 
vitro promote synthesis of cytokines, in particular IL-1β, TNFα, IL-6 and IL-8, 
and GM-CSF (Cameron et al., 2003; van Setten et al., 1996). These cytokines 
are pro-inflammatory and TNFα in particular has been shown to contribute 
to the pathological disease processes involved in HUS, by increasing the 
sensitivity of endothelial cells to VT (Eisenhauer et al., 2001; van Setten et al., 
1996). However studies show that VT is not cytolethal to monocytes when 
challenged with doses higher than those toxic to Vero cells (van Setten et al., 
1996). Bovine monocytes have also been investigated in terms of their 
responses to VT and significant animal variation was observed, however 60% 
of the monocytes from cattle tested responded to VT by production of 1000-
2000 pg/ml of TNFα. (Dr. P. Cameron, unpublished observations) In mice the 
B subunit of the toxin is sufficient to cause changes in BMDCs. In vitro 
BMDCs increase expression of MHC II, CD40, CD80 and CD86 in response to 
incubation with VT B sub-units, as well as production of TNFα and IL-12 
(Ohmura et al., 2005). This finding was tested in vivo and splenic DCs were 
found to also increase expression of MHC II, CD40, CD80 and CD86 
following subcutaneous injection of VT B (Ohmura et al., 2005). To date no 
work has been published indicating responses of bovine DCs to VT, although 
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taking into consideration the studies already mentioned it is likely that at 
least a proportion of cattle DCs would respond to VT by cytokine production 
and alterations in expression of maturational cell surface molecules. 
However, the lack of pathology in vivo to E. coli O157:H7 colonisation in 
cattle in comparison with human disease sequelae may indicate divergent 
responses to VT could play a role in this although the involvement if any of 
DCs in these responses is unknown. Investigation of DC responses to VT is 
one of the aims of work in this chapter. 
 
As important immune system cells DCs have been shown to produce various 
cytokines in response to pathogens, these key signals help shape the immune 
responses generated. The IL-12 cytokine response of DCs to microbial 
pathogens is possibly one of their most important determinants of 
downstream immune responses. IL-12 is a significant cytokine for the 
generation of the Th1 response (Macatonia et al., 1993b). DC secretion of IL-
12 in response to microbial products can occur in less than 24hrs and 
stimulates T cells to become interferon-γ (IFN-γ)-producing Th1 cells.  
Macrophages are activated by this IFN-γ and T cells can be induced to 
differentiate into killer cells. Thus the role that DCs play in producing IL-12 
and subsequently stimulating Th1 cells promotes resistance to microbial 
infection (Banchereau & Steinman, 1998). IL-12 gene expression is known to 
be upregulated by bovine day 3 moDCs in response to killed E. coli as 
reported by Langelaar et al (2005) although the strain that was used is not 
specified; the authors suggest that responses are likely to be via TLR4 
signalling. IL-10 is an important immunoregulatory cytokine producing 
varied effects and which shows a degree of species heterogeneity. An IL-10-
deficient mouse strain shows uninhibited IL-12 and TNFα release which 
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causes significant pathology in the host tissues, in particular intestinal 
enterocolitis (Rennick et al., 1997). IL-10 plays an important role in DC 
cellular interactions. IL-10, by its inhibition on DC as well as macrophage-
induced IFNγ production in vitro, may play a role in regulating the class of 
immune response directed towards pathogens, by affecting the downstream 
T cell populations (Macatonia et al., 1993a). In cattle IL-10 is generally 
considered to play an anti-inflammatory role in down regulation of 
responses following infection (Norimatsu et al., 2003). TNFα is an 
inflammatory cytokine, as an early inflammatory protein it signals to attract 
other immune cells involved in immune responses to varied stimuli 
including physical, and environmental as well as immunopathological. The 
immune response directed by TNFα involves induction of further cytokines 
(e.g. IL-1 and IL-6) (Kramer et al., 2007; McGee et al., 1995). TNFα is produced 
in response to bacterial endotoxin in vivo and in vitro (Cicala et al., 1997; 
Collart et al., 1990) and is also important in the direction of immune 
responses to intracellular bacteria (Kwong et al., 2010; Lin et al., 2007) and is 
known to sensitise endothelial cells to the effects of VT in vitro (Eisenhauer et 
al., 2001).  
 
The work in this chapter was carried out chiefly to generate and characterise 
bovine moDCs, to ensure methods and reagents in our laboratory were 
sufficient to successfully and reproducibly provide bovine DCs for 
investigation of interactions with E. coli O157:H7 strains and bacterial 
components and to correlate phenotype and responses with known 
parameters for bovine moDCs. Following validation of culture and 
downstream laboratory techniques including ELISA and flow cytometry, the 
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The aims of this chapter were: 
1. To generate bovine moDC cultures in a reproducible manner 
2. To characterise bovine moDCs used in this study by morphology, 
cytokine responses and cell surface marker expression to compare 
with known parameters for these cells. 
3. To investigate the interaction of bovine moDCs with selected bacterial 




4.2 Materials and Methods 
  
4.2.1 Generation of Monocyte Derived Dendritic Cells (moDCs) 
4.2.1.1 Donor animals 
All blood sampling was carried out according to the requirements of the 
Scientific Procedures Act (1986). All animals were reared conventionally 
either at Moredun Research Institute, Easter Bush Veterinary Centre or the 
Institute for Animal Health (IAH), Compton. Further animal information is 
detailed in Appendix A.2. 
4.2.1.2 Peripheral Blood Mononuclear Cell (PBMC) Isolation 
PBMC isolation was carried out following a protocol developed at IAH, 
Compton; and is summarised below (Werling et al., 1999). Collection of 
bovine blood was by venepuncture and collection into sodium heparin 
vacutainer tubes (BD) and used within 2 h of collection. Equal volumes of 
PBS and blood were mixed in a 50 ml Blue Max polypropylene tube (Falcon, 
Oxford) and peripheral blood mononuclear cells (PBMC) were separated 
from whole blood by density gradient centrifugation (1.083 g/ml Histopaque, 
Sigma). The blood and PBS mix was underlaid with half the volume of 
Histopaque. These cell suspensions were centrifuged at 1200 x g for 35 min, 
at 20°C with the brake off. The PBMC layer was removed and these cells 
were pelleted in 30 ml PBS at 400 x g at 4°C for 10 min, resuspended in 10 ml 
PBS and counted (section 4.2.1.6). Cells were washed in 30 ml PBS by 
pelleting at 300 x g at 4°C for 8 min. All residual fluid was removed from the 




4.2.1.3 Monocyte Purification 
107 PBMCs were labelled with 2.5 μl αCD14-conjugated paramagnetic beads 
(MACS, Miltenyi Biotec). The cells and beads were gently mixed by pipetting 
and then incubated at room temperature for 10 min. To wash the cells, 15 ml 
of PBS was added and the suspension was centrifuged at 400 x g for 5 min at 
4°C. The wash step was repeated then cells were re-suspended in 3 ml 
FACSflow (Becton Dickinson) containing 1% w/v BSA (Sigma) 
(FACSflow/BSA). A MACS LS separation column (Miltenyi Biotec) was 
assembled with the midiMACS magnet (Miltenyi Biotec). 2.5 ml of 
FACSflow/BSA was applied to the column and allowed to run through to a 
waste container. When the solution had passed the through the column the 
cell suspension was added and unbound cells were allowed to flow into a 
waste container. The bound cells were washed by addition of 2.5 ml 
FACSflow/BSA to the column which also flowed into the waste container. To 
elute the bound cells, 5 ml of Tissue Culture Medium (TCM, Appendix 
A.4.2.3) was applied to the column. The column was quickly removed, held 
over a 50 ml tube containing 5 ml TCM and labelled cells were eluted using 
the plunger. This solution was made up to 35 ml with PBS and then 
centrifuged at 400 x g for 5 min. The cell pellet was re-suspended in 1 ml of 
TCM and viable cells were counted (section 4.2.1.6.). The cell yield was 
expected to fall within the range of 5-15% of the starting cell number (based 
on average percentages of CD14+ cells within bovine PBMC). The purity of 





4.2.1.4 Dendritic Cell Generation and Culture 
The monocyte cell pellet was re-suspended to between 8 x 105 and 1 x 106 
cells / ml in Dendritic Cell Tissue Culture Medium (DC-TCM, Appendix 
A.4.2.4). 3 ml of this cell suspension was added to each well of a six well 
plate. Optimal concentrations of recombinant bovine GM-CSF (rboGM-CSF) 
and recombinant bovine interleukin 4 (rboIL-4) were determined empirically. 
GM-CSF (IAH, Compton) and recombinant bovine IL-4 (Moredun Research 
Institute) were added to the culture medium at final concentrations of 0.2 U/ 
ml and 200 U/ml respectively, to stimulate differentiation of cells. The rboIL-
4 was expressed from a permanently-transfected Chinese hamster ovary cell 
line (Hope et al., 2005), and rboGM-CSF was produced from transiently-
transfected COS cells. The six well plate was incubated at 37°C, 5% CO2 for 
three or seven days. Cells incubated for seven days were fed after three days 
in culture by the removal of the culture supernatant and the addition of DC-
TCM to all wells.  
4.2.1.5 Harvesting Dendritic Cells 
Non-adherent cells and media were removed from the 6-well plate, placed 
into a Falcon™ tube and stored at 4˚C. 1 ml of pre-warmed cell dissociation 
fluid (Sigma) was added to each well and the plate was incubated at 37°C, 
5% CO2 for 30 min. Cells were detached by pipetting and were pooled with 
the non-adherent cells. Cells were centrifuged at 400 x g for 5 min and re-




4.2.1.6 Viable cell counting 
Viable cell counts were carried out using Trypan Blue exclusion dye (0.4%) or 
0.1 % Nigrosin in a disposable counting chamber (Fast-read counting 
chamber, ISL, Immune Systems Ltd). 
 
4.2.2 Cytospin and slide preparations of moDC 
To prepare slide preparations, two methods were used.  Firstly the cells were 
re-suspended to 5 x 105 cells per ml. Superfrost™ plus slides were assembled 
with cytofunnels™, filters and clamps. 100 µl of the cell suspension was 
pipetted into the funnel and spun in the Cytospin centrifuge (Thermo 
Shandon) at 300 x g for 3 min. The slides were left to air dry at room 
temperature and then stored at -20°C. Alternatively slide preparations were 
generated as described previously (section 3.2.4). 
 
4.2.3 Immunohistochemistry (IHC) 
IHC was carried out as described previously (Section 2.1). 
 
4.2.4 Challenge of moDCs with E. coli components 
In preparation for challenge, the cells were collected on day three or seven of 
culture and counted. Wells of a 12 well plate were seeded with 1 x 106 cells 
with 1 ml TCM per well. Cells were challenged for 18 h at 37˚C and 5% CO2 
with either purified H7 flagellin (Dr. T. McNeilly), LPS (Sigma) or Verotoxin 
2 (VT2) (Sigma) at concentrations indicated in figure legends. VT2 stock was 
diluted into sterile PBS in low protein bind tubes. In control wells, moDCs 
were cultured in RPMI alone. Cell supernatants were collected and stored at 
-20°C and moDCs were collected for analysis of cell surface markers by 
FACS (section 3.2.7). 
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4.2.5 Enzyme Linked Immunosorbent Assay (ELISA) analysis of bovine 
cytokines 
IL-10, IL-12 and TNFα were determined by ELISA. The protocol for these 
ELISAs was developed at IAH (Hope et al., 2002; Kwong et al., 2010; Kwong 
et al., 2002) using reagents as in Table 4.1. Black or clear 96-well microtitre 
plates (Nunc Maxisorp) were coated overnight with 100 μl/well of capture 
mAb diluted in coating buffer. Coating buffer, 0.05 M carbonate-bicarbonate 
buffer, pH 9.6, was made up using Carbonate/Bicarbonate buffer capsules 
(Sigma) and 100 ml DDW in a suitable container. The plates were then 
incubated either at room temperature O/N or for 36 h at 4°C sealed in an 
airtight container. The plates were either washed 3 x manually or 5 times on 
a Skatron Skanwasher/stacker 300 Version B on an appropriate programme 
with wash buffer (PBS + 0.05% Tween 20). Plates were blocked for 1-2 h with 
300 μl/ well of 1 mg/ml sodium casein (Sigma) in PBS at room temperature in 
a sealed container. Following a wash step, 100 μl of each sample to be tested 
in duplicate, or triplicate if volume of sample allowed, was added to the 
plates. Standards diluted in 1 mg/ml sodium casein in PBS were included in 
every plate. Internal standards were also included for some assays as a 
positive control and blocking buffer was added to two wells per plate as a 
blank. Samples and standards were incubated for 1-2 h at room temperature 
in sealed container and subsequently washed. Supernatants from transiently 
transfected COS cells were used to generate standards to be used at 
predetermined ranges. The internal standards were also COS cell 
supernatant, diluted to a concentration falling within the linear range of the 
standard curve and optimised to fall within a specified range of 
concentrations. These ensure accuracy between multiple plates or assays. 100 
μl/well of biotinylated detection mAb, diluted in blocking buffer was added 
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and incubated for 1-2 h at room temperature in sealed container. Another 
wash step was followed by adding 100 μl/well of Streptavidin-HRP at 1:500 
diluted in reagent diluent (PBS + 1 mg/ml sodium casein + 0.05% Tween 20) 
which were incubated for 45-90 min at room temperature. Plates were 
developed using TMB or luminol. For TMB development, clear plates were 
washed before addition of 100 μl/well of TMB substrate solution (Appendix 
A.4.1.6) and then stopped with 50 μl/well of 1M H2SO4 as soon as a colour 
change was observed in blank/control wells. The optical density was read on 
an Ultra microplate reader ELX808iu (BIO-TEK Instruments) at 450nm using 
DASDAQ Stingray software, or a DYNEX Technologies MRX II ELISA plate 
reader linked to a computer running MRX EndPointSoftware, (Version 2.02).. 
For luminol development, black plates were washed 3 times with a 5 min 
soak in wash buffer between each wash before the contents of the wells was 
aspirated. The plates were developed with 100 μl/well of a 50:50 solution of 
luminol and peroxide, gently mixing the plates for 1 min. Relative light unit 
values were read immediately on an Anthos Lucy 1.0 
photometer/luminometer (Anthos Labtec, Salzburg, Austria) connected to a 








Table 4.1 IL-10, IL-12 and TNFα ELISA antibody pairs and standard concentrations 
 
4.2.6 Flow Cytometry for Cellular Expression of Cell Surface Molecules 
Flow cytometry was carried out as described in Chapter 3 (section 3.2.7).  
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4.2.7 Culture and Passage of Cell Lines 
Vero cells (ATCC # CCL-81™) were resuscitated from liquid nitrogen stock 
and defrosted at 37˚C, and diluted into cell culture medium (CCM, Appendix 
A.4.2.1) and seeded into a T75 tissue culture flask with a vented cap 
(Corning). For routine passage, cells were trypsinised at approximately 80% 
confluence. Briefly, cells were detached by incubation in 3 ml Trypsin EDTA 
(Lonza) for 10 min, followed by the addition of 7 ml CCM. Cells were 
pelleted at 170 x g for 4 min, resuspended in fresh media and used to seed 
flasks for further culture or plates for challenges.  Caco-2 cells (ATCC # HTB-
37™) were provided by Dr. Pamela Cameron, cultured in cell culture 
medium (CCM Appendix A.4.2.1) and passaged as above at 70-80% 
confluence.  
 
4.2.8 Vero cell challenge with Vero toxin 2 (VT2) 
Vero cells were challenged with Verotoxin (Sigma) at concentrations 
indicated in figure legends for 18 h at 37˚C, 5% CO2. Unchallenged control 
wells were included. For challenges where viability was to be assessed with 
the Vybrant MTT cell Proliferation Assay Kit, Phenol Red free CCM 
(Appendix A.4.2.1) was used. 
 
4.2.9 Cell Viability Assay  
To assess the viability of challenged cells, the Vybrant MTT cell Proliferation 
Assay Kit, (Molecular probes) was used, following the manufacturer’s 
instructions.  Following Vero cell challenge, cell supernatants were removed 
and replaced with 100 µl of fresh media. A 12 mM MTT stock solution was 
prepared by dissolving 5 mg of MTT in 1 ml of sterile PBS. 10 µl of the MTT 
stock solution was then added to each well and incubated at 37˚C for 4 h. 
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Control wells included unchallenged cells, cells with media alone and wells 
with media and MTT only. 100 μl of SDS-HCL solution (Appendix A.4.2.6) 
was added per well and mixed by pipetting. A further incubation at 37˚C 
was carried out for 4 h in a humidified chamber.  Before reading on a plate 
reader, each well was then mixed by pipetting.  The absorbance was read at 
570nm on a DYNEX Technologies MRX II ELISA plate reader linked to a 
computer running MRX EndPointSoftware. 
 
4.2.10 Live Cell Imaging 
Live cell images were taken using an AxioCam MRm digital camera 
mounted on a Ziess Axiovert microscope with an integrated cell culture 
incubator. 
 
4.2.11 Endotoxin removal from H7 flagellin samples 
The H7 flagellin samples were lyophillised over night in a ModulyoD-230 
Freeze Dryer (Thermo), resuspended in 300 µl of ultrapure endotoxin free 
water (Sigma) and quantified on a NanoDrop (Thermo Scientific). The 
samples were then run through an endotoxin removal column (Detoxi-Gel 
columns, Pierce) following the manufacturer’s instructions. Briefly, the 
column was equilibrated to room temperature. The column was washed with 
five resin bed volumes of 1% w/v sodium deoxycholate solution followed by 
five resin bed volumes of distilled water. The H7 flagellin sample was 
applied to the top of the column and when it was fully contained within the 
reservoir bed, the ends of the column were capped off and the column was 
incubated for 1 h at room temperature. Following incubation, the sample was 
washed through the column into an endotoxin-free tube with ultrapure 
water. The sample was placed at -70˚C for 2 h prior to lyophilising overnight. 
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The following day the sample was again suspended in water (Sigma) and 
quantified on a NanoDrop Spectrophotometer (Thermo, ND-1000, UV-Vis) to 
allow calculation of the quantity of H7 flagellin retained within the column 
(usually around 4 µg). This purified sample was used for moDC and Caco2 
cell challenges.   
 
4.2.12 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
The BIO-RAD Mini-Protean III system™ was used for SDS-PAGE analysis 
according to principles described by Laemmli (Laemmli, 1970). 1 mm glass 
plates were cleaned with 70% 74OP, assembled in the casting stand and 
approximately 5 ml resolving gel mixture (Appendix A.4.3.1) was poured 
between them, 250 µl of 1% w/v SDS was added over the top to exclude air 
and allow a level interface between resolving and stacking gels. This was left 
to polymerise at room temperature for 1 h. SDS solution was removed using 
filter paper and the stacking gel mixture (Appendix A.4.3.2) was overlaid to 
the top. Plastic well-forming combs were cleaned with 70% 74OP and 
immediately pushed into the top of the gel. The gel was again allowed to set 
at room temperature. When polymerisation was complete, after 
approximately 10 min, the combs were removed. The fully assembled gel 
was placed into an electrophoresis tank. The tank reservoirs were filled with 
running buffer (Appendix A.4.3.3). Samples were adjusted to appropriate 
concentrations in 20μl reducing sample buffer (Appendix A.4.3.4) in a 1.5 ml 
centrifuge tube.  Protein quantities are indicated in figure legends. Samples 
were boiled for 5 min, briefly pulsed in a microcentrifuge and gently mixed. 
Samples were run concurrently with a prestained broad range protein ladder 
(Fermentas; SM0671) and loaded into the wells using gel loading pipette tips. 
A current was passed across the gel at 135v (BioRad PowerPac HC) at room 
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temperature for approximately 60-90 min, until the bromophenol blue front 
reached the end of the gel.  
 
4.2.13 Coomassie Staining 
The gel was removed from the gel tank and the glass plates; the stacking gel 
was cut off and discarded. To visualise proteins, the gel was placed into a 
staining tray and washed with three washes of distilled water. Gels were 
immersed in Coomassie® G-250 stain (SimplyBlue ™, Invitrogen) and placed 
on a rocker overnight at room temperature. The following day the gel was 
destained in distilled water until protein bands were clearly differentiated.  
 
4.2.14 Western Blotting 
Following separation of proteins by SDS-PAGE, proteins were transferred 
from acrylamide gels onto nitrocellulose membranes. Six pieces of blotting 
paper (Hybond) and a nitrocellulose membrane (0.45 μm, Hybond-C) cut to 
the dimensions of the gel were soaked in electroblotting transfer buffer 
(Appendix A.4.4.1) for 5-10 min. The gels were assembled next to the 
nitrocellulose with three sheets of blotting paper on either side. The 
assembled gels, nitrocellulose and blotting paper were placed onto a semidry 
blotter (Fisherbrand) with the nitrocellulose towards the anode, and 
smoothed to remove any air bubbles. A small volume of transfer buffer was 
poured onto the blotting components to ensure saturation before assembling 





4.2.15 Probing Blots with Antisera 
Detection of H7 flagellin on Western blots was carried out according to 
McNeilly et al 2008. To reduce non-specific antibody binding the blots were 
incubated with blocking buffer (Appendix A.4.4.2) for 1 h at room 
temperature. Blots were probed with primary antisera, either rabbit 
polyclonal αH7 (Mast-Assure) or naïve rabbit serum (Scottish Antibody 
Production Unit) at 1:500 in blocking buffer  for 1 h at room temperature.  
The blots were then rinsed twice in blocking buffer followed by a 15 min and 
two 5 min washes. Blots were then incubated in goat α rabbit HRP 
conjugated secondary antibody diluted 1:1000 in blocking buffer for 1 h at 
room temperature. Wash steps were carried out as described above with an 
additional wash for 1 h. Bound antibody was detected using enhanced 
chemiluminescence (ECL) system (Pierce) according to manufacturer’s 
instructions.  The bands were visualised by incubating the blots with 
radiograph film (Kodak) which was developed in an X-ray developer 
(OPTIMAX 2010).  
 
4.2.16 Challenge of Caco2 cells with H7 flagellin  
To assess biological activity of the H7 flagellin, Caco2 cells were used 
because they have been shown to produce IL-8 in response to H7 (Donnelly 
& Steiner, 2002). Caco2 cells were cultured in CCM in 12 well plates until 2 
days post confluency and then serum starved for 24 h. The cells were 
challenged on the third day post confluence with 500 ng/ml of H7 flagellin in 
fresh serum free CCM  for 18 h at 37˚C and 5% CO2. Six biological replicates 
were used for challenged cells and unchallenged controls. Following 




4.2.17 Interleukin 8 (IL-8) ELISA 
Levels of IL-8 in Caco2 cell supernatants were monitored using a human IL-8 
ELISA kit (Duoset, R&D Systems) according to the manufacturer’s 
instructions. Overnight, 96-well EIA/RIA stripwell plates (Costar) were 
coated with 100 µl/well of capture antibody (4 µg/ml in PBS) at room 
temperature and sealed to prevent drying. After incubation the wells were 
aspirated and each well washed three times with 400 µl of PBS containing 
0.05% v/v Tween-20. Any residual washing buffer was removed by blotting 
on clean paper towels. Wells were blocked with 300 µl of PBS containing 1% 
w/v BSA for at least 1 h. All wells were aspirated and washed as before. 100 
μl of samples were added in triplicate and incubated for 2 h. 100 μl of IL-8 
standards were included, in doubling dilutions, in IL-8 ELISA reagent 
diluent (Appendix A.4.1.5). Three wells with 100 µl reagent diluent alone 
were also included. Wells were washed and 100 µl of 20 ng/ml detection 
antibody in IL-8 ELISA reagent diluent was added. A further 2 h incubation 
was carried out at room temperature followed by three washes. 100 µl/well 
of Streptavidin-HRP (diluted 1:200 in IL-8 ELISA reagent diluent) was added 
and incubated for 20 min in the dark and then washed as before. 100 µl of 
substrate solution, made up with a 1:1 mix of colour reagent A (H2O2) and 
colour reagent B (trimethylbenzidine), was added and the plate was 
incubated for 20 min in the dark. To stop the reaction 50 µl/ well of 2 N 
H2SO4 was added and the plate read at 450 nm using an ELx808IU Ultra 




4.2.18 Determination of Toll-Like Receptor 5 (TLR5) expression by RT-
PCR 
Previous studies have shown bovine moDC cultured for seven days 
transcribe TLR5 (Werling et al., 2006); RT-PCR was employed to investigate 
whether moDC cultured in the conditions described in this study (4 day 
culture) express this receptor.  
 
4.2.18.1 Preparation of moDC for RT-PCR 
Monocyte derived dendritic cells were prepared as described above (section 
4.2.1) and collected after four days in culture to correspond with the timing 
of challenges used in this work. Briefly, cells were collected, counted (section 
4.2.1.6) and re-suspended to 1 x 10 7 / ml in PBS. 1 ml of the cell suspension 
was added to 1.5 ml centrifuge tubes, the cells were washed twice with PBS, 
each consisting of 5 min in a centrifuge at 300 x g. Supernatant was then 
discarded, and 50 μl of fresh PBS was added. To this suspension 500 μl 
RNAlater® (Qiagen) was added and mixed by pipetting. These cell 
suspensions were stored at 4°C for 24 h then transferred to storage at -20°C 
until required. Two positive controls were also employed in this study, 
human derived Caco2 cells (section 4.2.7), and primary bovine epithelial 
cells. Primary bovine epithelial cells, stored in liquid nitrogen and defrosted 
at room temperature, were previously prepared by Arvind Mahajan. 
 
4.2.18.2 Isolation of RNA using RNeasy Mini Kit (Qiagen) 
All reagents used in this section, unless otherwise stated, are included in the 
RNeasy Mini kit (Qiagen) and the manufacturer’s instructions were 
followed. Briefly, the cell preparations were pelleted at 3000 x g for 4 min. 
The supernatant was discarded and the pellet was resuspended in 300 μl of 
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RLT then passed through a sterile 21G needle several times. 250 μl of ethanol 
was added to each sample and mixed by pipetting. The samples were then 
placed into the RNeasy mini columns. The columns were pulsed in a 
microcentrifuge for 15 sec at 8000 x g and the flow-through discarded. The 
column was then washed with 700 μl of buffer RW1 in the microcentrifuge 
for a further 15 sec at 8000 x g and the flow-through again discarded. 500 μl 
of Buffer RPE, was applied to the column and placed in the microcentrifuge 
as before, again the flow through was discarded. A further 500 μl of Buffer 
RPE was added and microfuged at 8000 x g for 2 min. The samples were then 
eluted by the addition of 50 μl of RNase-free water and centrifugation at 8000 
x g for 1 min. The samples were quantified by using a Nanodrop 
Spectrophotometer (Thermo, ND-1000, UV Vis) and stored at -20°C until 
required. 
4.2.18.3 Reverse Transcription 
Reverse transcription of extracted RNA was carried out using Superscript III 
Reverse Transcriptase (Invitrogen) as per manufacturer’s instructions. 
Briefly, in a nuclease free 0.2 ml microcentrifuge tubes, 100 ng of total RNA 
was added to 4 μl 5x first strand buffer, 1 μl RNaseOUT, 1 μl 10 mM dNTP 
mix (10mM each) 0.5 μl random primers and 1 μl SuperscriptIII (200 U/μl) 
reverse transcriptase and made up to a total of 20 μl with nuclease free 
water. The tubes were then incubated at 50°C for 60 min, 70°C for 15 min 
followed by a final denaturation step of in a TC-512 thermocycler (Techne). 
The samples were then stored at -20°C until required for PCR. 
4.2.18.4 Polymerase chain reaction (PCR) 
Forward and reverse TLR5 Primers were obtained from MWG-Biotech and 
were designed based on published work (Menzies & Ingham, 2006). PCR 
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amplification was carried out using Platinum Taq (Invitrogen) in a TC-512 
thermocycler (Techne). 
 









Menzies & Ingham, 2006 
 
 
Table 4.2 Primer sequences used for TLR5 PCR 
 
4.2.18.5 PCR Mix & PCR cycling conditions 
PCR mix was made up with 5 μl 10x buffer, 1.5 μl MgCl, 1 μl each of forward 
and reverse primers (see table 4.2), 1 μl dNTPs and 0.2 μl Taq. 5 μl of 
template was then added and made up to a total volume of 50 μl. RNA 
which had not been reverse transcribed was also subjected to PCR as a 

















4.2.18.6 Agarose gel electrophoresis 
The samples were subject to gel electrophoresis on a 1.8% agarose gel 
containing 1x Gel Red (Biotium Inc.) according to manufacturer’s 
instructions. Gels were made by melting 0.9 g agarose in 50 ml of 0.5x Tris 
Acetate EDTA (TAE) buffer (Appendix A.4.6.1) in a microwave oven 
(PROline micro chef ST44); following melting of the agarose, 5 μl of Gel Red 
(10000 x stock) was added prior to allowing the molten agarose to cool to 
56°C in a water bath (Grant, SUB28). Following cooling to 56°C, the molten 
agarose was poured into a submarine gel casting tray with appropriate 
comb. The gel was left at room temperature on a flat surface to set. The gel 
was then placed into a tank (Bio Rad) containing 0.5x TAE buffer. 50 μl of 
sample was mixed with 5 μl 6x Blue/Orange loading dye (Promega), 15 µl of 
each sample was then loaded per well. Each end well contained 10 μl of 
100bp ladder (Promega). The electrodes were fitted onto the tank with the lid 
and 80v was applied to the gel for approximately 80 min using a Bio Rad 
PowerPac 200/2.0. The gel was then visualised by UV transillumination on a 
Bio Rad imager. 
 
4.2.19 Data Analyses 
Flow Cytometry data was analysed using FCSExpress software (DeNovo 
software, Canada), the limit was set at 10,000 live cells, these were gated and 
histograms of fluorescence were generated. Isotype controls were included. 
MFI levels were calculated by subtracting the MFI for the relevant isotype 
control from the MFI of the molecule of interest for the selected cell 
population. Graphs were plotted in Microsoft Excel, with error bars to 
represent the standard error of the mean. All ELISA data was analysed using 
linear regression analysis, a standard curve was constructed from the data 
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points using Microsoft Excel and concentration figures were calculated by 
inputting the absorbance readings into the equation of the line. Statistical 
analysis was carried out using Minitab (v13) software. Paired t-tests were 
used for ELISA and FACS results of challenged and unchallenged cells 
where only two conditions were tested. The flow cytometry profiles of the 3 
day and 7 day moDCs were analysed using a 2 sample t-test with unequal 
variance for each cell surface molecule. If more than two conditions were to 
be examined a one-way ANOVA was carried out. Significance for all data 







4.3.1 Bovine moDCs: phenotype of cultured cells 
Bovine moDCs were generated as described (Price, 2009; section 4.2.1). The 
cells had differentiated by three days in culture to exhibit dendritic cell 
morphology (Fig 4.1 A) when compared with the same population of CD14+ 
cells concurrently cultured without cytokines (Fig. 4.1 B) Cytospin samples of 
the cultured cells were subjected to IHC to investigate expression of DC cell 
surface molecules MHC II, SIRPα, CD40, CD1b and CD205. The results from 
IHC staining are shown in Fig 4.2. The cells showed positive staining for all 
the antibodies tested. MHC II expression was widespread at a high level 
throughout the majority of cells. (Fig. 4.2 A) SIRPα expression was strong 
and ubiquitous within the cell population. (Fig. 4.2 B) CD1b expression was 
also widespread and strong. (Fig. 4.2 C) CD205 was expressed on very few 
cells but those cells which showed positive expression of CD205 were 
generally large cells with an irregular morphology. (Fig. 4.2 D) CD14 
expression was very strong on a small sub-population of cells, and weak on a 
larger population. A further population was negative for CD14. (Fig. 4.2 E) 
CD40 expression was moderate in strength and observed on the majority of 
the cells. (Fig. 4.2 F). In all of the cytospin preparations the majority of the 
cells were large with eccentric nuclei and cells with dendrites of varying 
length were observed. Flow cytometry for cell surface molecules was carried 
out with day three moDCs from seven animals. Four animals were housed at 
IAH and three were at MRI. The pooled data is shown in Fig 4.3. The results 
were relatively consistent between animals. The majority of cells showed 
expression of MHC II, MHC I, and SIRPα with further cell surface molecules 
CD1b, CD40, CD80, CD14 and CD11c also expressed. The percentage of cells 
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expressing B cell (CD5) and T cell (CD3) molecules was low (<5%), and 
although not specific for these cell types, they provide indication of moDC 
cell population characteristics. The percentage of cells expressing CD205 was 
also low, which correlates with known parameters for bovine moDCs. There 
were no differences in the percentage of cells expressing each molecule when 
comparing the 3 and 7 day moDCs. The MFI for most of the molecules was 
higher for the 7 day moDCs when compared to the 3 day moDCs (p<0.05), 
except for MHC I, MHC II, CD205 and CD3. For these molecule there was a 
trend for increase in MFI of the seven day moDCs although no statistical 
















Fig. 4.1 Live cell images of bovine CD14
+
 cells cultured for 3 days (A) in TCM which has no GM-CSF or IL-4 or (B) DC-TCM with 0.2 U/ml of 
GM-CSF and 200 U/ml IL-4. Representative images of cells from the same animal. Culturing cells in medium with the addition of GM-CSF and IL-4 
promotes differentiation of the cells into a DC phenotype. The cells in panel (B) are much more heterogeneous, dendrites are easily observable on 


















Fig. 4.2 Results of moDC IHC on cytospin preparations. (A) MHC II, (B) SIRPα, (C) 
CD1b, (D) CD205, (E) CD14, (F) CD40. Positive staining is indicated by brown colour, cell 
nuclei are counterstained blue. Positive staining was observed for all molecules. 
Corresponding Isotype controls were negative (data not shown) (A) The majority of the cells 
were positive for MHC II, this image shows large positively stained cells with eccentric 
nuclei and expression of dendrites of varied length. (B) SIRPα staining was widespread 
throughout the cell population at a moderate level. (C) CD1b staining was observed in most 
of the moDCs. Dendritic morphology is clear. (D) There were a small population of cells 
which stained positively for CD205. Staining was not as strong as that observed with MHC II 
or CD1b. (E) CD14 expression was varied throughout the population. Some cells were 
strongly stained, a significant population were more weakly stained and a further 
population were negative. (F) CD40 staining was strong and prevalent in the moDC 

































Fig. 4.3 Phenotyping of bovine moDCs by flow cytometry (A) A representative dot plot 
of moDC forward (FSC) and side scatter (SSC) showing the gated population of cells used 
for analyses (one animal). (B) Histogram of Fluorescence vs cell number showing isotype 
control (black) and MHC I (red) staining and the marker used for analyses. (C) Results of 
FACS analysis of 3 day and 7 day moDCs; percentage of positive cells (in gate 1) of cells 
which are positive for each cell surface molecule. (D) Results of FACS analysis of 3 day and 7 
day moDCs; MFI of the positive cells with the MFI for the isotype control subtracted. Pooled 
data from seven animals – 3 day moDCs, pooled data for 3 animals – 7 day moDCs. Error 
bars represent standard error of the mean.  The FACS data for the moDCs was relatively 
consistent between animals and corresponded to known expression for bovine moDCs. The 
percentage of the population positive for each molecule was not statistically significantly 
different between 3 day and 7 day moDCs (2 sample t-test, p>0.05). The mean MFI was 
higher for each molecule tested which was due to increased autofluorescence. For the 7 day 
moDC this difference was significant compared to the 3 day moDCs for all molecules (2 
sample t-test, p<0.05) except MHC I, MHC II, CD205 and CD3 (2 sample t-test, p>0.05). 
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4.3.2 Challenge of moDCs with LPS 
Bovine moDCs (3 day and 7 day cultures) were challenged with 1 µg/ml of 
LPS to measure cytokine response and changes in cell surface molecules. 
ELISA for IL-10, IL-12 and TNFα were carried out on cell supernatants from 
3 day moDCs from six animals and 7 day moDCs from 3 animals (Fig. 4.4). 
IL-10, IL-12 and TNFα were all produced in response to LPS challenge by 
both 3 day (Fig. 4.4 A, C & E) and 7 day (Fig. 4.4 B, D & E) moDCs. The 
graphs also give an indication of the large spread of responses by individual 
animals, for example, the 3 day moDCs results show that cow 5 did not 
produce any IL-10, IL-12 or TNFα in response to LPS. Statistical analysis of 
the ELISA data using paired t-tests show a significant difference in IL-10 
production by the 3 day moDCs in response to LPS challenge, compared to 
non-challenged controls. (p<0.05) No significant difference was observed for 
IL-12 (p=0.09) or TNFα (p=0.22) compared to unchallenged cells. The 7 day 
moDCs stimulated with LPS showed a significant increase in TNFα 
production (p<0.05) but no significant differences for IL-10 (p=0.10) or IL-12 
(p=0.06) production compared to unchallenged cells. Flow cytometry was 
carried out for MHC II, CD1b and CD40 on 3 day moDCs (Fig. 4.5) and 7 day 
moDCs (Fig. 4.6) from three animals. FACS results show a trend for increase 
in MFI for MHC II (Fig 4.5 A), CD1b (Fig 4.5 B) and CD40 (Fig 4.5 C) in 
response to LPS challenge with the 3 day moDCs. For the 3 day moDCs only 
three animals were challenged to provide this data and of these three, two 
animals (cow 401 and cow 501) had greatly increased expression of all three 
cell surface molecules in response to LPS stimulation compared to 
unchallenged cells however the third animal (cow 600) showed no such 
response. This diversity in animal responses provided data that, when 
pooled, showed no statistically significant differences measured by a paired 
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t-test. (p>0.05)  For the 7 day moDCs, again only three animals were used to 
produce the data. There was a trend for increase in expression of MHC II, but 
the expression of CD1b and CD40 showed even greater animal variation in 
response to LPS where cells from one animal showed increased expression, 
one decreased expression and the third remained relatively unchanged (Fig. 
4.5).  
The results from these early LPS challenges showed that the moDCs were 
able to produce cytokines IL-10, IL-12 and TNFα, and that these cells were 
also able to up-regulate cell surface molecules in response to LPS challenge. 
However, some considerable animal to animal variation was observed in the 
magnitude of responses, and this combined with the smaller sample sizes, 
meant that statistically significant differences were not observed. The aim of 
the LPS challenges was to observe and measure cytokine responses and 
changes in cell surface molecule expression to confirm the activity of the 
generated cells and the efficacy of the detection methods. The results shown 
here when taken into account with the morphological and expression profile 
data confirm that bovine moDCs have been successfully generated. If these 
results were to constitute a discrete study in itself then larger sample sizes 
would have been employed and a greater emphasis placed on statistical 
significance of the data. However, these results were sufficient to progress 
with further moDC challenges with confidence in phenotype and function of 






























Fig. 4.4 Results of ELISA for cytokines in cellular supernatant following moDC 
challenge with LPS (1 µg/ml, for 18 h) (A) IL-10 3 day moDC, (B) IL-12 3 day moDC, (C) 
TNFα 3 day moDC, (D) IL-10 7 day moDC, (E) IL-12  7 day moDC, (F) TNFα  7 day moDC 
(A), (B) & (C) pooled data from six animals. (D), (E) & (F) pooled data from three animals 
The presence of IL-10, IL-12 and TNFα were assessed and compared to levels in supernatant 
from unchallenged cells. Mean = Black Marker. Stimulation of production of all three 
cytokines was observed, however there was found to be animal variation in the magnitude 
of responses as shown by the spread of the data points in panels (A) and (B) in particular. 
The data were analysed by paired t-tests. P values of less than 0.05 were found (*) for IL-10 
production by 3 day moDCs (A), and TNFα production by 7 day moDCs (F). All other p 











































Fig. 4.5 FACS analysis of 3 day moDCs challenged with LPS (1 µg/ml). MFI for (A) 
MHC II, (B) CD1b and (C) CD40 are shown. All graphs show pooled data from three 
animals. Error bars represent standard error of the mean. moDCs were challenged with LPS 
for 18 h. The tables show the individual values obtained for three animals. Two of the three 
animals responded by increasing expression of MHC II, CD1b and CD40 (Cows 401 and 501) 
One animal did not respond to LPS challenge (cow 600) by changes in cell surface molecule 
expression. The changes in cell surface molecule expression were not significant (p>0.05) 
when compared to the levels on unchallenged control cells. However, this value will have 
been affected by cow 600, and the small sample size. A larger sample size would be required 




























Fig. 4.6 FACS analysis of 7 day moDCs challenged with LPS (1 µg/ml). MFI for (A) 
MHC II, (B) CD1b and (C) CD40 are shown. All graphs show pooled data from three 
animals. Error bars represent standard error of the mean. moDCs were challenged with LPS 
for 18 h. The tables show the individual values obtained for three animals. MHC II 
expression was increased on cells from two animals following LPS challenge (cow 401 and 
cow 501) cow 600 was relatively unchanged. Overall, no significant difference in MHC II 
expression was observed between LPS challenged and unchallenged cells. (p=0.30) CD1b 
expression was varied following LPS challenge. One animal increase expression, (501) one 
decreased expression (401) and one was relatively unchanged (600). No statistical difference 
was observed. (p=0.56) CD40 expression showed a similar pattern to CD1b; One animal 
increased expression in response to LPS (600), one decreased (401) and one was relatively 
unchanged (501) A larger sample size would be required to clarify the heterogeneity of 
animal responses. All data was analysed using paired t-tests. 
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4.3.3 Challenge of bovine moDCs with H7 flagellin 
Purified E. coli O157:H7 flagellin was supplied by Dr. T. McNeilly (McNeilly, 
2008) for use in moDC challenges. The samples had been made by acid 
dissociation, neutral-pH re-association and ammonium sulphate 
precipitation (Ibrahim et al., 1985). therefore LPS could have been present in 
the samples. To investigate the response of the moDCs to H7 flagellin it was 
desirable to remove LPS from the samples as it has already been shown that 
moDCs in this study produce cytokine in response to LPS (see section 4.3.2 
and Fig. 4.5) The moDCs showed no cytokine response to the H7 flagellin 
challenge, or any significant change in expression of MHC II and CD1b (Fig. 
4.7) so the presence and activity of the H7 in the samples was assessed. The 
column-treated sample and an untreated control sample (from the same 
batch) were first subjected to SDS-PAGE analysis to visualise protein, 
followed by Western blot to confirm any bands on the gels were H7 flagellin. 
The results of the SDS-PAGE and Western blot analysis are shown in Fig 4.8. 
The untreated sample was visualised on the coomassie stained gel and was 
also detected by the αH7 antibody in the Western Blot. The sample which 
had pre-treatment in the endotoxin removal column was not observed on a 
gel or detected by probing with αH7 antibody. These results suggested that 
the H7 flagellin had been adversely affected by laboratory manipulations 
and was no longer active or present in the sample used to challenge the 
moDCs. To confirm any activity of the H7 flagellin, the treated sample was 
used to challenge Caco2 cells which are known to produce IL-8 following 
challenge with E. coli flagellin (Donnelly & Steiner, 2002). The results of an 
ELISA to detect production of IL-8 by Caco2 cells are shown in Fig. 4.9. There 
was no significant IL-8 production by the challenged cells compared to 
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unchallenged controls (p=0.376) and the H7 flagellin sample was concluded 















Fig. 4.7 Results from moDC challenge with a purified H7 flagellin sample 
ELISA for (A) IL-10, (B) IL-12, (C) TNFα in cell supernatant following challenge with a purified H7 flagellin sample and FACS analysis of these cells 
showing (D) MHC II expression and (E) CD1b expression. The H7 sample had been pre-treated by endotoxin removal. The concentration of H7 used 
for challenge as quantified by nanodrop is indicated on the Y axes. Each graph represents pooled data from three animals; error bars represent the 
standard error of the mean. The cells for FACS analysis were gated through gate 1 (Fig. 4.3) Range of the number of cells in gate: 300-5000. There 
was no significant cytokine response to challenge with this purified H7 flagellin preparation. The levels of IL-10, IL-12 and TNFα were not 
significantly different from the levels found in the supernatant of unchallenged cells. (one-way ANOVA; p=0.987, p=0.698 & p=0.439 respectively) 
There was no significant change in the mean fluorescence intensity (MFI) of cell surface molecules MHC II or CD1b on the moDCs following H7 

























Fig. 4.8 Investigation of the effect of an endotoxin removal column on H7 samples (A) 
Coomassie Blue stained gel of H7 flagellin samples & (B) Western Blot of H7 flagellin 
samples probed with polyclonal anti-H7 antibody. M: Marker, Lane 1: H7 flagellin sample 















Fig. 4.9 Results of an IL-8 ELISA on Caco2 cell supernatants. Results are the means of 
six biological replicates. Error bars represent standard error of the mean. Caco2 cells were 
challenged with 500 ng/ml of H7 flagellin diluted in serum–free Cell culture medium (CCM) 
or serum-free CCM alone. There was no production of IL-8 in response to challenge with the 
H7 flagellin which had been passed through an endotoxin removal column. There was no 
significant difference between the IL-8 levels with challenged cells and unchallenged 
controls when tested with a paired t-test. (p=0.38)  
169 
 
4.3.4 RT-PCR for TLR5 on bovine moDCs 
RT-PCR was carried out for TLR5 on bovine moDCs (Fig 4.10). Cells from 
three animals after 4 days in culture were tested. The human cell line Caco-2, 
and bovine primary epithelial cells were used as positive controls. All the 
moDCs were PCR-negative for TLR5, as were the human Caco-2 cells. The 
bovine primary epithelial cells were PCR-positive. (Fig. 4.10 lane 9) The 
bovine primary cells were run on a separate gel as there were not sufficient 
lanes for all the samples on one gel. Furthermore, the viability of the primary 
cells was uncertain because earlier attempts to resurrect vials of these cells 
from liquid nitrogen storage for culture purposes had proved unsuccessful. 
After 24 h in culture, many non-viable cells and large amounts of cell debris 
were observed. The results shown here indicate that although the primary 
cells may not have been viable for culture following liquid nitrogen storage, 
















Fig. 4.10. Results from Reverse Transcription PCR for TLR5 with bovine moDCs and 
controls. M: 100bp molecular weight marker. Lanes 1-3: moDC cDNA from three animals, 
5-7: moDC RNA controls (same three animals), lane 4: Caco2 cell cDNA, lane 8: Caco2 cell 
RNA control, lane 9: primary bovine epithelial cell cDNA positive control. All moDCs from 
the three animals tested were negative for TLR5, the human Caco2 cell line were also 
negative. The bovine primary epithelial cells were positive for TLR5, as shown by a band 
(arrow) of expected size at approximately 301 bp.  
~ 301 bp 
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4.3.5 Challenge of moDCs with VT2 
Bovine moDCs were challenged with 25, 50 and 100 ng/ml of VT2 for 18 
hours and supernatants were examined for IL-10, TNFα and IL-12 by ELISA. 
No difference in the production of these cytokines was observed compared 
to the unchallenged controls for 3 day (Fig. 4.11) or 7 day (Fig. 4.13) moDCs. 
The results were analysed by means of a one-way ANOVA and no 
significant differences were observed. (p=0.96, p=0.99 & p=0.97 respectively) 
The challenged moDCs were also examined for changes in cell surface 
markers, MHC I, MHC II, CD1b, SIRPα, CD205, CD40, CD80 and CD86 by 
flow cytometry. No change in the levels of expression of these molecules was 
found for the 3 day moDCs from three animals, the results are shown in Fig. 
4.12. The MFI was calculated by subtracting the MFI for an isotype matched 
control from the MFI of the molecule of interest. This flow cytometry data for 
MHC II was analysed by one-way ANOVA and no significant differences 
from the levels on unchallenged cells were observed. (p=0.86) The expression 
levels for the remaining cell surface molecules could not be analysed 
statistically due to cell numbers only providing sufficient cells for two 
animals, however, no changes in expression were observed.  The 7 day 
moDCs were from one animal only, due to limited cell numbers. The results 
are shown in Fig. 4.14. No change in expression of cell surface molecules was 
observed and again no statistical analysis was possible. The activity of the 
VT2 was then examined because some effect on the moDCs was expected 
and it is known that human monocytes as well as murine macrophages and 
BMDCs respond to VT or VT subunits (Ohmura et al., 2005; Tesh et al., 1994; 
van Setten et al., 1996). In addition to these studies, work carried out by a 
colleague, which included monocytes from the same animals used in this 
study, showed that at least 60% of bovine monocytes responded to VT by 
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production of TNFα (Dr. P. Cameron, unpublished data). Vero cells were 
challenged with VT2 from three batches, one which had been aliquotted and 
stored at -20˚C, one aliquot from a store at -70˚C and a new, previously 
unopened batch which had also been stored at -70˚C. The Vero cells were 
assessed by microscopy and by MTT assay for viability following an 18 h 
challenge. A range of concentrations of VT2 up to 1 µg/ml were used and no 
effect on viability or cell morphology was observed (Fig. 4.15). This indicated 
that all the aliquots of VT2 were inactive. Several published studies have 
shown the 50% lethal dose for Vero cells can be variable but 5 ng/ml 
(Cameron et al., 2002), 10-100 pg/ml (Tesh et al., 1994), or even as little as 0.8 
pg/ml (Stamm et al., 2008) have all been reported, therefore concentrations of 
1 μg/ml (i.e. 200 to 100000 times the reported LD50 values) should have 
produced a marked effect on Vero cell viability. The three aliquots were 
tested to investigate whether the storage conditions of the toxin had any 
effect. Storage of the toxin at -70°C is recommended by the supplier, and one 
of the batches had been aliquotted and stored at -20°C. However because 
none of the batches was active it seemed unlikely that storage conditions 
were the cause. In the absence of a reliable source for biologically-active VT 
this work was then abandoned; if the VT2 had shown activity and therefore 
indicated that moDCs did not respond in ways detectible by these methods 
then experimental replicates would have been carried out to enable statistical 
























































Fig. 4.11 Results of ELISA with 3 day moDC supernatant following challenge with VT2 
(A) IL-10, (B) IL-12, & (C) TNFα. Cells challenged at concentrations indicated. Each graph 
represents pooled data from three animals; error bars represent the standard error of the 
mean. There was no significant cytokine response to challenge with VT2. The levels of IL-10, 
IL-12 and TNFα were not significantly different from the levels in the supernatant of 















































Fig. 4.12 FACS analysis of 3 day moDCs challenged with a range of doses of VT2. 
Concentrations of VT as indicated on the graphs: 25 ng/ml, 50 ng/ml and 100 ng/ml. MFI for 
various cell surface molecules are shown. The MHC II panel shows pooled data from three 
animals; all other molecules show duplicate data sets. Error bars represent standard error of 
the mean. moDCs were challenged with VT2 at the concentrations indicated for 18 h. No 
changes in cell surface molecule expression were observed compared to unchallenged 
control cells. Statistical analysis of MHC II expression showed no significant differences. 
(one-way ANOVA, p=0.86, 95% confidence interval) The duplicate data sets for the 






















































Fig. 4.13 Results of ELISA with 7 day moDC supernatant following challenge with VT2 
(A) IL-10, (B) IL-12, (C) TNFα. Cells were challenged at the concentrations indicated. Each 
graph shows data from only one animal due to limits of the numbers of cells generated. 
There was no cytokine response to challenge with VT2. Although it appears that there were 
differences in panel (B) for IL-12, the actual levels, (represented here on the Y axes) are so 
small that it can be concluded that there was no cytokine production. No statistical analyses 



























Fig. 4.14 FACS analysis of 7 day moDCs challenged with a titration of VT2. MFI for 
various cell surface molecules are shown. The MHC II panel shows pooled data from three 
animals; all other molecules show duplicate data sets. Error bars represent standard error of 
the mean. moDCs were challenged with VT2 at the concentrations indicated for 18 h. No 
significant changes in cell surface molecule expression were observed compared to 











































Fig. 4.15 Vero cell viability following challenge with VT. Results of an MTT assay (A) and 
live cell imaging of Vero cells in 96-well plates (B) & (C) to show viability of Vero cells 
following challenge with a titration of VT2 (Sigma) samples. The mean values from a 
duplicate experiment are shown. Error bars represent standard error of the mean. Aliquot A: 
stored at -20˚C, Aliquot B: stored at -70˚C, New Batch: unopened new batch of VT2 stored at 
-70˚C. Images taken 18 h post challenge (A) The MTT assay indicates no loss of viability for 
any of the VT2 samples at any of the concentrations tested. (B) Representative live cell image 
of unchallenged Vero Cells showing a monolayer of viable cells. (C) Representative live cell 
image of Vero cells, challenged with 1 µg/ml of VT2 shows slight rounding of a very small 
number of cells, but overall morphology of the monolayer is unaffected. No statistical 









4.4 Discussion  
Monocyte derived – DCs (moDCs) are a widely used model for investigation 
of the interactions of various pathogens with the host immune system. Since 
they were first generated bovine moDCs have been well characterised and 
are a key element used by various research groups. These cells have been 
well characterised both phenotypically and in their responses to various 
pathogens. However, this cell generation technique while providing a 
reliable method to create numerous DCs for in vitro investigations, 
nonetheless is still a complex process which may be affected by variations in 
techniques, reagents and equipment as well as animal factors. The aim of this 
chapter was to follow published methods for generation of moDCs and 
assess the resulting cells according to published parameters. Day three 
moDCs were chosen primarily as they are generally accepted as representing 
immature DCs of the type likely to encounter E. coli O157:H7 in vivo.  
Bovine moDCs were successfully generated from several groups of donor 
animals as defined by cell surface molecule expression, morphology and 
cytokine response to LPS stimulation, and were used throughout the 
remainder of this work. Early work also presented here also generated seven 
day moDCs for comparison of cell surface molecule expression and there 
was no significant difference in percentages of cells expressing DC molecules 
from the 3 day moDCs. Mean fluorescence intensity (MFI) of the positive cell 
populations were also compared and the 7 day moDCs expressed most of the 
molecules at a higher level which was due to increased autofluorescence of 
the 7 day cells (Fig. 4.3). A pilot study comparing the responses of 3 day 
moDC and 7 day moDC to LPS was carried out and the responses by the 7 
day moDCs were very disparate, showing much animal variation and for 
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such a small sample size it is difficult to compare this data to the 3 day 
moDCs. However, there was a trend for production of cytokines (IL-12, IL-10 
and TNFα) and upregulation of cell surface molecules (MHC II, CD1b & 
CD40) in response to LPS challenge. One point of interest, and a further area 
of animal variation was noted when animal 600 responded to LPS challenge 
by production of cytokine (Fig. 4.4 cow 3) but with no changes in expression 
of cell surface molecules (Fig. 4.5), whereas cow 501 responded by increased 
expression of cell surface molecules (Fig. 4.5) but not production of cytokine 
(Fig. 4.4 cow 5). Larger sample sizes would be required to clarify this result 
and further probe the prevalence of animal variation.  This was not the 
purpose of this chapter but rather it was to characterise and validate DC 
phenotype and investigate interactions with bacterial components. 
To assess interactions of moDCs with various pathogenicity factors of E. coli 
O157:H7, challenges of cells with first H7 flagellin and then Verotoxin (VT2) 
were planned. These were both hampered by technical constraints and the 
nature of the cellular response requires further work for full characterisation. 
First, H7 flagellin challenges were carried out. H7 flagellin is known to 
stimulate IL-12 production from murine DCs in vitro (Uematsu & Akira, 
2009; Vicente-Suarez et al., 2009), and upregulation of cell surface 
costimulatory molecules in vivo (Salazar-Gonzalez et al., 2007). It has also 
been published that bovine moDCs express TLR5 (Werling et al., 2006), 
which is the pattern recognition receptor for flagellin, thus it was expected 
that bovine moDCs would respond to H7 flagellin challenge by changes in 
cell surface molecules and production of cytokine. However, no response 
was observed (Section 4.3.3) prompting further work to determine whether a 
technical issue was the reason for this or whether this was a confirmed 
179 
 
finding. It seemed possible that the endotoxin removal treatments affected 
the H7 flagellin sample in some way, although LPS removal from Flagellin 
samples has been published by Donnelly et al (2002) and no detrimental 
effects were reported (Donnelly & Steiner, 2002), and no loss of activity of the 
flagellin was noted following use of an endotoxin-removal column by 
McDermott et al (McDermott et al., 2000). Despite this, the postulate appeared 
to be supported by SDS-PAGE analysis and Western blotting of untreated 
and treated H7 flagellin samples, whereas H7 protein was not detectible in 
the treated sample by either of these methods, a strong band was observed 
for the untreated sample (Fig. 4.7). The lyophilisation of the H7 flagellin is 
another area where alteration of structure or function could have occurred, 
although this seems unlikely as these methods were used by Dr. McNeilly 
following the initial preparation of the sample and activity was evident.  
However, there could be an additional factor involved which is worth 
mentioning. It is also possible that the quantification of the treated sample 
was inaccurate. The sample was quantified using a Nanodrop 
Spectrophotometer (ND-1000, UV-Vis) before and after endotoxin-removal 
treatment. Colleagues have since observed potential discrepancies in the 
accuracy of the Nanodrop measurements when compared to a method of 
quantification used by an external laboratory. This could indicate that 
challenges and SDS-PAGE analysis was carried out on a much smaller 
quantity of H7 than was detectible by these methods. Although the 
Nanodrop too was the method used to first quantify the H7 flagellin when it 
was purified and was the method that had been used to quantify the 
untreated sample used as a control. The treated H7 sample was also unable 
to induce IL-8 secretion in Caco2 cells, thus it appeared to be not only 
structurally but also functionally altered and inactive. As these experiments 
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were unable to definitively elucidate the nature of the response of bovine 
moDCs to H7 flagellin, PCR was carried out on day 3 moDCs from three 
animals for TLR5. This was intended to facilitate the appraisal of potential 
cellular responses to H7 flagellin, had the sample remained active. As 
mentioned previously, earlier work has indicated that moDCs do express 
TLR5 (Werling et al., 2006), however the study by Werling et al was carried 
out with moDCs cultured for seven days. It was interesting to note that the 
day 4 moDCs used in this study were RT-PCR negative for TLR5 using 
published methods (Menzies & Ingham, 2006) although Werling et al. (2006) 
found that bovine monocytes expressed TLR5 using RT-PCR. Also of interest 
was that the human cell line Caco2, a widely-reported flagella-responsive 
cell, which were used as a positive control, and known to express TLR5 
(Sierro et al., 2001) which has 83% nucleotide similarity to bovine TLR5 
(Werling et al., 2006) however the primer sequences used here did not 
amplify RNA from these cells. It would be of interest to carry out further 
investigation of TLR5 expression of bovine moDCs, to investigate whether 
the negative results generated here are due to animal heterogeneity or a 
feature relating to the length of time of culture or some factor relating to 
laboratory technique. Bovine TLR heterogeneity is an area of active research 
at present and has not been fully characterised. The results of these studies 
may be able to shed some light on variations in bovine responses to micro-
organisms in vitro and in vivo (Jann et al., 2009; Werling et al., 2009) 
(http://www.roslin.ac.uk/research/people.php/Liz.Glass/). 
The next moDC challenge to be carried out was with a titration of VT2. It is 
known that VT affects immune cells in other species including human 
monocytes (van Setten et al., 1996) murine macrophages (Tesh et al., 1994), 
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and murine DCs (Ohmura et al., 2005) by stimulating production of 
cytokines, in particular TNFα, as well as an upregulation of maturational cell 
surface molecules on the DCs. However, no studies had investigated the 
responses of bovine DCs to VT, and because cattle are a major reservoir of E. 
coli O157:H7, which localises to DC-rich intestinal sites, and VT is one of this 
pathogen’s main virulence factors it is of great interest to assess the in vitro 
responses of these cells to VT. As with the H7 flagellin challenges, no 
responses were observed, and although the VT2 was ordered from a 
reputable supplier (Sigma), further testing to establish the efficacy of this 
toxin was carried out, to establish whether this was a tangible result showing 
no cellular response or whether it stemmed from some form of 
methodological difficulty. Two aliquots of an opened, previously used batch 
of VT2, one stored at -20˚C and one stored at -70˚C, as well as an unopened 
new batch (-70˚C stored) were tested for activity on Vero cells by visual 
examination for cell death and by MTT assay. A titration of VT2 was 
employed up to a maximum concentration of 1 µg/ml. A study on cellular 
signalling by Vero cells following challenge has been published and although 
it was carried out to investigate cellular signalling factors in the first few 
hours following VT2 challenge, a cytotoxicity study was performed and it 
was shown that 50% cytolethal dose of toxin was 5 ng/ml (Cameron et al., 
2002)(Toxin sourced from Toxin Technologies) Other studies too have 
published 50% lethal doses of VT or Vero cells as 0.8 pg/ml (Stamm et al., 
2008) and 10-100 pg/ml (Tesh et al., 1994). Verotoxin purchased from Sigma 
failed this basic test of VT2 bioactivity as it showed no toxicity against 
cultured Vero cells. No effects on Vero cell viability were observed with any 
of the batches of VT2 and it was concluded that they were inactive. At the 
time the VT2 was purchased the Sigma website listed several publications 
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which had used purified VT2 (Nakao & Takeda, 2000; Sugatani et al., 2000; 
Suzuki et al., 2000). Each of these studies examines the bioactivity of VT2, and 
demonstrated activity with both in vitro and in vivo experiments. Sigma 
customer services were contacted regarding this matter and the response 
received suggested that that activity was not guaranteed by their testing 
procedures prior to sale, only toxin purity, which did not provide a 
satisfactory explanation. Due to time constraints these experiments were not 
repeated, although VT effects were addressed in some way when VT+ strains 
were used for challenges with moDC and compared with VT- strains 
(Chapter 5). The loss of activity was not ever accounted for, however at the 
time of writing Sigma have discontinued sales of VT2. Further work would 
source a toxin with proven efficacy against Vero cells for challenging moDCs 
to characterise responses in vitro. 
In Summary, bovine moDCs were successfully and reproducibly generated 
for use in investigations with E. coli O157:H7, this was shown by dendritic 
morphology and cell surface molecule expression profiles as well as cytokine 
responses to LPS. Challenges of moDCs with E. coli O157:H7 with both H7 
and VT2 were complicated by issues with efficacy of these components. 
These challenges would ideally be repeated with components of confirmed 
efficacy. These experiments while not providing the expected insights into 
bovine immune responses to E. coli O157:H7 pathogenicity factors were still 
valuable as technical problem solving exercises and highlight that purchased 
products may be subject to varying quality. The bovine moDCs used in this 
study were found not to express TLR5, and further work to examine whether 




The following two chapters investigate the bovine moDCs as characterised 
here and their interaction with various E. coli strains. The VT effects on 
moDCs are in some way addressed by challenges with Verotoxin positive 
and negative strains; however, a challenge with active purified toxin and 
moDCs would be an important area for future work.  
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Chapter 5 Challenge of bovine moDCs with various  
























5.1 Introduction  
Bovine moDCs are a useful model for investigating in vitro the interactions of 
pathogens with cells central to the development of immune response. They 
have been well characterised both in this study (Chapter 4) and elsewhere 
(Hope et al., 2000a; Werling et al., 1999). The aim of work in this chapter was 
to investigate the possible contribution of DCs in the asymptomatic carriage 
of E. coli O157:H7 in cattle by challenging bovine moDCs with various E. coli 
strains; subsequently measuring cytokine response, cell surface molecule 
expression, phenotype and intracellular bacterial numbers. Interactions 
between bacteria and DCs are initiated through the interactions of a number 
of ligands and their receptors, principally PAMPs (e.g. flagella and LPS) and 
PRRs, (e.g. TLRs) (See Chapter 4). Many of these bacterial signals will be 
available to moDC receptors following in vitro challenge with live E. coli 
strains, and the subsequent cellular responses have not been characterised to 
date.  
 
E. coli are a diverse species of bacteria of which many strains are beneficial to 
the host and indeed E. coli strains occur as part of the normal gut flora in 
numerous species of animals and man. However, other strains are 
pathogenic, and this pathogenicity can often be host specific. One interesting 
feature of E. coli O157:H7 in particular is its significant pathological effects on 
man, including potentially fatal outcomes; while these bacteria can colonise 
ruminant hosts with no clinical signs and little or no pathological 
consequences. A/E lesions, which are a feature of human disease, have been 
found in animal tissues but without the ensuing gastrointestinal symptoms. 
These differences are likely to be due to host factors and an understanding of 
which features are involved in these disparate responses would not only 
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advance understanding of bovine immunopathology but would potentially 
allow novel intervention methods to be developed by which outbreaks of 
human disease can be reduced. This study focused on in vitro EHEC 
challenges and bovine DC responses, as key immune cells found at the site of 
O157 colonisation, which could be key to the different responses observed in 
vivo between human and bovine hosts.   
 
Several E. coli strains were selected to challenge moDCs. The rationale 
behind the selection of strains was to use a group of bovine commensal E. coli 
strains and a group of bovine pathogenic E. coli strains (entrotoxigenic E. coli, 
ETEC) to compare to E. coli O157:H7 strains both in terms of bacterial 
characterisation and in the responses generated by moDCs following 
challenge. This would enable the characterisation of bovine moDC responses 
to E. coli O157:H7 and assess whether the responses generated were more 
comparable to those generated by harmless commensal bacteria or those of 
pathogenic E. coli, and facilitate the further investigation of any differences 
observed. This comparison of EHEC, ETEC and commensal strains has not 
been undertaken with bovine DCs to date.  
 
The motility phenotype of the panel of bacterial strains used for moDC 
challenges was assessed. Motility is conferred on E. coli strains by the 
presence of flagella. These filament-like appendages rotate to facilitate 
bacterial movement (Berg & Anderson, 1973). Motility is an important aspect 
of bacterial pathogenicity as it enables bacteria to travel into areas of plentiful 
nutrients or away from locations of harmful substances. Flagella have also 
been shown to be important in the formation of biofilm by E. coli, which is a 
further important facet of bacterial virulence (Pratt & Kolter, 1998). Flagella 
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are comprised of polymerised flagellin monomers, and these sub-units are 
ligands for host cell TLR5 (Hayashi et al., 2001). It is important to be aware of 
the motility phenotype of bacterial strains because this factor may contribute 
to the responses of moDCs to E. coli. The presence of flagella within EHEC 
strains has been shown to be an important factor for adherence to bovine 
intestinal tissues in vitro (Erdem et al., 2007; Mahajan et al., 2009).  Therefore 
the presence or absence of this important PAMP may also affect interactions 
with bovine moDCs.  
 
A recent study has compared the responses of bovine primary colonic cells to 
various bacterial strains including EHEC, EPEC, ETEC and commensal E. coli 
in vitro (Bridger et al., 2010). The study by Bridger et al. does suggest some 
strain differences but also acknowledges the limitations of concentrating 
solely on epithelial cells and recognises the importance of immune cells in 
the ultimate response to encountered bacteria in vivo. That study suggested 
that co-cultures of epithelial cells and immune cells could help further 
characterise reactions of the intestinal micro-environment to these various E. 
coli strains. Gene transcripts for inflammatory factors such as IL-8 were 
increased in response to EHEC when compared to EPEC, and interestingly 
this response was also observed in response to a commensal strain (Aktan et 
al., 2004; Bridger et al., 2010). However, the ‘commensal’ strain used in the 
Bridger et al. study was isolated from a calf displaying diarrhoeic symptoms, 
and although was found to be negative for the tested virulence factors, it is 
possible that it may not be a true commensal strain. Indeed several of the 
commensal strains in this study were collected from clinically normal cattle 
and as well as a lack of virulence factors, these strains were usually collected 
from more than one animal and had been localised to several intestinal sites. 
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Bovine moDC cytokine responses to bacterial challenges in vitro were 
investigated in this study. Cytokines are produced by DCs in response to 
various bacteria and bacterial agonists to signal to other cell types and 
initiate the generation of immune responses. IL-10, IL-12 and TNFα 
production were measured as important cytokines in Th1 responses (IL-12, 
TNFα) and tolerance (IL-10) as well as inflammation and pathology (TNFα). 
These cytokines, or probably a combination of these cytokines, as well as 
other factors are important in vivo for initiating immune responses against 
pathogenic bacteria and tolerance to commensal bacteria. For further 
information on the functions of these cytokines in cattle see section 4.1. 
 
In response to bacterial challenge the expression of cell surface molecules 
MHC II, CD1b, CD205 and SIRPα on moDCs was measured. As key 
molecules expressed on, and with important roles for the function of DCs 
any differences in expression following challenge with various E. coli strains 
could indicate variation in cellular functions such as antigen presentation for 
example. See section 2.1 for further information on the functions of these 
molecules. 
 
Many of the more severe clinical sequelae of EHEC infection in humans have 
been shown to be due to the effects of VT. VT does not have the same 
pathological effects on bovine hosts in vivo although has been shown to 
stimulate production of TNFα in bovine monocytes in vitro from a 
proportion of animals sampled. (Dr. P Cameron, personal communication) 
Problems with the activity of purified toxin discussed in Chapter 4 prevented 
investigation of its effects on moDCs in vitro so the work in this chapter 
compared moDC responses to VT+ and VT- O157 strains. Murine BMDCs 
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have been shown to respond to VT (Ohmura et al., 2005)(discussed further in 
Chapter 4 section 4.1) and these responses are blocked following incubation 
with an antibody treatment for the VT receptor Gb3 indicating expression by 
this cell type. Bovine moDCs have not been investigated for the presence of 
Gb3. The aim of this work was to discover any role for VT in bovine moDC 
responses. 
 
As a pathogen which is primarily extracellular within the host, the fate of E. 
coli which become phagocytosed have not been fully characterised. DCs in 
vivo are efficient in antigen uptake by numerous methods including 
phagocytosis. This study investigated the uptake of E. coli strains by moDCs 
to investigate whether intracellular bacterial survival was possible and 
whether any differences of bacterial uptake between the strains was evident. 
As an extracellular pathogen it was assumed that E. coli could be 
phagocytosed by moDCs and that its antigens would be processed and 
presented for generation of appropriate immune responses. The fact that E. 
coli is not an obligate intracellular pathogen suggests that any intracellular 
survival mechanisms which it does express are likely to differ from those 
mechanisms which are known for pathogens which are dependent on this 
method of virulence.  
 
Although the phagocytosis of E. coli by DCs has not so far been investigated, 
phagocytosis of E. coli by human macrophages has been studied and one 
strain (E. coli strain EDL933) was shown both to be internalised by human 
macrophages and to resist killing by these cells (Poirier et al., 2008). The 
numbers of intracellular viable bacteria were measured up to 24 h and 
intracellular bacteria were still viable at this time. It was also found that E. 
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coli O157:H7 could replicate within the macrophages, as although fewer 
infected cells were detected at 24 h, each infected cell had higher numbers of 
internal bacteria than those detected at 2 h. VT was also found to play an 
important role in this interaction, the presence of the toxin reduced bacterial 
uptake by the macrophages as well as promoted bacterial survival (Poirier et 
al., 2008). In contrast E. coli O157:H7 was rapidly killed when taken up by 
murine macrophages in vitro. Around 15 minutes after infection the bacteria 
were killed within the cells, and these remained alive for up to 24 h (Shimada 
et al., 1999). A search of the literature reveals no comparable studies with 
EHEC strains and bovine macrophages. 
 
Intracellular bacterial studies have been carried out with DC for numerous 
intracellular pathogens in various species. Bovine moDCs in particular have 
been studied in greater depth with intracellular pathogens such as M. bovis 
(Denis, 2008) and Salmonella typhimurium (Norimatsu et al., 2003; Norimatsu 
et al., 2004).  Non-pathogenic E. coli strains have been used in some human 
studies as control strains for Salmonella infections (Schoppet et al., 2000) 
however, no discrete studies investigating the uptake of pathogenic E. coli 
strains by DC have been carried out. Phagocytosis of E. coli by murine 
BMDCs has been demonstrated but the strain was not identified and was 
unlikely to be O157:H7 (Holt et al., 2007). DCs are known to be phagocytic, 
and have been shown to internalise several bacterial species in vitro. 
However no studies have been carried out to date which investigate 




The aims of this chapter were: 
1. To characterise the growth and motility phenotypes of the bacterial 
strains selected for investigation. 
2. To investigate the effects of E. coli strains on the cytokine production 
and cell surface expression profiles of bovine moDCs. 
3. To compare the effects of VT2+ E. coli O157:H7 strains and a VT- strain 
on the cytokine production and cell surface expression profile of 
bovine moDCs. 
4. To compare characteristics of phagocytosis of E. coli strains by moDCs, 




5.2 Materials and Methods  
 
5.2.1 Background 
The bacterial challenges were developed from published moDC bacterial 
challenge techniques with Salmonella strains (Norimatsu et al., 2003; 
Norimatsu et al., 2004). (Norimatsu et al 2003 & 2004) 
 
5.2.2 Selection of Bacterial Strains 
The E. coli O157:H7 category 2 containment level (CAT 2) strains selected 
were chosen for study because the corresponding category 3 containment 
level (CAT 3) strains were also available. For strain information see 
Appendix A.3. The ETEC strains were kindly gifted by Roberto LaRagione 
(VLA, Weybridge) and were isolated from cases of bovine diarrhoea (Turner 
et al., 2006). Commensal strains were collected by Dr. E Clark and were 
selected from the in-house collection. These commensal strains were chosen 
based on prevalence within the population of sampled animals, the numbers 
of bacteria at selected intestinal sites and absence of known virulence factors. 
The commensal strains were selected if they were isolated from more than 
one animal and had been present in significant numbers at more than one 
intestinal site. A lack of virulence factors was also a requirement for 
classification as a commensal in this study. The absence of virulence factors 
was confirmed by various laboratory techniques including PCR (Dr. E. Clark, 
Ph.D. Thesis, http://theses.gla.ac.uk/706/). 
193 
 
5.2.3 Bacterial Characterisation  
5.2.3.1 Motility Assay 
Phenotyping of E. coli strains, by means of stab cultures were carried out to 
assess motility. The bacterial stocks were kept in glycerol or in cryobank vials 
(Mast Diagnostics) at -80°C and were grown up on nutrient agar plates 
(Oxoid). Two to five colonies were used for overnight bacterial culture in 5 
ml MEM/HEPES (Sigma) and placed in a shaking incubator at 37C and 200 
rpm.  Universal containers were filled with 20 ml of 0.3% agar containing 
0.01% of TTC (Fluka) pre-heated to 50˚C, and placed on a level surface at 4˚C 
to set. Following the overnight incubation a sterile inoculating needle was 
coated with bacterial culture and used to inoculate the agar in a single 
vertical stab, through the agar to the bottom of the universal container. The 
stab cultures were incubated overnight at 37C, 5% CO2. TTC reduction 
reflects bacterial growth and is indicated by a red colour change. Following 
16-18 h incubation the cultures were visually examined for areas of bacterial 
growth. Motility was confirmed if red colour had spread throughout the agar 
and the strain was non-motile if the red colouring was restricted to the stab 
line.  
5.2.3.2 Bacterial growth assay 
The Bioscreen C system (Oy Growth Curves Ab Ltd.) allows investigation of 
bacterial growth dynamics using optical density measurements. Culture 
conditions, wavelengths and frequency of data recording may all be user-
defined. Cultures of bacterial strains were set up in triplicate in MEM/ 
HEPES, in a shaking incubator at 200 rpm and 37˚C. Following overnight 
incubation, triplicate 1:10 dilutions were made in MEM/HEPES. These 
cultures were incubated for a further two hours in the same conditions. 
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Further 1:10 dilutions were made in MEM/HEPES or DC-TCM and 250 µl of 
these cultures were added in triplicate to wells of a Bioscreen micro-plate. 
Media alone was included as a reference sample. Further serial 1:10 dilutions 
were made in sterile PBS to allow determination of the numbers of bacteria 
present at the start of the growth curve measurements. 100 µl of dilutions 
10^5 and 10^6 were plated out on nutrient agar plates (Oxoid) in triplicate and 
incubated over night at 37˚C. The bioscreen provided static incubation at 
37˚C and took O.D.600 measurements every 15 min for defined durations, 
either 2 h, or 24 h. The plate was shaken for 15 sec before each O.D. reading. 
When culture and sampling was complete serial dilutions of the cultures 
were made in sterile PBS and dilutions 10^7 and 10^8 were plated out in 
triplicate to determine bacterial numbers. Bacterial colonies were counted 
and used to calculate cfu/ml at the start and end points of the growth curves. 
The O.D. readings from the Bioscreen C were used to generate growth curves 
for each bacterial strain over different time periods. 
 
5.2.4 Calculation of bacterial MOI based on O.D.600 measurements 
Bacterial strains were grown overnight in 10 ml MEM/HEPES (Sigma) in a 
shaking incubator set to 200 rpm and 37°C. A 1:10 dilution in 9 ml of fresh 
MEM/HEPES was made and cultured under the same conditions for 
approximately 3 h.  At this point, serial 1:10 dilutions of bacterial cultures, for 
three strains, were plated out to calculate challenge cfu. The cultures for all 
three bacterial strains contained approximately 3 x 108/ml cfu (data not 
shown) at optical density of between 0.25 and 0.35 O.D.600 (typically 0.31), 
this data was used to calculate the MOI for further challenges. 
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5.2.5 Preparation of bacterial cultures for moDC challenge 
After overnight growth at 200 rpm and 37°C in 10 ml MEM/HEPES, bacteria 
were diluted 1:10 into 9 ml of fresh MEM/HEPES. When the O.D.600 of these 
cultures was between 0.25 and 0.35, serial 1:10 dilutions was made into RPMI 
1640 (Invitrogen) and 100 μl of the appropriate dilution was used to 
challenge the cells. Usually 100 μl of dilution 103 was added per well of a 12 
well plate for each strain. This corresponded to an MOI of approximately 0.5. 
Optical density was measured on an Amersham Pharmacia Novaspec II 
spectrophotometer.  
 
5.2.6 Preparation of moDC 
Bovine moDC were generated as described (section 4.2.1.4). Cells were 
harvested after 3 days in culture (section 4.2.1.5). The harvested cells were 
washed with three washes of gentamicin-free DC-TCM by pelleting at 1000 x 
g for 4 min, then counted (section 4.2.1.6) and diluted to 1 x 106 cells per ml in 
gentamicin-free DC-TCM. 1 ml of this cell suspension was added to one well 
of a twelve well plate. These cells were incubated overnight at 37°C and then 
used for bacterial challenges on day 4. 
 
5.2.7 Bovine moDC challenges 
100 μl of bacterial culture at the appropriate O.D. and dilution for the 
experiment was added per well of the 12 well plate. Where cell numbers 
allowed each different strain or condition was carried out in triplicate.  100 μl 
of pre-warmed RPMI was added for control wells. Bacteria were also added 
to wells containing gentamicin-free TCM only as a control for bacterial 
growth in the medium. The challenged cells were incubated for 2 h at 37°C 
and 5% CO2 then gentamicin was added (50 µg/ml) to each well to kill 
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extracellular bacteria. Gentamicin was used as it has been shown to have 
little uptake by eukaryotic cells and therefore unlikely to affect the viability 
of intracellular bacteria. (Vaudaux, 1979) The cell culture plates were 
replaced in the incubator and incubated at the same conditions for a further 
22 h. (total culture time 24 h, pulse-chase experiment) For CAT 2 organisms, 
following this incubation the plates of challenged cells were placed in the 
centrifuge for 2 min at 480 x g. The supernatants were carefully removed and 
stored individually at -20°C until used for Enzyme Linked Immunosorbent 
Assays (ELISA). For CAT 3 organisms the plates were removed from the 
incubator and placed on the level work surface in the hood for three minutes 
to let non-adherent cells settle to the bottom. The supernatants were very 
gently removed and then individually filter-sterilized with a 1 ml syringe 
and a 0.2 µm filter before removal to CAT 2 and stored at -20°C. To harvest 
the challenged cells, 500 μl of pre-warmed Cell Dissociation Medium (Sigma) 
was added per well (section 4.2.1.5). The cells were then washed in TCM, 
counted (section 4.2.1.6) and resuspended for FACS analysis. CAT 3 
organisms underwent an additional 15 min incubation in FACS buffer 
(Appendix A.4.2.7) containing ampicillin 100 mg/ml; this was required before 
the cells were removed to the CAT 2 laboratory for further procedures. 
 
5.2.8 Enzyme Linked Immunosorbent Assay (ELISA) analysis of bovine 
cytokines 
ELISA for IL-10, IL-12 and TNFα were carried out as described previously 
(section 4.2.5). 
 
5.2.9 Flow Cytometry for Cellular Expression of Cell Surface Molecules 
Flow cytometry was carried out as described previously (section 3.2.7).  
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5.2.10 Determination of viable intracellular bacterial numbers following 
moDC challenges 
One E. coli O157:H7 strain (MCI 0010), one bovine ETEC (MCI 0132) and one 
bovine commensal (MCI 0430) strain were selected for this experiment as 
representative for each group of bacteria (O157, ETEC & commensal). The 
experiment was carried out using cells from three animals on two separate 
occasions. Following the 2 h challenge, the media was removed and replaced 
with pre-warmed media containing 50 µg/ml gentamicin to kill extracellular 
bacteria. After further incubation two wells of cells were harvested (section 
4.2.1.5) for each strain and pooled. Time points for cell collection were 4, 8, 
12, 24 and 36 h after commencement of challenge.  Cells were then collected 
into universal tubes and washed three times by pelletting at 800 x g for 4 min 
and resuspending in sterile PBS. After the first wash the cells were 
transferred into centrifuge tubes, and all supernatants were discarded. To 
lyse the cells 1 ml of 1 % v/v Triton-X 100 (Sigma) in PBS was added to the 
cell pellet and mixed by pipetting. Serial 1:10 dilutions for each strain were 
made in sterile PBS and plated out in triplicate on nutrient agar plates. The 
dilutions used for plating out were neat, 10^1 and 10^2. The agar plates were 
incubated overnight at 37˚C.  
 
5.2.11 Live Cell images 
Live cell images were obtained as described previously (section 4.2.10). 
 
5.2.12 Data Analysis 
Data analysis for FACS and ELISA were carried out as described previously 
(4.1.19). Graphs were plotted in Microsoft Excel and statistical analysis was 
carried out using Minitab (v13).  
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5.3 Results  
 
5.3.1 Bacterial Motility Assay 
Stab cultures in 0.3% agar were used to assess the motility of the panel of 
bacterial strains selected for interactions with moDCs. The addition of TTC to 
the agar provided a red colour change indicating the location of viable 
bacteria (Fig. 5.1 A). The resulting motility phenotypes of the strains are 
shown in a table (Fig. 5.1 B) All of the E. coli O157:H7 strains were motile as 
were all the bovine commensal E. coli strains. Two of the bovine ETEC strains 
were also motile (MCI 0132 & MCI 0688). One bovine ETEC strain (MCI 
0690) was non-motile while the final bovine ETEC strain (MCI 0693) gave 
inconclusive results, as it demonstrated non-motility in one experiment and 
partial or reduced motility in a repeat experiment. 
 
5.3.2 Bacterial growth characteristics in two culture media 
The growth curves of all of the bacterial strains were obtained over an 18 h 
period in both MEM/HEPES (Sigma) (Fig. 5.2) and dendritic cell tissue 
culture medium (DC-TCM) (Fig. 5.3). The aim of these experiments was to 
compare bacterial growth rates for the different strains to determine whether 
the growth of the strains was similar enough to be used in experiments with 
moDCs. Also growth rates were assessed in the DC-TCM to observe the 
presence and nature of any changes in growth rates which would need to be 
considered in experimental planning and in the interpretation of 
downstream results.  The growth rates of all the strains were faster and much 
more consistent in DC-TCM than the MEM/HEPES and this suggests that 
during the challenge period all the bacteria will be exhibiting similar growth 
characteristics. The bacteria all reached a stationary phase of growth by 6 h in 
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DC-TCM, but this took approximately 10 h in MEM/HEPES for most strains, 
one strain reached stationary phase at around 15 h (MCI 0132, an ETEC) and 
a further strain (MCI 0688, an ETEC) did not reach a stationary phase by the 
end of the experiment (18 h). The bacteria also reached higher final O.D.600 
readings in the DC-TCM (0.65 – 0.9) compared to the MEM/HEPES (0.25 – 
0.45). This corresponded with higher final cfu/ml calculated for the bacterial 
strains grown in DC-TCM (between 5 x 1010 and 1 x 1011) and MEM/HEPES 
(approximately 1 x 107 – 1 x 108). The challenges were planned to be carried 
out at an approximate MOI of 0.5; this was to be obtained by O.D.600 
measurements in MEM/HEPES. At an O.D.600 of 0.31 the bacterial strains 
were to be diluted before adding to the cells to provide this approximate 
MOI. Dynamics of the bacterial growth in the cellular supernatant should not 
be a variable factor affecting the results of the challenge experiments because 
a similar number of bacteria will have been added to each well as 
determined by O.D.600 readings and this data shows that the bacteria will all 
grow at similar rates in the DC-TCM. Growth to a particular O.D.600 is used 
as an approximation of cfu, and although not exact, O.D. readings are 
commonly used in bacterial challenges for this purpose, but as can be seen 
from the cfu/ml data here, there is some variability in numbers of bacteria at 



























Fig. 5.1 Motility assay for selected panel of bacteria. (A) Image of stab cultures for all the 
strains showing results from a duplicate experiment. Red colour represents bacterial growth. 
(B) Table of results from the motility assay. All the strains displayed a motile phenotype 














Fig. 5.2 Growth of bacterial strains in MEM/HEPES, Data is pooled from a triplicate experiment. After 10 hours all the strains had reached a 
stationary phase of growth except two of the ETEC strains: MCI 0688 and MCI 0132. MCI 0688 did not reach stationary phase before the end of the 
experiment but was at a similar O.D.600 to the rest of the strains at this time. MCI 0132 reached stationary phase by around 15 h. The final O.D.600 of 
the bacterial cultures at 18 h ranged from 0.25 to 0.45, and there were some variations in growth pattern during the experiment. The cfu/ml at 0 h 













Fig. 5.3 Growth of bacterial strains in DC-TCM. Data is pooled from a triplicate experiment. After 7 hours all the strains had reached a stationary 
phase of growth; however the O.D.600 of the strains continued to climb slowly after this time. The final O.D.600 of the bacterial culture at 18 h ranged 
from 0.65 to 0.90. The growth of MCI 0483 (a commensal strain) was consistently lower than the other strains. The growth of all the strains was 
quicker and more consistent in DC-TCM than MEM/HEPES, and reached higher final O.D.600 readings. The cfu/ml at 0 h and 18 h were calculated by 
serial dilution on Agar plates and these are shown in the table. 
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5.3.3 Phenotype of moDCs challenged with viable bacteria 
Bovine moDCs challenged with viable E. coli for 2 h and cultured for a 
further 22 h took on an activated morphology with many more elongated 
dendrites visible. No differences in morphology were observed when 
different strains were used for challenge. Cells from some animals showed 
less pronounced morphological changes, however the challenged cells 
always displayed increased frequency of longer dendrites than unchallenged 










Fig. 5.4 Representative live cell images of bovine moDCs challenged with live 
bacteria. Representative images from one animal are shown. Changes in morphology were 
observed from unchallenged cell phenotype (A) and cells challenged for 2 h with viable E. 
coli, at an MOI of 0.5 (B) (strain MCI 0430). The cells took on an activated morphology with 








5.3.4 Cytokine responses of moDCs challenged with E. coli strains 
Following the 24 h total challenge time, supernatants were collected and 
subjected to ELISA for IL-10, IL-12 and TNFα. All three cytokines were 
produced in response to challenge with all of the bacterial strains compared 
to unchallenged cells (p<0.001). When the data for all the strains and all the 
animals is pooled, no statistically significant difference is observed (tested at 
the 95 or 99% confidence intervals) (Fig. 5.5). However, the magnitude of 
responses of cells from individual animals is subject to great variability, and 
therefore individual animal and strain data is also presented here (Fig. 5.6 – 
5.8). When considering the data from individual animals there are some 
trends that appear. IL-10 is produced by moDCs from all the animals studied 
following challenge with all strains. There is a great animal variation in 
magnitude of cytokine response to bacterial challenge, which makes it 
difficult to pool data. However, Fig. 5.6 indicates that there may be a trend 
for increased IL-10 production in response to commensal strains when 
compared to ETEC or EHEC strains. This pattern can be observed in many of 
the graphs in Fig. 5.6 (A, C, D, F & K) although commensal strain MCI 0483 
did not stimulate this increased IL-10 production in any of the animals (G, H 
& I), and a selection of data sets do not indicate any strain differences. (B, E & 
H) IL-12 was produced in response to all the E coli strains with cells from all 
the animals when compared to unchallenged cells (Fig. 5.7). Again, great 
variations in the magnitude of responses were observed between animals. 
There appeared to be no differences related to strain; in the majority of the 
panels the levels of IL-12 for each strain is comparable. (Fig. 5.7 A, D, E, F, G, 
H & J). TNFα is also produced in response to challenge with all the strains, 
compared to levels produced by unchallenged cells. (Fig. 5.8) A trend is 
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observed is several of the panels where TNFα production is lower for the 
ETEC strain compared to O157 and commensal strains (Fig. 5.8 A, D, E, F, J 



































Fig. 5.5 Results of ELISA of moDC supernatant following challenge with E. coli 
strains. IL-10 (A), IL-12 (B) and TNFα (C) ELISA of moDC supernatant following challenge 
with four O157:H7 strains, four ETEC strains and four commensal strains. Results for each 
strain group are pooled. Data is pooled results of individual challenges carried out each time 
with moDCs from three animals. Each challenge was also carried out in duplicate or 
triplicate if cell numbers allowed. Error bars represent the standard error of the mean. 
Statistically significant levels of IL-10, IL-12 and TNFα were produced in response to 
challenge with bacteria from all three groups compared to the levels for unchallenged cells. 
Analysis using a one-way analysis of variance (ANOVA) gave a main p value <0.001, 
significant at the 99% confidence interval, There were no significant differences noted 
between cytokine levels produced in response to the strain pathotypes however, also tested 

















Fig. 5.6 Results of ELISA for IL-10 production by moDCs in response to challenge with E. coli strains. Each histogram shows data from one 
animal. Error bars represent the standard error of the mean where duplicate or triplicate experiments were carried out. N.C. = No Challenge. IL-10 
was produced in response to all of the bacterial strains. A trend is observed greater IL-10 production in response to commensal strains compared to 
ETEC and O157:H7 strains, however, this trend was not observed with all the animals for all the commensal strains. The magnitude of response also 
varied greatly between animals (note the difference in scale of the axes). In each histogram the first column is an O157:H7 strain, the second column 
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Fig. 5.7 Results of ELISA for IL-12 production by moDCs in response to challenge with E. coli strains. Each histogram shows data from one 
animal. Error bars represent the standard error of the mean where duplicate or triplicate experiments were carried out. N.C. = No Challenge. IL-12 
was produced in response to all of the bacterial strains. There were no trends observed for differences in cytokine production between the strains – 
within each histogram the levels of IL-12 production were similar for each strain, and above that of the unchallenged cells. The magnitude of IL-12 
response varied between animals. (note the difference in scale of the axes). In each histogram the first column is an O157:H7 strain, the second 
column is an ETEC, the third column is a commensal and the fourth is unchallenged. 



























Fig. 5.8 Results of ELISA for TNFα production by moDCs in response to challenge with E. coli strains. Each histogram shows data from one 
animal. Error bars represent the standard error of the mean if duplicate or triplicate experiments were carried out. N.C. = No Challenge. TNFα was 
produced in response to all of the bacterial strains. A trend, which many of the histograms show, was observed. Slightly lower levels of TNFα were 
produced in response to the ETEC strains compared to the O157 and commensal strains. The magnitude of TNFα response varied between animals. 
(note the difference in scale of the axes) In each histogram the first column is an O157:H7 strain, the second column is an ETEC, the third column is a 
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5.3.5 Expression of cell surface molecules on moDCs challenged with 
E. coli strains 
Bovine moDCs were challenged with a panel of 12 E. coli strains in total, and 
the levels of expression of cell surface molecules MHC II, CD1b, CD205 and 
SIRPα were measured. The pooled data is shown (Fig. 5.9 C) Each 
experiment consisted of one O157 strain, one ETEC strain, one commensal 
strain and unchallenged cells. Each experiment (consisting of three strains 
and unchallenged cells) was carried out with moDCs from three animals on 
the same day in 12 well plates. Often cell numbers limited the number of 
replicate wells which could be used for each condition, but three wells for 
each strain were challenged if numbers allowed, and the wells were then 
pooled for FACS labelling. One experiment was repeated in full, (Fig. 5.10 D) 
giving data from six animals. The complete pooled data for all 12 strains (Fig. 
5.9 C) shows no significant differences in levels of expression for any of the 
molecules either between the pathotypes themselves or the levels expressed 
by the pathotype challenged moDCs compared to the unchallenged cells. 
(MHC II, p=0.759; CD1b, p=0.843; CD205, p=0.991; SIRPα, p=0.963) Fig 5.10 
shows data from individual challenges. Challenge 1 (Fig. 5.10 A) shows there 
was little difference between the strains for expression of MHC II, CD1b, 
CD205 or SIRPα compared to unchallenged cells. The differences were not 
statistically significant for MHC II (p=0.759) Challenge with MCI 0132 
(ETEC) appeared to downregulate SIRPα expression; however a sample size 
of one for CD1b, CD205 and SIRPα would make it impossible to draw 
conclusions from this. The data from this challenge was not repeated as the 
level of expression observed in this experiment was much greater compared 
to the other three challenges (Fig. 5.10 B, C & D) and in fact when the data 
from challenge 1 is removed from the pooled data the upregulation of MHC 
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II in response to all the pathotypes becomes clearer but is still not statistically 
significant (p=0.2) (data not shown). Experiment 2 (Fig 5.10 B) shows that 
there was no difference in expression levels of MHC II (p=0.911), CD1b 
(p=0.936), or CD205 (p=0.806) compared to unchallenged cells. SIRPα 
appeared to be down regulated in response to MCI 0465 but this difference 
was not significant (p=0.753) Experiment 3 (Fig. 5.10 C) showed no 
differences in expression of MHC II (p=0.135), CD1b (p=0.494), CD205 
(p=0.977) or SIRPα (p=0.531) compared to unchallenged moDCs. MHC II 
expression appeared to be upregulated by challenge with MCI 0200 and MCI 
0483 but not MCI 0690 when compared to unchallenged cells and expression 
of SIRPα seemed to increase in response to MCI 0200 and MCI 0690 but not 
MCI 0483. However, these differences were not significant in comparison to 
the expression levels on unchallenged moDCs. Experiment 4 (Fig. 5.10 D) 
indicated that MHC II was upregulated in response to all three strains (MCI 
0279, MCI 0693, and MCI 0490) compared to unchallenged cells but this 
change was not significant (p=0.706), and no differences were evident 
between the pathotypes. There were no significant differences observed for 
expression of CD1b (p=0.998), CD205 (p=0.479), or SIRPα (p=0.889). 
Experiment 4 comprised pooled data from six separate animals and is 
therefore the most robust data set. To summarise these results, challenge of 
bovine moDCs with E. coli strains tends to lead to increased expression of 
MHC II, which is an expected finding, showing that the moDCs are 
responding to bacteria by increasing their antigen presenting capacity in 
order to initiate immune responses. However there were no differences 
observed between the levels of response to the different pathotypes 
suggesting that this is a generalised MHC II upregulation, not specific to 
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individual strains or pathotypes. No other cell surface molecule was 













Fig. 5.9. Flow cytometry for cell surface molecules expressed by moDCs following challenge with various E. coli strains. (A) Dot plot of forward 
and side scatter of moDCs showing the gated population of cells used for analysis (gate 1) The limit on the gated population was set at 10,000 cells 
but due to limits on cell numbers the actual number of cells in the gate ranged from 3,000 to 10,000. (B) A representative histogram generated by the 
flow cytometry data of fluorescence vs cell count: Black: isotype control AV37; red, blue, purple and green: MHC II expression of cells challenged 
with various E. coli strains (Red: MCI 0010, Blue: MCI 0132, Purple: MCI 0430, Green: unchallenged).The MFI for the relevant isotype control was 
subtracted from the MFI for each molecule to give the values presented here and the results shown are pooled from 15 data sets for MHC II and 12 
data sets for CD1b, CD205 and SIRPα (C). These data sets consisted of moDCs challenged with four O157:H7 strains, four ETEC strains and four 
commensal strains. Error bars represent standard error of the mean. There was a trend observed in which MHC II was upregulated in response to 
challenge with all strains compared to unchallenged cells, but this difference was not significant (p=0.759) There were no change in expression for 
CD1b, CD205 or SIRPα (p=0.843, p=0.991 & p=0.963 respectively) compared to unchallenged cells and there was no difference observed between the 



















Fig. 5.10 Flow cytometry for cell surface molecules expressed by moDCs following 
challenge with various E. coli strains. Data for each experiment used to generate Fig. 5.9. 
The cells were gated as in Fig. 5.9. (A). The MFI for the relevant isotype control was 
subtracted from the MFI for each molecule to give the values presented here. The results 
shown are data from (A) 3 animals for MHC II, one animal only for CD1b, CD205 and 
SIRPα, (B) 3 animals, (C) 3 animals for MHC II and 2 animals for CD1b, CD205 and SIRPα, 
(D) 6 animals. Error bars represent standard error of the mean. (A) shows little differences 
between the strains for expression of MHC II (p=0.759), CD1b or CD205 compared to 
unchallenged cells, except possibly challenge with MCI 0132 to down regulate SIRPα 
compared to control and other strains. As this represents only a sample size of one it would 
be difficult to draw conclusions from this. (B) There was no difference in expression levels of 
MHC II (p=0.911), CD1b (p=0.936), CD205 (p=0.806) or SIRPα (p=0.753) compared to 
unchallenged cells. (C) There were no differences in expression of any of the molecules 
compared to unchallenged cells MHC II p=0.135, CD1b p=0.494, CD205 = 0.977 and SIRPα 
p=0.531 (D) MHC II is upregulated in response to all three strains (MCI 0279, MCI 0693, and 
MCI 0490) compared to unchallenged cells but this difference is not significant (p=0.706) 
There are no significant differences observed for expression of CD1b, CD205, or SIRPα 
either. (p=0.998, 0.479 & 0.889 respectively) Also, note the difference in the scale of the axes 
between (B), (C) & (D) which are similar and compare with (A) which is much larger. This 
experiment (A) was not repeated. In each graph dark blue represents the O157:H7 strain, 




5.3.6 Cytokine responses and cell surface molecule expression of 
moDCs challenged with VT+ and VT- E. coli O157:H7 strains  
Three E. coli O157:H7 VT+ strains (CAT 3) were selected to challenge the 
moDCs to assess the effects of VT on moDCs during challenge. These strains 
produce VT2 only (MCI 0066) or both VT1 & VT2 (MCI 0045 and MCI 0218). 
These were chosen over strains that produce only VT1 as challenges of 
moDCs with purified VT2 were planned (Chapter 4) and it was intended that 
the results would be complimentary. These strains were also chosen as they 
are the ‘parent’ strains for the CAT 2 strains selected, in that they are the 
same strains but lack VT producing capabilities. The challenges with the 
three VT+ strains were carried out concurrently with a representative VT- 
strain (MCI 0010, CAT 2) to compare any differences in cytokine production 
stimulated by these strains. Three experiments were carried out with cells 
from three animals each time; technical replicates were also included where 
cell numbers allowed. ELISA was carried out on the cell supernatant for IL-
10, IL-12 and TNFα. The results of the ELISA are shown in Fig. 5.11. All three 
cytokines were produced in response to bacterial challenge when compared 
to levels in unchallenged supernatant (ANOVA, p<0.05). No differences were 
observed between the different VT+ strains themselves or between the levels 
of cytokine stimulated by the VT+ strains and the VT- strains when tested at 
the 95% confidence interval. FACS analysis of these cells was also carried out 
to assess any changes in cell surface molecule expression. The molecules 
selected for examination by this method were MHC II, CD1b, CD205 and 
SIRPα. The results are shown in Fig. 5.12. There was an increase in MHC II 
cell surface expression for cell challenges with all strain studied, but this data 
was not significantly different (p=0.058) compared to unchallenged cells. 
There was also a trend for an upregulation of CD1b for all strains however 
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the difference was not significant. (p=0.118). There was no statistical 
difference observed in cellular expression of SIRPα (p=0.877) or CD205 
(p=0.594). There were no significant differences observed within the VT+ 






































Fig. 5.11 Results of ELISA of moDC supernatant following challenge with VT
+
 strains. 
(A) IL-10, (B) IL-12 and (C) TNFα ELISA results are shown following challenge with three 
VT+ strains (MCI 0045, 0066 and 0218) and one VT- strain (MCI 0010). Results are pooled 
from three individual experiments; error bars represent the standard error of the mean. IL-
10, IL-12 and TNFα were all produced in response to bacterial challenge (ANOVA p<0.05). 
Using an ANOVA and a post hoc Tukey’s test, no differences were observed between the 
























Fig. 5.12 Flow cytometry for cell surface molecules expressed by moDCs following 
challenge with various E. coli strains. The results shown are pooled from three animals 
collected from three separate experiments. Error bars represent standard error of the mean. 
The MFI for the relevant isotype control was subtracted from the MFI for each molecule to 
give the values presented here. Cells were gated as shown in gate 1 in Chapter 4 (Fig. 4.3 A) 
MHC II was upregulated in response to challenge with all strains compared to unchallenged 
cells, although the differences were not significant. (p=0.058) There was a trend for 
upregulation of CD1b for all strains however any difference was not significant. (p=0.118) 
There was no change in expression for CD205 (p=0.594) or SIRPα (p=0.887). There were no 
significant differences in responses to challenge with VT+ or VT- strains. All data was 





5.3.7 Determination of numbers of intracellular bacteria following moDC 
challenge over a time-course up to 36 h: comparison of an O157:H7 
strain with an ETEC and commensal E. coli strain 
Numbers of intracellular bacteria following 2 h challenge were determined at 
various time-points up to 36 h by lysing cells and subsequent spreading on 
agar plates of the cell lysate. To compare differences between O157 strains, 
ETEC and commensal E. coli strains a representative strain for each was 
chosen for study. (MCI 0010, MCI 0132 & MCI 0430) Two separate 
experiments were carried out, each with three animals. The results are shown 
in Fig. 5.13 where some interesting strain differences can be observed. There 
were very few viable intracellular O157:H7 bacteria at any of the time points 
selected for measurement and these levels did not change over time. The 
ETEC strain yielded moderate numbers of viable intracellular bacteria, and 
these numbers remained fairly constant at all the time points. The 
commensal strain proved to have many more numerous viable intracellular 
bacteria than either the ETEC or the O157:H7 strains for time points up to 12 
h. After 12 h the numbers of viable commensal bacteria retrieved started to 
reduce and by 36 h the numbers were comparable to those of the ETEC 
strain. The numbers of viable intracellular O157:H7 bacteria were always 
significantly lower than that of the ETEC or the commensal. Overall the 
numbers of intracellular bacteria were small, ranging from one bacterium per 
500 cells for the commensal strain to one bacterium per 700,000+ cells for the 
O157:H7 strain. It is not known whether single cells had several internalised 
bacteria or whether only one bacterium was internalised per cell. This would 






















Fig. 5.13 Results of experiments to investigate viable intracellular bacterial numbers. 
moDCs were challenged and subsequently collected at various time points up to a 
maximum time of 36 h. Challenges were carried out with an O157 strain (MCI 0010), an 
ETEC strain (MCI 0132) and a bovine commensal strain (MCI 0430). Two experiments were 
carried out; experiment 1 results are shown in (A) & (B) and experiment 2 results are shown 
in (C) & (D). Pooled data, for both experiments is also shown (E) & (F). Challenges were 
carried out at an MOI of between 60 and 200 with three animals. Panels (A), (C) and (E) 
show cfu recovered per ml of cellular supernatant at each time point. Panels (B), (D) and (F) 
show the intracellular bacteria as a percentage of the numbers of bacteria added for each 
strain (i.e. takes into account any variation in MOI between the strains). Error bars represent 
the standard error of the mean. Infection with MCI 0430 showed the highest numbers of 
intracellular bacteria, these numbers started to fall after 12 h. Infection with MCI 0010 
showed very low numbers of intracellular bacteria at close to zero and was consistent for all 
the time points examined. Infection with MCI 0132 resulted in fewer intracellular bacteria 





The experiments carried out in this chapter were designed to characterise 
any role of DCs in the interactions of EHEC with the bovine host. 
Characterising moDC reactions as pathogenic in type, represented by ETEC 
strains, or non-pathogenic as represented by commensal strains and then 
attempt to assess to which group the responses to O157:H7 strains most 
closely resembled proved difficult. 
 
Growth characteristics were assessed in this study as it is likely that phase of 
growth and culture medium may have important effects on bacterial 
expression of various virulence factors and pathogenicity of EHEC in vitro. 
(discussed in (Law, 2000)) Using the various strains at defined O.D.600 
measurements was used in order to minimise differences. 
 
 In terms of cytokine responses and changes in cell surface molecule 
expression there were no statistically significant differences observed 
between the pathotypes in the moDC responses with pooled data. All three 
cytokines, IL-10, IL-12 and TNFα were produced in response to bacterial 
challenge, compared to unchallenged cells; however there were great 
variations in the magnitude of responses generated by individual animals. 
When individual animal data was considered some trends for differences in 
cytokine production emerge. Observation of the individual animal data, IL-
10 production was possibly greater in response to most of the commensal 
strains compared to ETEC and EHEC strains. This data was difficult to tease 
apart as the IL-10 production to commensal strain MCI 0483 did not follow 
the trend. There are potential reasons for this which are discussed in Chapter 
6, where virulence factors were identified within MCI 0483 which had effects 
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on moDC viability at higher MOI. Therefore if the data for MCI 0483 is not 
considered here, the trend for greater production of IL-10 in response to 
commensal strains compared to ETEC and EHEC becomes somewhat more 
evident. TNFα production also indicated a trend for differences between the 
pathotypes, where the levels in response to ETEC strains was lower than 
those in response to EHEC or commensal. It appeared that IL-12 was indeed 
produced equally in response to all the strains as this was observed for the 
majority of the individual animals studied. However, it must be remembered 
that, when pooled, this data showed no significant differences and therefore 
little weight can be attributed to these trends, however, they are useful to 
dissect in this way as they could indicate areas for further study. A further 
point of interest in the ELISA data is IL-12 production by challenged cells 
shows a greater fold change over levels produced by unchallenged cells 
when compared with IL-10. This was observed in all the viable bacteria 
challenges in this chapter and suggests that IL-12, a Th1 cytokine, is more 
dominant in the host response to E. coli strains. Following this work it would 
appear to be preferable to carry out challenges with fewer strains for 
example; possibly a representative strain from each group. Also, to carry out 
challenges on cells from larger numbers of animals would be of value to see 
if the trends observed here are indeed characteristic of in vitro responses. 
 
Cell surface molecule expression of the moDCs showed no differences in 
response to the three pathotypes. Challenge with all the E. coli strains tended 
to increase the level of expression of MHC II, indicating a change in the cells 
from a phagocytic cell type to an antigen processing cell type as expected. No 
other cell surface molecule studied (i.e. SIRPa, CD205 or CD1b) was 
significantly affected.  There was a corresponding change in morphology of 
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the challenged moDCs to an activated phenotype following bacterial 
challenge and although not directly measured there appeared to be no 
detrimental effect observed on moDC viability; these factors were similar for 
all the strains.  
 
There was no difference in the responses of the cell to three VT+ and a 
corresponding VT- O157:H7 strain. Cytokines were produced at similar levels 
in response to all strains indicating that the presence of VT does not 
significantly affect the cytokine responses of moDCs. MHC II was 
upregulated in response to the VT+ strains, but no other cell surface molecule 
in this study was altered. 
 
All of this data indicates that the moDCs tend not to detect differences 
between various strains of E. coli. This could be due to the presence of such 
high levels of similar PAMPs (LPS, H7 flagellin and CpG) that any smaller 
differences are not able to be observed. No differences between responses to 
EHEC strains, ETEC strains and commensal strains were observed using the 
methods described above. It is possible however that there were differences 
in parameters that were not measured here. It could be that investigation of 
different cell surface molecules or cytokines may have clarified differential 
responses. Norimatsu et al. (2003) studied expression of co-stimulatory 
molecules (CD40, CD80 & CD86) and transcripts of proinflammatory 
cytokines (e.g. IL-6) of moDCs following Salmonella challenge and study of 
those parameters could be considered for studies with the E. coli strains 




The trends observed in the ELISA data would require further elucidation to 
see if these indicate detectable differences. Flow cytometry protocols using 
two-colour (or more) staining protocols would help to retrieve the additional 
data from these populations of limited cell numbers, and may help to 
uncover any differences. Challenge of moDCs with purified VT would be of 
use to assess any cellular responses to this important bacterial virulence 
factor. As the main role of DCs is to present antigen and generate immune 
responses it would also be interesting to observe any differences in the T cell 
responses to moDCs challenged with these various strains, by employing 
commonly used techniques such as T cell proliferation studies; unfortunately 
time constraints precluded the inclusion of these experiments in this study. 
 
The most striking differences observed in this chapter between the three 
pathotypes were discovered when measuring intracellular bacteria. A time 
course experiment was carried out to detect viable intracellular bacteria 
following challenge of moDCs, up to a time of 36 h. A representative strain 
from each group was chosen for study. The commensal strain was 
internalised by the moDCs at greater numbers than the ETEC or the EHEC 
strains. Viable bacteria were detected for all strains during the full course of 
the experiment up to 36 h post challenge. The EHEC strain did not readily 
enter the moDCs and there were very few EHEC recovered at any of the time 
points, compared to the ETEC and commensal strains. A further difference 
was observed with the intracellular numbers. The commensal strain entered 
the moDCs at higher numbers and these numbers of viable bacteria retrieved 
remained at these high levels until 12 h post challenge when they began to 
decline. The numbers of both the ETEC and the EHEC remained relatively 
constant during the sampling period. This suggests that the commensal 
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strains are easily phagocytosed and begin to be killed around 12 h post 
challenge, whereas the ETEC strains are less easily phagocytosed, but when 
they become intracellular, they are able to resist intracellular killing for 
periods up to 36 h. The EHEC strain is even less likely to be phagocytosed 
and, although only small numbers of bacteria become intracellular this strain 
too shows extended periods of survival within the moDCs, as the small 
number of viable bacteria retrieved did not change during the sampling 
period, and could still be detected at 36 h. It is important to be aware that the 
ETEC and EHEC strains could be taken up and quickly killed by the moDC 
and studies to investigate this possibility would be valuable. Extracellular 
counts from parallel cultures would be required to validate moDC uptake 
and/or killing of these strains. However, by evading phagocytosis it is 
possible that E. coli O157:H7 strains are able to colonise cattle and induce 
scant immune response to clear them from the intestinal environment. By 
resisting intracellular killing for extended periods, this too reduces 
generation of specific immune responses to bacteria. DCs are able to migrate 
to local lymph organs to present antigens within hours following uptake to 
initiate immune responses. If bacteria are able to resist intracellular killing 
and therefore specific antigen presentation for prolonged periods, then 
generation of immune responses too will be delayed permitting 
multiplication of these organisms and potential colonisation of the host. The 
intracellular bacteria would be interesting to study further with repeats of 
this experiment using other strains to see if these differences are specific to 
pathotype or merely specific to these particular strains. Observation of 




The results presented here for the first time indicate intracellular survival of 
low numbers of EHEC in bovine moDCs and how this differs from the 
numbers and survival time observed for commensal and ETEC strains. This 
has relevance for the in vivo situation where, evasion of phagocytosis and 
survival for extended periods inside immune cells could both be an 
advantage to colonisation of the host. This data could indicate an important 
role for DCs in colonisation of cattle, and highlights areas for further 
investigation. This study progressed to investigate the effect of MOI on 
moDC challenges, to see if higher MOI would elucidate further differences 







Chapter 6 Investigation of the effects of a high 
multiplicity of infection on the responses of bovine 
















6.1 Introduction  
Challenges of the moDCs with E. coli strains showed differences in 
phenotype and functions depending on the challenge strain. Within this 
chapter the role that multiplicity of infection plays in bacterial interactions 
with moDCs was investigated. 
Multiplicity of infection is an area where it is difficult to predict accurately 
values that reflect the in vivo state. In Chapter 5 an approximate calculation 
was carried out based on colonisation information of the bovine intestinal 
tract with E. coli strains and the approximate number of tissue DCs that 
could be present. The DC numbers were based on work that had been carried 
out in ovine mucosal tissues (specifically lung) which indicated numbers of 
DCs per mm2 of tissue within the airways (McNeilly et al., 2006). These 
numbers led to early challenges being carried out at low MOIs of 0.05, 0.5 
and 5. These MOI were tested in a pilot study and there was little difference 
in effect on cytokine responses thus an MOI of 0.5 was selected for the 
majority of the challenges in Chapter 5. Chapter five showed that moDCs 
responded to challenge with viable bacteria at low MOI by cytokine 
production and changes in cell surface molecules, but without any 
observable detrimental effects on moDC viability.  Similar MOI to those used 
in Chapter 5 have been used with other bacterial challenges on moDCs. A 
very recent human study using moDCs challenged with S. typhimurium, to 
investigate downstream signalling pathways used challenges at MOIs of 1, 5 
and 10 (Pietila et al., 2010). As this project progressed it became clear that 
there are many more DCs within the tissues of the terminal rectum than that 
found within lung tissues, and that there is also great animal to animal 
variation in the numbers of E. coli carried in the bovine intestine (Dr. E. 
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Clark, Thesis:  http://theses.gla.ac.uk/706/). Although it is known that DCs 
can actively sample antigen from the intestinal lumen by means of dendrites 
extending between the epithelial cells, it is unclear what proportion of DCs 
within the tissues will be contacting the bacteria within the lumen at any 
time. In mice, the number of trans-epithelial DC extensions into the intestinal 
lumen is known to change with intestinal location and presence of bacteria 
(Chieppa et al., 2006). The presence of trans-epithelial DC extensions was 
significantly reduced in vivo by treatment with a broad-spectrum antibiotic, 
indicating that DC lumen sampling is affected by the bacterial load of the 
intestine, and it is not necessarily pathogenic bacteria alone but commensal 
organisms too which are able to induce this response. Chieppa et al. also 
proposed that this increase in sampling following bacterial challenge was 
mediated by TLR signalling via epithelial cells and DCs. Signalling via TLRs 
2, 4 and 9 when initiated by their ligands peptidoglycan (PG), LPS and CpGs 
all increased frequency of DC trans epithelial extensions, As the selected E. 
coli strains used in this study contain LPS, CpGs and PG they too must be 
expected to signal through these same TLR on bovine epithelial cells and 
DCs and could lead to increased bacterial interactions with DCs via the 
resulting trans-epithelial extensions.  However, it was interesting to note that 
signalling by TLR 5 and its ligand flagellin showed no such increase and was 
reported to be due to the low or lack of TLR5 expression of the epithelium at 
the intestinal site and species tested in this study (murine ileum). TLR 1-10 
have been detected in ovine intestinal tissues using quantitative PCR 
(Menzies & Ingham, 2006) and the presence of a wide range of mRNA 
transcripts for TLR have been found on bovine antigen presenting cells 
(Werling et al., 2006). Primary bovine colonic cells have also been examined 
for TLR mRNA expression and it was found that TLR1, TLR3, TLR4 and 
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TLR6 were all detectible, although the authors postulate whether further TLR 
mRNA would be identified using a technique with greater sensitivity 
(Bridger et al., 2010). Therefore it is likely that there will be many TLR present 
within the tissues of the bovine intestinal mucosa which can recognise PRR 
of E. coli O157:H7. Any disruption in epithelial integrity due to injury or 
inflammation is also likely to lead to higher numbers of lamina propria DCs 
contacting the luminal contents directly.  
All of these factors indicate that there are many issues which affect the in vivo 
ratios of bacteria to DCs. These ratios are also dynamic and have potential to 
be high at certain times and at certain intestinal locations, thus in vitro studies 
at a range of MOI are of relevance to host situations. 
To investigate the effect of MOI on moDCs a high MOI of approximately 100 
was selected, this being a multiplicity of infection used quite frequently for in 
vitro experiments with other cell types and pathogens. EPEC and EHEC 
strains have both been used at MOI of 100 with epithelial cells to investigate 
attachment of bacteria to the cells and concurrent protein signalling. (Kenny, 
1995) The pathogenesis of Listeria monocytogenes, which initiates infections in 
human and animal hosts by entering GALT, was also investigated at MOI of 
100 with a murine splenic DC line (CB1 cells) (Guzman et al., 1995). A study 
using heat-inactivated E. coli strain DH5α to challenge human moDCs has 
employed a wide range of MOI from 10 to 1250 to investigate sepsis in 
humans (Falcone et al., 2004). Sepsis is a syndrome whereby, among other 
cellular and signalling effects, DCs are found to be profoundly reduced in 
number by apoptosis in affected patients (Hotchkiss et al., 2002).  
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The effects of challenge at high MOI were intended to be investigated using 
similar assays to those used in Chapters 4 and 5. These would include FACS, 
ELISA and intra- and extracellular bacterial counts. However, the initial 
challenge immediately illustrated effects of bacteria on moDC viability and 
the decision was made instead to explore this interesting discovery further. 
A search of the literature has yielded only sparse information concerning 
moDC viability during challenge with viable bacteria. The study mentioned 
earlier by Falcone et al (2004) however, has investigated apoptosis of DCs 
following challenge with E. coli laboratory strain (DH5α) as a model for 
studying sepsis in human patients. Apoptosis of human moDCs was 
observed in that study but only at MOIs of 500 or greater and the killing 
effect was maximal and plateaued at an MOI of 1000. The Falcone study 
predominantly carried out challenges with heat-inactivated bacteria in 
contrast to the work presented here which used live E. coli strains isolated 
from the bovine intestinal tract. Some bacterial components too have been 
shown to have effects on DC viability. Bacillus anthracis lethal toxin (LT) has 
been shown to kill both murine and human moDCs in vitro and murine DCs 
in vivo. Observation of morphological changes and MTT assays were used to 
characterise apoptotic cell killing (Alileche et al., 2005). Listeriolysin, the main 
virulence factor of the bacterial pathogen Listeria monocytogenes is also able to 
induce DC apoptosis when used to challenge murine DCs of the cell line CB1 
in vitro as well as ex vivo bone marrow derived DCs (BMDCs) (Guzman et al., 
1996). Viral challenges too have been found to effect DC viability in vitro: 
herpes simplex virus 2 (HSV-2) induces rapid death of murine BMDCs by 
apoptosis (Jones et al., 2003). MHC II has been implicated in DC cell death 
pathways. Immature human moDCs have been stimulated to mature when 
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cultured with an anti-MHC II antibody, whereas mature moDCs were 
induced to apoptose; these outcomes were found to be mediated by 
independent cell signalling pathways (Lokshin et al., 2002). This indicates a 
role in vivo for MHC II mediated DC death. Rapid DC death following T cell 
interactions in vitro has been observed (Matsue et al., 1999), and suggests that 
mature DCs in vivo are likely to have a very limited lifespan following 
migration from peripheral tissues. So, although DC apoptosis in response to 
challenge is not a completely new finding, few other studies have reported 
DC killing by bacterial pathogens. 
Salmonella and its interactions with moDCs have been studied by Norimatsu 
et al. (2003 & 2004) Salmonella, although it has notable differences from E. coli 
O157:H7, is worthy of note here as some similarities can be drawn. On a 
basic bacteriological level both are Gram-negative rods which can use 
flagella for motility. Both Salmonella and E. coli are intestinal pathogens with 
their effects in human and bovine hosts (among others) and cause diarrhoeal 
disease. Although Salmonella is an intracellular pathogen, initially it too 
makes use of a TTSS, similar to O157:H7, to introduce virulence factors to 
host cells and it is this action which then induces uptake of the bacterium by 
the cell (Brumell et al., 1999; Collazo & Galan, 1997). Live salmonellae have 
been found to elicit different moDC cell responses following challenge when 
compared to killed salmonellae (Norimatsu et al., 2003). Both live and killed 
S. Typhimurium induced moDC maturation, cytokine expression, and T cell 
proliferation. The responses observed with the live bacteria however were 
generally greater. Both live and killed challenges upregulated MHC I and 
MHC II, and CD80 to similar extents showing a maturation of the moDCs. 
The live bacteria stimulated a greater up regulation of CD40 and CD86 than 
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the killed bacteria. A greater magnitude of cytokine response was observed 
with the live salmonella challenge, where up-regulation of the transcription 
of IL-6, IL-12p40 and GM-CSF were all increased over the killed challenge, 
which in turn was greater than the minimal levels observed with 
unchallenged cells. The authors suggest that these differences indicate the 
important role that DCs play in priming the immune response, in particular 
when discussed in terms of vaccination; this is because live bacterial vaccines 
tend to provide greater protection against subsequent infection than killed 
(Lindberg & Robertsson, 1983; Mastroeni et al., 2001; Robertsson et al., 1983). 
This live vaccine perspective may not have such an impact with EHEC, as 
current vaccine research is not centred on whole bacteria but rather 
combinations of bacterial components such as TTSS and outer membrane 
proteins (Khare et al., 2010; McNeilly et al., 2010b). However, the underlying 
immune responses whereby killed bacteria tend to prime a Th2 response and 
live bacteria tend towards a Th1 response very much corresponds to the 
known key roles that DCs play in directing immune responses (Haeberle et 
al., 1997; Thatte et al., 1993) and could be integral to the carriage of O157:H7 
by cattle. If these responses could be fully characterised, it may open up 
additional areas of research for reduction of colonisation and spread by these 
bovine hosts. 
Given the role of DCs in directing immune responses and the possibility for 
bovine intestinal DCs to interact with O157:H7; in vitro methods to explore 






The aims of this chapter were: 
1. To investigate the effect of high MOI (100) during moDC challenges. 
2. To investigate any differences in the effect of moDC challenge with 
gentamicin-killed bacteria and live bacteria. 
3. To investigate whether the cattle used in this study were colonised by 




6.2 Materials and Methods 
 
6.2.1 Animals 
The animals used in this chapter were clinically healthy adult cattle 
conventionally managed and housed at MRI. They were all male Holstein 
Friesian (HF) between 2 and 5 years old. Blood sampling was carried out 
according to the requirements of the Animal Scientific Procedures Act (1986). 
 
6.2.2 Preparation of moDCs 
Bovine moDCs were prepared for challenges as described in Chapter 5 
(section 5.2.6). Briefly, moDCs were generated from bovine blood and 
cultured for 3 days in culture medium containing GM-CSF and IL-4 (DC-
TCM Appendix A.4.2.4). On day three the cells were collected, counted and 
washed three times in antibiotic-free TCM (Appendix A.4.2.3, no 
Gentamicin). They were then seeded into a suitable well plate for challenges 
(usually 12 well or 96 well) cultured overnight and challenged on day four. 
The choice of day for cell challenge is discussed in Chapter 4 and was 
selected to represent immature DCs  
 
6.2.3 Preparation of bacterial strains 
The bacterial panel selected for use in this chapter are as described in 
Chapter 5 section 5.2.2 and Appendix A.3 Four bovine ETEC strains, four 
bovine commensal strains and four E. coli O157:H7 (CAT 2) strains were 
selected for investigation. In addition moDC challenge with MCI 0200 was 
compared with its corresponding type three secretion system knockout 
strain. (∆TTSS, MCI 0201). Bacteria for challenges were grown overnight in 
MEM/HEPES (Sigma) at 37˚C in a shaking incubator set to 200 rpm. Sub-
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cultures were made (1:10 v/v) into fresh MEM/HEPES and grown at the same 
conditions for a further three hours until the O.D.600 nm reading was between 
0.25 and 0.35 (approximately 0.31) to correspond to the required MOI 
(bacterial numbers at this O.D.600 had been confirmed in Chapter 5). Where 
killed bacteria were required for challenge a 1 ml sample of the bacterial 
culture was removed and incubated at 37˚C for 1 h with gentamicin (50 
µg/ml). Effective bacterial killing was confirmed by plating out on nutrient 
agar plates. 
 
6.2.4 Bacterial Challenge of moDCs 
The bacterial culture was used undiluted to challenge the cells at relative 
volumes of 100 µl of culture to 1 ml of cell culture medium (cells adjusted to 
1 x 106). Plating out serial dilutions of the challenge media allowed the MOI 
to be calculated and this was approximately 100, where unchallenged cells 
were required as controls, an appropriate volume of warmed MEM/HEPES 
was added to the moDCs in place of the bacterial culture. Killed bacterial 
challenges were carried out concurrently with the corresponding live 
bacterial challenge. All challenges were pulse chase as follows: after 2 hours 
of challenge gentamicin was added to all wells (50 μg/ml) and then cultured 
for a further 22 hours. Challenges were carried out in an incubator set to 37˚C 
and 5% CO2 Following this time, viability counts or MTT assays were 
performed, or images were obtained as required. 
 
6.2.5 Viability counts 
Following challenge with bacteria the numbers of live and dead moDCs were 
counted and percentages were compared for each challenge. The cells were 
diluted in Nigrosin (final concentration of 0.1% w/v) stain (Sigma) and were 
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counted using disposable chambers (Fast-read 102, ISL, Devon). Nigrosin 
darkly stains dead cells and is excluded from live cells. Live cells can be 
observed clearly as light or clear against the dark Nigrosin milieu. 
 
6.2.6 MTT Viability Assay 
An MTT viability assay (Molecular Probes) was carried out on the moDCs 
following bacterial challenge. The MTT assay (Mossman, 1983) detects live 
cells and the response depends on the activation level of the cells on test, 
although it is widely used as a proliferation test to indicate numbers of viable 
cells in a population because it indicates mitochondrial function. At the end 
of the challenge the cellular supernatant is removed and fresh pre-warmed 
phenol red-free TCM (Appendix A.4.2.2) is added to the cells in the 96 well 
plates. The MTT assay is then carried out as described (section 4.2.9). 
 
6.2.7 Images of Cells 
Live cell images were taken using an AxioCam MRm digital camera 
mounted on a Ziess Axiovert microscope with an integrated cell culture 
incubator. 
 
6.2.8 Determination of eae and escN by PCR 
To determine which strains contained the eae and escN genes PCR was 
carried out for all strains (Appendix A.3) Template DNA was provided by Dr 
E. Clark (Moredun Research Institute). Briefly, for strains MCI 0688, MCI 
0690 and MCI 0693: one bacterial colony was suspended in 50 μl of Instagene 
Chelex matrix (BioRad). This was vortexed for 10 sec, heated to 100°C for 10 
min, briefly cooled and vortexed for a further 10 sec. These samples were 
stored at -20°C until required, at which time the samples were centrifuged to 
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pellet to allow the supernatant to be used for the template. For the other 
strains template DNA had been obtained by using the Wizard genomic DNA 
kit (Promega), following the manufacturer’s instructions. Primers were 
designed based on published work (see table 6.1) The PCR reaction was 
made up as follows: 1μl of template was added to 2.5 μl of 10x buffer, 
(included with the Hotstart kit (Promega)) 0.25 μl each of forward and 
reverse primers (100 μM each), 0.25 μl of dNTPs (10 μM), 0.25 μl of Hotstart 
Taq (Promega) and made up to 25 μl with dH2O. The samples were placed 













Table 6.2 PCR cycling conditions used for eae and escN  
 
6.2.9 Agarose gel electrophoresis 
The samples were run on a 1.1% agarose gel with Gel Red (Biotium Inc.) 
added according to the manufacturer’s instructions to visualise the bands. 
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Gels were made up using 0.8 mg agarose and 75 ml TAE buffer (Appendix 
A.4.6.1); 7.5 μl of Gel Red (10000 x stock) was added after heating in a 
microwave to dissolve the agarose. This solution was allowed to cool for 
approximately 15 min before pouring into a suitable gel casting tray. The gel 
was left at room temperature to set. The gel was then placed into a tank (Bio 
Rad) and 1 x TAE buffer was added up to the manufacturers fill level. 3μl of 
sample was mixed into 1 μl Blue/Orange loading dye, 6 x (Promega) and 
these were loaded into the wells. The far left well contained 3 μl of 100 bp 
ladder. The electrodes were fitted onto the tank with the lid and 100 v were 
applied to the gel for 40 min using a Bio Rad PowerPac. The gel was then 
visualised with a Bio Rad imager using the UV light settings. 
 
6.2.10 ELISA for H7-specific IgA in Bovine Serum 
This method is taken from published work and the reagents were kindly 
gifted by Dr T. McNeilly (McNeilly et al., 2010a). See Appendix section A.4.1 
for recipes for all ELISA solutions and buffers. 
An ELISA plate (Immulon 2HB, thermoelectron 3455) was coated with 50 μl 
H7 antigen/well at 1 µg/ml in coating buffer. The plate was then sealed and 
incubated at 4oC overnight. All wash steps were carried out with five manual 
washes of wash buffer (PBST20). Blocking buffer at 100 µl/well was added 
and incubated for 1 hr at 37oC. The plate was then washed again before the 
addition of the samples diluted in dilution buffer. 50 µl/well final volume 
was used of four doubling dilutions from 1:5 to 1:40 followed by further 1hr 
incubation at 37oC. The plate was washed as before. The plate was incubated 
with 100 µl/well anti-ovine/bovine IgA (AbDSerotec MCA628) diluted 1:1000 
in dilution buffer, for 1 hr at 37oC and washed. An incubation with 50 µl/well 
of rat anti-mouse IgG1-HRP tertiary antibody (AbDSerotec MCA336P) 
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diluted 1:1000 in dilution buffer was carried out for 1 hr at 37oC and followed 
with a  final wash. The plate was developed with 100 μl/well of OPD 
substrate (SigmaFast OPD, P9187) at room temperature for 5-10 minutes and 
the reaction stopped by the addition of 25 µl 2.5 M H2SO4. The plate was read 
OD 492 nm using an ELISA plate reader (DYNEX Technologies MRX II) 
linked to a computer running MRX EndPointSoftware, Version 2.02) An 
average of the reading for the blank wells was calculated and subtracted 
from all the readings before plotting the data in Excel as a line graph. 
 
6.2.11 Data Analyses 
To ensure an approximately normal distribution of values, MTT assay data 
from the full bacterial panel challenge was log10 transformed before analysis. 
This data was then analysed using a one-way analysis of variance (ANOVA). 
The ANOVA was followed by a Tukey’s post hoc test for pair-wise 
comparisons of means (data was tested at 95% and 99% confidence intervals). 
A p value of <0.05 were considered significant. Percentage viability data for 
the WT vs. ∆TTSS challenge was subjected to a paired t-test. P values of <0.05 
were considered significant.  Statistical analyses were carried out using 







6.3 Results  
 
6.3.1 Investigation of MOI on moDCs challenged with bacterial strains 
Bovine moDCs were challenged with bacterial strains as described in section 
6.2.4. Four animals were challenged with the panel of bacteria in 96 well 
plates. 4-6 wells were challenged for each strain. The cells were imaged and 
subjected to an MTT viability assay following challenge (see section 6.3.2 for 
MTT assay results). Results of the imaging can be seen in Figs. 6.1 – 6.4. 
The E. coli O157:H7 strains all had an effect on the morphology of the moDCs 
following challenge, compared to control cells (Figure 6.4). Three O157:H7 
strains visibly affected the viability of the cells as there was a great deal of 
cell debris, rounded, small cells and cellular particles present. Few, if any 
cells were observed displaying a dendritic morphology (Fig. 6.1 A, B & C). 
This was not the case for the cells challenged with strain MCI 0279, which 
did have a proportion of cells with normal morphology among some 
rounded dead cells and debris (Fig. 6.1 D). None of the ETEC strains had a 
marked affect on the morphology of the moDCs when compared to control 
cells; an activated morphology was observed with some cells which 
exhibited longer dendrites following challenge (Fig. 6.2). Three of the 
commensal strains gave results very similar to the ETEC strains, (MCI 0132, 
MCI 0465 & MCI 0490), where little detrimental effect on the viability or 
morphology was recorded, and only some activation phenotypes were 
observed (Fig. 6.3 A, B & D) However, the fourth commensal strain, MCI 
0483, produced results similar to the O157:H7 strains where all the cells 
appeared non-viable and no dendritic morphology was observed following 




















Fig. 6.1 Representative images of moDCs from four animals challenged with E. coli O157:H7 strains. (A) MCI 0010, (B) MCI 0191, (C) MCI 
0200, (D) MCI 0279. Cells challenged for 2 h at MOI 100 followed by the addition of gentamicin to the culture medium. Images were taken 
approximately 24 h after challenge. Cells were challenged in 96 well plates and each strain was added to 4 – 6 wells. All strains had a pronounced 
effect on the moDCs. Visual inspection revealed many non-viable cells and a widespread loss of dendritic cell morphology. The changes were less 
obvious with strain MCI 0279 (D) where a mixed population of cells, some with normal activated DC morphology expressing long dendrites as well 




















Fig. 6.2 Representative images of moDCs from four animals challenged with ETEC strains. (A) MCI 0132, (B) MCI 0688, (C) MCI 0690, (D) 
MCI 0693. Cells challenged for 2 h at MOI 100 followed by the addition of gentamicin to the culture medium. Images were taken approximately 24 h 
after challenge. Cells were challenged in 96 well plates and 4 – 6 wells per strain were challenged. All strains showed similar results. Visual 
inspection revealed the majority of cells showed basic dendritic morphology. The numbers of cells with long dendrites increased and the length of 



















Fig. 6.3 Representative images of moDCs from four animals challenged with E. coli commensal strains. (A) MCI 0430, (B) MCI 0465, (C) MCI 
0483, (D) MCI 0490. Cells challenged for 2 h at MOI 100 followed by the addition of gentamicin to the culture medium. Images were taken 
approximately 24 h after challenge. Cells were challenged in 96 well plates and 4 – 6 wells per strain were challenged. Three strains had little effect 
on the viability of the moDCs: MCI 0430, MCI 0465 & MCI 0490. Visual inspection of cells challenged with these strains revealed many with long 
thin dendrites of activated DC morphology. The changes in the cells challenged with strain MCI 0483 (C) were marked with the majority of cells 





















Fig. 6.4 Unchallenged moDC live cell image. A representative image of unchallenged bovine moDCs (similar images were obtained from four 
animals). These cells were cultured concurrently with challenged cells for the same duration and conditions. Warmed MEM/HEPES was added to 
the wells in place of bacterial culture. Images were taken approximately 24 h after challenge. Cells were challenged in 96 well plates and 4 – 6 wells 
remained unchallenged. Normal appearance of moDCs on day 4 after generation. Some rounded cells with short ‘hairy’ dendrites and some cells 
elaborating long cytoplasmic processes were observed. 
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An MTT assay (Molecular Probes) was employed to investigate cell viability 
following challenge with E. coli strains. This test assesses mitochondrial 
function and in this way indicates cellular viability. The principal of this test 
involves the MTT being converted to formazan by the mitochondria, and this 
is associated with a colour change. The change in optical density that occurs 
can be measured, and the higher values obtained in turn correspond to 

















Fig. 6.5 Results of MTT viability assay of moDCs challenged with E. coli strains. The 
graph shows absorbance measured at O.D. 570nm, lower values represent reduced cellular 
viability. Data shows the mean of four animals, Error bars represent Standard error of the 
mean. (**) significance at the 99% confidence interval; (*) significance at the 95% confidence 
interval. Analysis using a one-way analysis of variance (ANOVA) gave a main p value 
<0.001. Three O157:H7 strains (0010, 0191 & 0200) produced significantly reduced moDC 
viability compared with unchallenged cells (0010 & 0191 significant at the 99% confidence 
interval, and (*) 0200 significant at the 95% confidence interval). Strain 0279 had no 
significant effect on moDC viability. None of the ETEC strains significantly reduced moDC 
viability. Of the commensal strains, 0483 significantly reduced moDC viability (at the 99% 





6.3.2 Investigation of bacterial virulence factors by PCR 
PCR was carried out for virulence factors associated with the TTSS of EHEC 
on the strains from the bacterial panel, as it was postulated that the TTSS 
may play a role in the moDC killing observed in 6.3.1. All the O157:H7 
strains were positive by PCR for eae and escN. None of the ETEC strains were 
positive for eae or escN using this method as expected. Of the commensal 
strains only MCI 0483 was PCR positive for both eae and escN. (Fig. 6.6, 
results summarised in table) The strains expressing eae and escN were those 
shown to induce reductions in moDC viability, measured by MTT assay as 
found in the experiments in section 6.3.1 with the exception of the O157:H7 
strain MCI 0279, which was PCR positive but did not significantly reduce 

































Fig 6.6 PCR for eae (A) and escN (B) genes in 
bovine E. coli strains. M: 100 bp ladder. Strains were 
analysed for eae and escN by PCR and run in separate 
lanes of an agarose gel. The strains in each lane and 
the results obtained are summarized in the table. All 
O157:H7 strains were positive for both eae and escN 
and all of the bovine ETEC strains were negative. The 
bovine commensal strains, with the exception of 
strain MCI 0483, were negative for both eae and escN. 
MCI 0483 gave the same positive results for both eae 
and escN as the O157:H7 strains. Positive bands for eae 
and escN are indicated with an arrow (at expected 
sizes of approximately 907 bp and 856 bp 




6.3.3 Comparison of viability of moDCs following challenge with E. coli 
O157:H7 and a corresponding ∆TTSS strain 
Paired bacterial strains MCI 0200 (E. coli O157:H7) and MCI 0201 (∆TTSS) 
were used to challenge moDCs at MOI of 100 to confirm whether the 
differences observed in moDC viability (section 6.3.1) was related to the 
bacterial type three secretion system (TTSS) as indicated by the PCR results 
(section 6.3.2). Initially, moDCs from three animals were challenged (401, 
501, 600; group C) as previously described. Following challenge viable cells 
were counted and the percentage of viable cells was calculated. Using a 
paired T test there was a significant difference between the viability of the 
cells challenged with the E. coli O157:H7 WT strain and the ∆TTSS strain. 
(p<0.01; individual data not shown). However, these moDCs, challenged 
with the W.T. E. coli O157:H7 strain (MCI 0200) were not visibly affected to 
the same extent as observed in previous experiments (section 6.3.1) This was 
attributed, at the time, to the challenge O.D.600 nm of the bacterial cultures 
because this experiment had been carried out at a slightly lower O.D.600 nm of 
0.27 and not 0.31. It was postulated that this lower O.D. represented a 
reduction in MOI close to a threshold which at which the viability of the 
entire population of moDCs are affected, although the bacterial numbers 
were not confirmed at this absorbance. These experiments were repeated 
with the aim of replicating the original O.D. and the effect on viability 
observed in the previous experiments (section 6.3.1) With this aim, the 
experiment was repeated with three animals from group D. The O.D. 
readings for the bacteria at the time of challenge were 0.32 – 0.39, to ensure 
an MOI of at least 100 was employed. Using Nigrosin as a vital stain, the 
results of this experiment showed that there was still a significant difference 
in numbers of viable moDC following challenge with MCI 0200 when 
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compared with MCI 0201. (p<0.05) (pooled data for all six animals is shown 
in Fig. 6.7) However, the previously observed effect on the morphology and 
viability of the total population of moDCs still was not observed. It is unclear 
whether this is due to differences in OD of the challenge strains or some 
animal factor, however, these differences are explored further in section 6.4. 
Although these results indicate a role for the TTSS in moDC viability further 
























Fig. 6.7 Viability of moDCs following challenge with an E. coli O157:H7 strain (MCI 
0200) and a corresponding ∆TTSS strain (MCI 0201). Viability was measured using 
Nigrosin as a vital stain. Results are pooled from six animals and error bars represent 
standard error of the mean. There was a significant reduction (*) in the numbers of viable 
moDCs challenged with MCI 0200 compared to MCI 0201. (p<0.05) 
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6.3.4 Investigation of the effect of a gentamicin-killed E. coli O157:H7 
strain on moDC viability 
Bovine moDCs were challenged using MCI 0010, as a representative E. coli 
O157:H7 strain, at an MOI of 100. A challenge with live bacteria was run 
concurrently with a bacterial challenge using a sample of the same challenge 
culture in which the bacteria had been killed. Bacterial killing was carried out 
during a one hour incubation with gentamicin (50 µg/ml). The pilot 
experiment was carried out on one animal (cow 002, group B; one of the 
animals from which cells were obtained for the experiment in 6.3.1) and the 
results showed that the gentamicin-killed bacteria had little effect on the 
moDC morphology or viability, while the live bacteria killed 100% of the 
moDCs (Fig. 6.8). Due to time constraints and limits to the number of cells 
that could be generated, further repeats were unable to be completed. The 
loss of viability of the moDCs following challenge with live and killed E. coli 
O157:H7 at MOI 100 therefore requires repeats to confirm the results from 









Fig. 6.8 Results from a single experiment to investigate the effect of killed 
bacteria on moDCs. Live cell images were taken approximately 24hrs after 
challenge. (A) moDCs challenged with live MCI 0010 at MOI 100 (B) moDCs 
challenged with a gentamicin-killed sample of MCI 0010, also at MOI 100. (C) 
Control moDCs: no bacterial challenge. (D) Graph of percentage of viable cells 
following challenge. Cell counts were carried out using the Nigrosin negative 
staining method and disposable counting chambers. Challenge of the moDCs 
with Live E. Coli O157:H7 clearly affected the morphology and viability of the 
moDCs compared to unchallenged cells. moDCs challenged with the 
gentamicin-killed bacteria expressed more elongated dendrites, and an active 
morphology compared to the unchallenged cells, This indicates that only live 








6.3.5 Investigation of H7-specific IgA responses in bovine serum 
Serum samples from two of the groups of cattle housed at MRI and used 
throughout this study to generate moDCs, (groups C and D, see Appendix 
A.2 for animal details) were subjected to an ELISA for serum IgA specific for 
H7. The results are shown in Fig. 6.9. All animals tested were negative by this 
method, suggesting at the time of sampling there was no systemic immune 
response to H7, and therefore that it was unlikely that the donor animals 
were colonised with E. coli O157:H7 at this time. The IgA immune response is 

















Fig. 6.9. Dilution series of samples from cattle tested for serum H7 - specific IgA by 
ELISA. All cows tested by this method were negative for serum H7 - specific IgA responses. 
The O.D. at 492 nm for all the animals tested was below the level of the negative control. 
Negative and positive serum samples, gifted by Dr. T. McNeilly were from challenged 




Using four strains each of E. coli O157:H7, ETEC and commensal E. coli 
strains, the results following challenge of moDCs yielded some interesting 
differences. At this MOI the E. coli O157:H7 strains and one commensal strain 
(MCI 0483) appeared to affect the viability of the moDCs when visually 
examined. With all other strains no effect on viability by visual examination 
was discovered. In order to investigate this phenomenon in more depth, the 
challenge was repeated in four animals in total, images of the cells were 
taken and the cells were subjected to a viability test using the MTT assay. The 
results were very similar for all the animals studied. Visually the cells 
challenged with the O157:H7 strains and also commensal strain MCI 0483 
were affected, while the remaining strains left the moDCs activated but still 
viable, and recognisable as DCs. One difference within the O157:H7 strains 
became clear. MCI 0279, originally known as the TT12B strain (Feng et al., 
2001), did produce changes in the moDC morphology and viability, although 
the effects were not as pronounced as with the other O157:H7 strains and did 
not affect the entire cell population. A proportion of cells retained normal 
activated morphology. The MTT assay in practice confirmed the microscopy 
results. Significant reductions in viability were found for O157:H7 strains, 
MCI 0010, 0191 and 0200 as well as the commensal strain MCI 0483. No 
significant reduction in viability was noted for MCI 0279, the commensal 
strains MCI 0430, 0465 & 0490, or any of the ETEC strains.  
This suggests that interaction with DCs is substantially affected by E. coli 
pathotype. O157 strains are typified by TTSS and it has been reported that 
some ruminants are colonised asymptomatically by LEE-positive E. coli 
pathotypes (Aktan et al., 2004). Therefore, it is possible that MCI 0483, despite 
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possessing known virulence factors, could still function as a bovine avirulent 
strain and the rigid parameters for bovine ‘commensal’ strains employed by 
this study may be too narrow to represent the true in vivo situation. 
 
Intimin is encoded by the gene eae which is found within the LEE5 operon of 
the LEE. Intimin is an outer membrane protein of EHEC which is important 
for attachment to the host cells by its interaction with its receptor Tir. Tir is 
secreted by the bacterium through the TTSS apparatus and embeds within 
the host cell membrane enabling the intimate attachment with A/E lesions to 
occur, and the formation of microcolonies (Kenny et al., 1997; Kenny & 
Finlay, 1997). Intimin and Tir are two of the bacterial components currently 
being studied with respect to production of an O157:H7 vaccine (Amani et al., 
2010; McNeilly et al., 2010b). EscN is a protein encoded for by the LEE3 
operon. It functions by hydrolysis of ATP to produce energy for the TTSS 
(Garmendia & Frankel, 2005). The structure and function of the TTSS is 
discussed further in Chapter 1.  
To investigate further a potential role for the TTSS in these moDC phenotype 
differences, PCR was carried out for the genes for intimin (eae), and TTSS 
(escN) in all the bacterial strains. The PCR results went some way to 
confirming the hypothesis.  All of the O157:H7 strains and the commensal 
strain 0483 were PCR-positive for both eae and escN. This indicates that the 
reduced moDC viability following challenge is related to the TTSS.  
 
The differing moDC viability that were discovered between the TT12B strain 
(MCI 0279) and the other O157:H7 strains could also be caused by TTSS 
effects. When preparations of secretomes from all the O157:H7 strains used 
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in this work were made by TCA precipitation of E. coli secreted proteins  the 
TT12B strain appeared to have reduced secretion of the TTSS components 
EspA and EspB. (Dr. D. Fraser-Pitt, Personal Communication) This lends 
further weight to the argument that the TTSS is of great importance during 
the interactions of E. coli strains and bovine DCs. 
 
The commensal strains were selected from a concurrently running study in 
which a colleague sampled and characterised E. coli strains from the bovine 
intestinal tract and carried out laboratory tests for numerous virulence 
factors, including VT, Intimin and TTSS to assign strains into commensal and 
pathogenic groups. At the time the commensal panel of bacteria were 
selected for this study, no virulence factors had been positively identified in 
any of these strains; it was only after the moDC challenges had commenced 
that the strain 0483 was found to be positive for eae and escN by PCR 
(confirmed by this study). So by the definition used for this study, E. coli 
strain MCI 0483 does not belong in the group alongside avirulent, 
commensal strains. The definition of a commensal strain for this study was: 
an E. coli strain present in moderate numbers in several intestinal locations in 
more than one animal which has not been identified to be carrying any 
virulence factor genes. During the rest of this discussion, strain MCI 0483 is 
excluded from the group of commensal strains. 
 
The fact that comparable numbers of ETEC and commensal strains did not 
cause the cellular killing seen with the O157:H7 strains at this MOI, suggests 
that it is not merely the numbers of bacteria, or quantity of bacterial 
components (LPS or flagellin for example) or the bacterial growth rate during 
the challenge time that overwhelms the moDCs as these were comparable for 
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all the strains. The bacterial growth rates during challenge were investigated 
in Chapter 4 and although the O157:H7 strains tended to reach O.D. readings 
nearer the top of the range recorded during the two hour challenge period, 
the strain that reached the highest O.D. overall was a commensal strain MCI 
0490. MCI 0483 which produced a pronounced killing effect had one of the 
lower final O.D. readings. So although it is important to consider the varied 
growth rates of the bacterial strains during the challenge period, it cannot 
account for the results generated here.  From the results presented here it is 
most likely that the presence of bacterial TTSS accounts for the differences 
observed in moDC viability. The role of the TTSS in the viability of the 
moDCs at this MOI is very interesting and could be the key to our 
understanding of the immune responses of cattle to E. coli O157:H7. The 
EHEC TTSS has been confirmed to be essential for colonisation in this species 
(Dean-Nystrom et al., 1998; Naylor et al., 2005a) and although this strain does 
not cause clinical disease in cattle it clearly makes use of this virulence factor 
to colonise and persist in this host and therefore disseminate further. The 
finding that TTSS PCR-positive strains induced killing of moDCs at MOI 100, 
whereas TTSS PCR-negative strains did not indicates the potential role for 
DCs in the colonisation of cattle by O157 in vivo. It is clear that the TTSS 
modulates DC function and viability demonstrating the potential 
significance of DCs in O157 colonisation and perhaps other LEE-positive E. 
coli. DCs are integral in generating immune responses to pathogens 
(Steinman, 1991), and if these vital immune cells can be killed by bacteria in 
vivo, as demonstrated here in vitro it could greatly reduce the rate of bacterial 
elimination and promote persistence within the hosts. This possibility would 




In the pilot experiment with the live bacteria compared to killed EHEC the 
different effect observed during challenge was marked. Replicates would 
enable this result to be confirmed, nonetheless, it does indicate that a live 
bacterium is required to effect the changes in viability observed in the 
moDCs. This could also be related to the TTSS because a killed bacterium is 
unable to secrete proteins via the TTSS structure. The killed bacteria are still 
‘sensed’ by the moDCs as they take up a more activated morphology. This 
correlates with research into Salmonella where the moDCs still recognise 
killed Salmonella as characterised by phenotypic changes in expression of cell 
surface molecules (Norimatsu et al., 2004).  
 
The method of moDC death in this study is presumed to be apoptotic as this 
has been found in other studies (Alileche et al., 2005; Falcone et al., 2004). 
Apoptosis also indicated by the changes in morphology noted on visual 
examination (rounding and loss of dendrites) however, further more 
definitive tests would be required for confirmation such as electron 
microscopy and FACS analysis for annexin V labelling. 
 
Research has indicated that around 10% of cattle could be asymptomatically 
colonised with E. coli O157:H7, (discussed in (Gansheroff & O'Brien, 2000)), 
and that serum response (IgA) to H7 can be used as a correlate of 
colonisation (McNeilly et al., 2008). Selected donor animals were assessed 
serologically for IgA specific to H7. Excretion of E. coli O157:H7 in the 
majority of colonized animals usually occurs for less than a month (Besser et 
al., 1997), and the half-life of serum IgA is a matter of days so it is unlikely 
that serum responses occur for weeks after colonization is resolved (Butler et 
al., 2006). A proportion of animals may be colonized for longer periods of 
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time however and discussion of the consequences of E. coli colonization and 
the outcomes for affected animals is discussed in further depth in Chapter 1. 
 
Where it was practical to do so, serum samples were tested for H7 specific 
IgA, and all were negative. IgA responses from all the animals could have 
been checked at time points throughout the study possibly with concurrent 
faecal sampling for E. coli O157:H7 strains to assess whether colonisation 
affected the in vitro results. In reality this was not a practical option though 
and also was not the aim of this study, although it is a factor which should be 
taken into consideration. This type of sampling also would not rule out 
concurrent infections or pathologies caused by other organisms, and it would 
be impractical to carry out numerous clinical tests before each set of moDCs 
was generated. As a general rule the animals were only used for sampling if 
they appeared clinically healthy as determined by non-invasive methods. 
During the length of time over which this study was carried out, several 
animals were euthanized for unrelated reasons and therefore serum samples 
from all animals were not available at the time of testing. However, because 
the presence of serum H7 specific IgA is a transient response, the possibility 
that the animals had been exposed to and colonised with E. coli O157:H7 at 
some point during this study cannot be excluded. The other two groups of 
animals that were unable to be tested in this way equally could have been 
colonised with EHEC at some time during the study and it is possible that 
this could account for the varied responses of the moDCs to E. coli strains in 
vitro. Concurrent colonisation of the donor animals with EHEC, or indeed 
infection with other pathogens could potentially affect the responses of the 
moDCs in vitro and attempts should be made to eliminate this where possible 
although much further work in this field would be required to confirm the 
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precise nature of effects, and would be beyond the scope of a project such as 
this. 
 
The results from the WT and ∆TTSS challenge in this chapter indicate that 
bovine moDC responses are subject to animal variation. Research using 
bovine hosts can be complex in several ways. Firstly, compared with the 
availability of reagents for murine or human research there are many fewer 
existing reagents and protocols with confirmed efficacy for the veterinary 
researcher. Also, in many ways there can be greater diversity in responses 
from animal species than with human or inbred murine strains. As shown in 
Chapter 3, there was great animal to animal variation in the quality of the 
tissue cell preparations and cell numbers recovered and although these 
differences were not confirmed to be due to individual animal factors, it 
must be a likely consideration. Also, Chapters 4 and 5 indicate that although 
trends in responses between cows may be similar, that the magnitude of 
responses can be very disparate. Furthermore, concurrent research has 
shown that bovine monocytes from approximately 60% of cattle tested 
responded to VT challenge by producing cytokine, with the remaining 40% 
not responding in this way. These animals were sourced from different 
geographical locations and rearing systems and were of varied breed, age 
and sex, and none of these factors correlated with the divergent responses 
observed. (Dr. P. Cameron, personal communication)  In addition those 
results were obtained from numerous donor animals which included some of 
the same animals used in this study. It has been put forward that the 
differences noted could be due to genetic differences and to the 
heterogeneous genetic nature of integral immune components such as 
pattern recognition receptors (PRR) in bovine hosts (Seabury et al., 2010). 
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Prior exposure to unknown stimuli, or concurrent sub-clinical infections in 
some of the donor animals could also be a consideration. A definitive reason 
for these animal differences would be difficult to confirm. None of the MRI 
cows were positive for H7-specific IgA suggesting that they were free from 
EHEC colonisation. It would be an advantage to replicate the study here with 
larger numbers of donor animals selected from outbred populations of cattle 
which have a more defined immune status. 
 
To summarise the findings in this chapter, DC responses vary considerably 
with E. coli pathotypes.  This study shows that E. coli O157:H7 strains kill 
moDCs in vitro. One E. coli strain, isolated from a clinically normal animal 
indicating strain avirulence, was VT-negative and LEE positive and was also 
found to kill moDCs. These results indicate that the TTSS is important and 
may play a significant role in vivo in modulating DC activity and promoting 
colonisation by LEE positive strains, at DC-rich sites. It has been published 
that macrophages can be killed in a TTSS dependant manner by other 
organisms in vitro including Yersinia, Psudomonas and Shigella strains (Hauser 
& Engel, 1999; Mills et al., 1997; Schroeder et al., 2007). No publications to 
date have been found which extend these findings to dendritic cells or E. coli 
strains. Therefore the results presented here corroborate the importance of 
TTSS with respect to the viability of APCs following infection but more 
importantly show a novel consequence of DC and EHEC interactions in vitro. 
The work presented here strongly indicates a role for the EHEC TTSS in 
colonisation of the bovine host by affecting the viability of the DCs and 





















7.1 Summary of Project Objectives 
E. coli O157:H7 is a pathogen which has serious effects on human health. 
Ruminants have been identified as a significant reservoir for this strain and 
within the bovine intestine it shows tropism for the terminal rectal tissues 
(Naylor et al., 2003). These terminal rectal tissues are characterised by the 
presence of numerous lymphoid follicles which contain important immune 
cell types. Cattle are not clinically affected by colonisation with this 
organism, and thus they can contribute to spread of EHEC into the 
environment, directly to humans following contact and also into food and 
water sources.  Both bacterial and host factors may play significant roles in E. 
coli O157:H7 colonisation persistence and excretion by cattle. Bacterial factors 
have been examined extensively but there is much less literature regarding 
potential host factors involved. In particular, there are few reports describing 
the interactions of E. coli O157:H7 with systemic or mucosal immune cells.  
As significant mucosal immune cells, DCs play a key role in directing 
immune responses towards Th1, Th2 or tolerance and these cells are the 
focus of this project. The aims of this study were to: 
 
1. Characterise the immune cells in the tissues of the bovine large 
intestine at several locations, including the terminal rectum, with a 
focus on DC populations (Chapter 2). 
2. Develop a protocol to extract DCs from the terminal rectum tissues for 
further characterisation and downstream investigations (Chapter 3). 
3. Characterise a bovine moDC culture system and investigate the 
reactions of these cells with bacterial virulence factors including LPS, 
VT2 and H7 flagellin (Chapter 4). 
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4. Investigate the responses of moDCs to various E. coli strains at low 
and high MOI, to include measuring cytokine responses, changes in 
cell surface molecule expression, viability, phenotype and bacterial 


























7.2 General Discussion 
The tissue tropism of E. coli O157:H7 to the bovine terminal rectum has been 
documented (Naylor et al., 2003) but the reasons for this colonisation pattern 
have not yet been fully elucidated. This project aimed to investigate bovine 
DCs, as a cell type expected to be found in this anatomical location, which 
could provide insight into the asymptomatic carriage of EHEC by cattle. As 
cells which have central roles in directing immune responses to encountered 
organisms and which are closely associated with epithelial layers, DCs are 
very likely to interact with E. coli O157:H7 within the terminal rectum of the 
bovine host, and therefore it is likely that the intestinal DCs play a key role in 
the persistence and colonisation of ruminants by this organism. It is 
important to characterise the cell types which are potentially involved in the 
interaction with bacteria in vivo to try to develop methods of intervention 
which can ultimately reduce carriage by the cattle population and 
subsequent human infections. In vitro work characterising the intestinal DC 
populations and DC interactions with cultured cells and E. coli O157:H7 is 
the first step to understanding the in vivo situation, and is of importance to 
supplement knowledge of bovine cellular immunology as well as to provide 
a basis for future studies, which could generate these effective control 
strategies. 
 
The work in this thesis has provided several main findings of potential 
significance to factors affecting bovine colonisation with E. coli O157:H7. 
 
Firstly, the cell types within the intestinal tissues including the terminal 
rectum of cattle were investigated. IHC at several sites showed widespread 
immune cells throughout the intestine, and these occurred with greater 
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frequency at areas populated by lymphoid follicles. Using the working 
definition of large irregular cells expressing MHC II as DCs, as used by 
numerous other studies, many DCs were identified within the bovine 
intestine. A number of molecules which have been reported to be expressed 
by DCs were also investigated. High level expression of MHC II, and CD205 
and CD40 in particular, was observed within all tissues and notably within 
the follicles, suggesting numerous immune cell types in this area. 
Considering the morphology of the positively stained cells it was clear that a 
significant proportion of these cells were DCs. Other molecules 
demonstrated different expression patterns within the tissues; SIRPα and 
CD1b were found to be expressed at much lower frequency in follicle cell 
populations but strong expression of both of these molecules were observed 
around the follicle periphery. It is not clear whether these cells were co-
expressing CD1b and SIRPα and further co-localisation studies would be 
required to confirm this possibility. However co-localisation of MHC II was 
observed on large irregular cells expressing CD205, CD1b and SIRPα, and 
significant differences were observed when expression patterns were 
investigated with respect to intestinal site. The significance of different cell 
populations found at these anatomical sites suggests the host’s 
microenvironment including antigen availability; cellular receptors and 
chemokines are indeed varied at these sites and could impact on the ability 
of various pathogens to colonise at these different areas within the intestine. 
Although specific subsets of DCs could not be definitively characterised, the 
varied expression patterns suggests that subsets do exist in the bovine 
intestine as has been identified in numerous other species and tissues. This 
was the first study of these cell types in the tissues of the bovine large 
intestine and has provided working protocols and a preliminary 
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characterisation of these cells, which future work will be able to successfully 
build upon. 
 
Some intriguing findings resulted from the experiments which investigated 
the dynamics of intracellular bacteria. It was revealed that an E. coli O157:H7 
strain was found in greatly reduced numbers within moDCs compared to 
both an ETEC and a commensal strain, at all times during a period of study 
(36 h). The highest numbers of viable intracellular bacteria were found for 
the commensal strain, and these numbers remained high until 12 h post 
challenge after which time the numbers declined to near comparable levels 
with the ETEC strain. The ETEC and O157 strain both maintained their 
intracellular numbers up to the 36 h limit of the study. This could have 
important implications for the interaction of E. coli O157:H7 and DCs in vivo 
as discussed (Section 5.4). These findings indicate that O157 appears to 
suppress its own uptake by DCs as well as resist intracellular killing. 
Resistance of phagocytosis as well as prolonged intracellular survival could 
both be important factors promoting persistence within hosts. Further work 
is required to confirm these novel findings and to assess any correlation with 
the presence and dynamics of intracellular of E. coli O157:H7 in vivo.  
 
Bacterial killing of immune cells is an important mechanism whereby it may 
be possible for pathogens to evade immune responses. The work in chapter 
six revealed that E. coli strains were able to kill moDCs in vitro in a dose-
dependent manner. This killing also appeared to be linked to the presence of 
TTSS within these strains. Although the TTSS has been shown to be 
important in colonisation with EHEC (Dean-Nystrom et al., 1998; Naylor et 
al., 2005b) this is the first time that the TTSS has been implicated in this way 
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in the bovine host with respect to the viability of DCs and points to a 
potential role for DCs in the colonisation of cattle by O157 in vivo. It is clear 
that the TTSS modulates DC function and viability and because DCs are key 
cells directing immune responses (Steinman, 1991) the possibility that these 
immune cells can be killed by bacteria in vivo, as demonstrated in this work 
in vitro it could significantly affect bacterial carriage within the intestine by 
potentially reducing the rate of bacterial elimination.  
 
Throughout this work animal to animal variation affected the reliability of 
the results. Not only were tissues variable between cows, with respect to the 
ease of collecting ex vivo cells, but also in the responses of the blood-derived 
cells to bacterial agonists and whole bacteria. Often moDCs responses 
followed the same trend but with greatly differing magnitude, however there 
were also occasions where even the responses were disparate. This variation 
meant that although sometimes trends could be observed, statistical 
significance could not be placed on a number of these results. The small 
sample sizes also reduce the significance of any data collected. It would be 
important to take these animal variations into account if at all possible when 
planning future experiments. This could be possible in a number of ways, 
either to use larger sample sizes to try to observe more consistent trends in 
data sets, or to assess the responses of the animals and select animals for 
further study which tend to respond similarly. Although this second method 
does exclude data, it could reduce the number of animals used for 
experiments in which data sets are so disparate that nothing relevant can be 
concluded. Problems with disparate animal data have been experienced by 
many researchers working in the field of ruminant research; however this 
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does not tend to be a problem encountered by colleagues working in murine 
and human research fields. 
 
A further practical aspect affecting the generation of large quantities of data 
from bovine systems is the relative lack of specific reagents and protocols. 
Although numerous groups are involved in the investigation of bovine 
cellular responses, new reagents only infrequently become available. It is 
hoped that in the future bovine research will become an even more active 
area as further reagents and protocols are developed. 
 
An important point of note is that epithelial cells will play an important role 
in the interactions between DCs and bacteria in vivo both as a structural 
barrier between these cells and as secretors of various signalling molecules, 
and these factors have not been taken into account in these experiments. It 
would be important to develop the moDC culture further to include co-
culture techniques or challenges with epithelial cell supernatants or 
migration assays. However, there is to date no well-characterised bovine 
intestinal cell line with which to co-culture the moDCs so the use of complex 
primary cell extraction techniques would have to be employed, this no doubt 
would require significant time to be spent optimising suitable conditions, 
before it could be used for challenges.  Indeed, previous attempts within the 
group to generate immortalised bovine intestinal epithelial cells proved 
complex and were ultimately unsuccessful.  
 
In conclusion, the data presented within this thesis puts forward several 
novel findings relevant to the interaction of E. coli O157:H7 with DCs and 
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opens up several important areas of work for future studies that could lead 








7.3 Conclusions and future areas for study 
In Chapter 2, Immunohistochemistry (IHC) techniques were carried out in 
bovine intestinal tissues.  Cells expressing surface molecules characteristic of 
dendritic cells (DCs) were identified.  This was the first IHC survey of these 
cell types within the bovine intestine. Cells with DC characteristics were 
distributed throughout the intestinal tract, and occurred more frequently in 
lymphoid follicle-dense regions.  These observations were consistent with 
those obtained in other studies in other species. The terminal rectal mucosa 
was richly-populated with cells of DC phenotype, and co-localisation of 
immune cell molecules was observed. However, further investigation 
perhaps utilising three colour IHC techniques could be used to confirm 
further co-localisation of surface molecules characteristic of DCs. A relevant 
future IHC study would be to compare DC populations in the terminal 
rectum of O157:H7 colonised cattle with those within O157:H7 negative 
tissues. This would be useful to observe any effect that colonisation has on 
the cellular expression and anatomical locations of the DCs.  
 
Chapter 3 appraised enrichment and culture protocols for ex vivo terminal 
rectal DCs to facilitate characterisation of these cells as well as the study of 
bacterial DC interactions. However, these techniques produced inconsistent 
cell yields which were insufficient to use routinely. Further work is required 
to build upon the techniques developed here. If cells could be collected from 
these tissues consistently then a FACSort system for collected cells could 




Chapter 4 established derivation of DCs in vitro from blood monocytes 
(moDCs) as a reproducible procedure, and confirmed the phenotypic 
characteristics of these cells to conform to published parameters. The bovine 
moDCs were also challenged with various bacterial agonists; however these 
experiments were hampered by technical difficulties. In contrast to published 
work detectable TLR5 transcripts were not found in the moDCs and further 
investigation of this feature should be carried out to compare the effects of 
culture time and also to collect data from more animal donors. 
 
In Chapter 5 the in vitro cultured moDCs were challenged with various E. coli 
strains.  O157:H7, bovine ETEC and bovine commensal E. coli challenges of 
bovine moDCs in vitro all led to cellular changes consistent with DC 
activation. These bacterial pathotypes showed diverse outcomes with respect 
to internalisation and intracellular survival. An O157:H7 isolate was least 
efficiently internalised by moDCs whereas a commensal strain was 
internalised at significantly higher numbers. Viable bacteria of all strains 
survived for extended periods within moDCs, however, only the numbers of 
intracellular commensal E. coli began to decline after 12 h, in contrast to the 
numbers of O157:H7 and ETEC which remained relatively constant up to 36 
h. This was an important feature of moDC-bacterial interaction and an 
important area for further work would be to address determinants of 
resistance to phagocytosis and intracellular killing. The TTSS should be one 
such target, to assess any role for TTSS specific effectors in these cellular 
events. In addition to adding biological replicates to the data sets it would 
also be useful to employ techniques to investigate the intracellular bacteria 
further. IHC and FACS would be useful for visualisation and localisation of 
the intracellular bacteria and to assess the numbers of cells affected at each 
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time point and whether bacterial multiplication can occur within moDCs. A 
longer time course would also be of interest to assess how long E. coli strains 
are able to survive the moDC intracellular environment. Repetition of this 
experiment with other strains may be able to validate attribution of these 
differences to pathotype rather than purely an effect of strain selection. 
 
The work in Chapter 6 investigated the role of MOI in bacterial challenges 
and discovered that E. coli O157:H7 showed dose-dependent killing of 
bovine moDCs in what appeared to be a TTSS-dependent manner.  These 
experiments were affected by animal variations and further work would be 
required to fully elucidate the moDC killing by E. coli O157:H7. 
 
To conclude, this work has shown that the contact of E. coli O157:H7 with 
DCs in situ is likely and furthermore that O157 has systems to overcome DCs 
by inhibiting cellular uptake and preventing or delaying intracellular killing. 
Manipulation of the interaction between O157 and DCs in vivo  represents a 
means by which host response could be targeted to reduce or eradicate E. coli  
O157:H7 in cattle and in consequence reduce the public health impact or 
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A.1 Antibodies used in this study 
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A.2  Details of animals used as blood donors for moDC cultures in this study. IAH: Institute of Animal Health, Compton; M: Male (castrated);  
EBVC: Easter Bush Veterinary Centre; MRI: Moredun Research Institute 
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Number Serotype (Original Designation) Original Supplier Verotoxin Pathotype   
 
MCI 0010 E. coli O157:H7 (WallaWalla3) M. Reynolds, Emory University, Atlanta - EHEC 
 
 
MCI 0045 E. coli O157:H7 (EDL933) G. Pόsfai, Institute of Biochemistry, Szeged, Hungary VT1 & VT2 EHEC 
 
 
MCI 0066 E. coli O157:H7 (WallaWalla1) M. Reynolds, Emory University, Atlanta VT2 EHEC 
 
 
MCI 0132 E. coli O9:K30 (EC46/04) R. M. La Ragione, VLA Weybridge - ETEC 
 
 
MCI 0191 E. coli O157:H7 (85-170) M. Stevens, IAH Compton - EHEC 
 
 
MCI 0200 E. coli O157:H7 (TUV933-0) D. Miller, Bristol University - EHEC 
 
 
MCI 0201 E. coli O157:H7 (∆OI148A) D. Miller, Bristol University - EHEC 
 
 
MCI 0218 E. coli O157:H7 (84-289) M. Stevens, IAH Compton VT1 & VT2 EHEC 
 
 
MCI 0279 E. coli O157:H7 (TT12B) D. Gally, Edinburgh University - EHEC 
 
 
MCI 0430 E. coli Or4:H37 E. Clark, MRI - Commensal 
 
 
MCI 0465 E. coli O103:H36 E. Clark, MRI - Commensal 
 
 
MCI 0483 E. coli O26:H47 E. Clark, MRI - Commensal 
 
 
MCI 0490 E. coli Or7:H+ E. Clark, MRI - Commensal 
 
 
MCI 0688 E. coli O9:K+ (EC219/06) R. M. La Ragione, VLA Weybridge - ETEC 
 
 
MCI 0690 E. coli O101:K30 (ED357/06) R. M. La Ragione, VLA Weybridge - ETEC 
 
 
MCI 0693 E. coli O101:K30 (EC546/05) R. M. La Ragione, VLA Weybridge - ETEC 
  
 
A.3 Bacterial strains used in this study. MCI: Microbial and cellular interactions; EHEC: Enterohaemorrhagic E. coli; VT: Verotoxin;  ETEC: Enterotoxigenic E. coli; 
IAH: Institute of Animal Health; MRI: Moredun Research Institute; VLA: Veterinary Laboratories Agency. 
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A.4. Solutions & Buffers 
A.4.1 ELISA Reagents 
A.4.1.1 H7 ELISA Coating buffer  
 
0.5 M Carbonate buffer (1.59 g Na2CO3, 2.93 g NaHCO3) 
Make up in 1L dH2O, pH to 9.6 
 
A.4.1.2. H7 ELSIA Wash buffer 
 
PBS 
0.05% Tween 20 (PBST20) 
 
A.4.1.3 H7 ELISA Blocking buffer 
  
PBS 
3% v/v fish gelatin (Sigma G7765)  
 
A.4.1.4 H7 ELISA Reagent Dilution buffer 
PBS 
0.5% Tween 80 
0.5 M NaCl (PBST80NaCl)  
 
A.4.1.5 IL-8 ELISA Reagent Diluent 
0.1% w/v BSA 
0.05% v/v Tween 20  
Make up in Tris-buffered saline (20 mM Trizma base, 150 mM NaCl)  
pH to 7.2 – 7.4 
 
A.4.1.6 TMB substrate solution 
0.1 M Sodium Acetate solution (titrated to pH 6 with 0.1 M citric acid solution)  
1% v/v 10mg/ml TMB in DMSO 






A.4.2 Cell and Tissue Culture solutions 
A.4.2.1 Cell culture medium – CCM 
 
DMEM (D6546, Sigma)  
2 mM Glutamine 
10% v/v FBS 
 
A.4.2.2 Phenol Red-free cell culture medium 
 
Iscove’s Modified Dulebcco’s Medium (IMDM, Invitrogen, 21056-023) 
2 mM Glutamine 
10% v/v FBS 
 
A.4.2.3 Tissue culture medium – TCM 
 
RPMI 1640 with Glutamax I & HEPES buffer 25 mM (Invitrogen),  
100 U/ml Gentamicin (Sigma)  
10% v/v FBS 
5 x 10-5 M β-Mercaptoethanol (β-ME) 
 
A.4.2.4 Dendritic cell tissue culture medium - DC-TCM 
 
TCM 
0.2 U/ ml GM-CSF (IAH, Compton) 
200 U/ml recombinant bovine IL-4 (Moredun Research Institute)  
 
A.4.2.5 Digestion Medium 
 
DMEM (D6546, Sigma) 
1% v/v FBS  
50 μg/ml Gentamicin,  
100 U/ml Penicillin  
30 μg/ml Streptomycin 
75 U/ml Collagenase &  
20 μg/ml Dispase I  









100 g/L Sodium dodecyl sulfate (SDS) in 0.01 M HCl and 1 g SDS 
 
A.4.2.7 FACS Buffer 
PBS 
1% w/v  BSA 
0.1% Sodium Azide (NaN3) 
 
A.4.3 SDS-PAGE Reagents 
A.4.3.1 SDS-PAGE Resolving Gel 
 
10% w/v Acrylamide:N,N’-methylenebisacrylamide (37.5:1) 
375 mM Tris (, pH8.8),  
0.1% w/v SDS  
0.025% w/v ammonium persulphate (APS) 
0.005% v/v N,N,N’,N’-tetramethylethyldiamine (TEMED) 
 
A.4.3.2 SDS-PAGE Stacking gel 
 
10% w/v Acrylamide:N,N’-methylenebisacrylamide (37.5:1),  
125 mM Tris (pH6.8),  
0.1% w/v SDS 
0.1% w/v APS  
0.14% v/v TEMED  
  
A.4.3.3 SDS-PAGE Running Buffer 
 
250 mM Tris, pH 6.8,  
192 mM glycine,  
0.1% SDS,  










A.4.3.4 SDS-PAGE Reducing sample buffer 
 
250 mM Tris, pH 6.8,  
40% v/v glycerol,  
8% w/v SDS,  
520 mM dithiothreitol (DTT), 
  0.01% w/v bromophenol blue 
 
A.4.4 Western Blotting Reagents 
A.4.4.1 Electoblotting Transfer Buffer 
 
25 mM Tris,  
192 mM Glycine,  
20% methanol  
Make up required volume in dH2O 
 
 
A.4.4.2 Western Blot Blocking Buffer 
 
PBS 
0.5 M NaCl  
0.5% v/v Tween 80 (Sigma) 
 
A.4.5 Cellular stains and Tissue Fixatives 
A.4.5.1 Sorensen’s buffer 
 
49ml of Na2HPO4 (0.06 M) and  
51 ml of KH2PO4 (0.06 M) 
Combine prior to use and titrate to pH 7.2. 
 
A.4.5.2 Zinc Salts Fixative - ZSF 
 
0.1 M Tris base buffer  
0.05% w/v calcium acetate (pH 7.0 – 7.4) 
0.5% w/v zinc acetate and zinc chloride. 
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A.4.6 Solutions for Molecular Techniques 
A.4.6.1 TAE Buffer 
 
40 mM tris-acetate pH 8.0  
1 mM EDTA  
Make up required volume in dH2O 
 
 
 
 
 
